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 Review of the Literature 
REVIEW OF THE LITERATURE 
 
1. The genus Helicobacter 
Since the description of the human pathogen Helicobacter pylori (Warren and Marchal, 1984; 
Goodwin et al., 1989), the number of known species in the genus Helicobacter has been 
increasingly enlarged. Currently this genus includes more than 40 identified species as shown 
in Table 1. The Helicobacter bacteria can roughly be divided into gastric and enterohepatic 
species. Gastric Helicobacter species are able to survive the acidic environment in the 
stomach by expressing urease at a high level (Weeks et al., 2000; Pot et al., 2007). 
Enterohepatic species thrive in the mucosal surfaces of the intestinal tract and/or the liver 
(Sterzenbach et al., 2007). Several of these animal-associated helicobacters have a pathogenic 
potential in different animal hosts and some are able to cause disease in humans (Table 1). 
The Helicobacteraceae family has the possibility to expand into new hosts as the intimate 
contact among different animal species and between animals and humans increases creating 
the opportunity for interspecies transmission and new strain formation. The presence and 
diversity of helicobacters in the vertebrate fauna and their transfer possibilities between hosts 
are critical factors on how fast the Helicobacter ecology will evolve and what their impact is 
on animal and human health (Schrenzel et al., 2010).  
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Table 1: Helicobacter spp. and their hosts (adapted from Flahou et al., 2016) 
Taxon Animal hosts Zoonotic  potential? 
Gastric Helicobacter spp. 
“Candidatus H. bovis”a cattle Yes 
“Candidatus H. homininae”a chimpanzee, gorilla Unknown 
H. acinonychis cheetah, tiger, lion Unknown 
H. ailurogastricus cat Unknown 
H. baculiformis cat Unknown 
H. bizzozeronii cat, dog Yes 
H. cetorum whale, dolphin Unknown 
H. cynogastricus dog Unknown 
H. felis dog, cat, cheetah,            Yes 
 new Guinea wild dog,   
 rabbit  
H. heilmannii dog, cat, cheetah, Yes 
 bobcat, tiger, lynx  
 leopard, puma  
H. mustelae ferret Unknown 
H. pylori human / 
H. salomonis cat, dog, rabbit Yes 
H. suis pig, mandrill monkey,  Yes  
 rhesus macaque,   
 crabeating macaque  
Taxon Natural hosts 
Zoonotic  
potential? 
Enterohepatic Helicobacter spp. 
“Candidatus H. colifelis”a cat Unknown 
H. anseris goose Unknown 
H. aurati hamster Unknown 
H. bilis mouse, rat, gerbil, dog,            Yes 
 cat, sheep  
H. brantae goose Unknown 
H. callitrichis marmoset Unknown 
H. canadensis bird, pig Yes 
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H. canis dog, cat Yes 
H. cholecystus hamster Unknown 
H. cinaedi hamster, rat, cat, dog,  Yes 
 rhesus monkey, baboon  
H. equorum horse Unknown 
H. fennelliae dog Yes 
H. ganmani mouse Yes 
H. hepaticus mouse, gerbil Yes 
H. macacae rhesus monkey, baboon Unknown 
H. marmotae woodchuck, cat Unknown 
H. magdeburgensis mice Unknown 
H. mastomyrinus rodents Unknown 
H. mesocricetorum hamster Unknown 
H. muricola wild mouse Unknown 
H. muridarum mouse, rat Unknown 
H. pamatensis bird, pig, cat Yes 
H. pullorum poultry Yes 
H. rappini mouse, sheep, dog Yes 
H. rodentium mouse, rat Unknown 
H. sanguine cotton-top tamarin Unknown 
H. suncus house musk skrew Unknown 
H. trogontum rat, pig, sheep Unknown 
H. typhlonius mouse, rat Unknown 
H. valdiviensis wild birds Unknown  
H. westmeadii human / 
H. winghamensis human, wild rodents Yes 
a These Helicobacter species have not yet been isolated and cultivated in vitro. 
 
2. Gastric Helicobacter species in humans and animals 
H. pylori is the most prevalent Helicobacter species in the stomach of humans and has been 
considered as one of the most successful human pathogens. This slightly-curved  
microorganism has been associated with a wide range of gastric disorders including, gastritis, 
peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma and cancer 
(Parsonnet et al., 1991; Stolte et al., 1993; Kusters et al., 1996; Ishaq & Nunn, 2015).  
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It is estimated that half of the human population in the world is infected with H. pylori albeit 
with large geographical variations. In developing countries, more than 80% is infected with H. 
pylori, whereas the prevalence rate of H. pylori in more developed countries varies from 20 to 
50% (Kusters et al., 2006; Pounder and Ng, 1995). This variation in prevalence can be 
explained by a combination of factors, such as the age at acquisition of infection, the type of 
H. pylori strain, the genetic profile and socioeconomic status of the host as well as 
environmental factors. H. pylori infections are frequently acquired during early childhood and 
the disease progresses with age (Suerbaum and Josenhans, 2007).  
 
 
Figure 1: Sequential steps of diseases resulting from H. pylori infection (Karczewska et al., 2014). The 
percentages of H. pylori-infected people developing a certain gastric pathology are indicated as well. Gastritis is 
localized mainly in the antral portion of the stomach (antrum-predominant gastritis) or potentially extending to 
the gastric corpus (corpus-predominant gastritis). There is a clear interaction between H. pylori-associated 
gastritis and gastric acid secretion. Predominant antral gastritis is associated with an increase in acid secretion 
and predisposes for duodenal ulceration. Patients with duodenal ulcers almost never develop gastric cancer. This 
finding may suggest that duodenal ulcers somehow provide a protective mechanism against gastric malignancy 
(Konturek et al., 2006; Figure 1). On the contrary, corpus-predominant atrophic gastritis is accompanied with a 
decrease in acid secretion. Humans showing this latter pathology have an increased risk to develop gastric cancer. 
The predisposition for developing gastric adenocarinoma involves the interaction of three major factors: the 
virulence of the pathogenic agent, the host immune system and environmental factors. 
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Most of the H. pylori infections in humans are asymptomatic and only 10-20% of the people 
carrying H. pylori will develop gastric symptoms later on in their lives (Kusters et al., 2006; 
Suerbaum and Josenhans, 2007). A schematic overview explaining the different gastric 
disease outcomes in humans induced by H. pylori infection is shown in Figure 1.  
However, H. pylori is not the only Helicobacter species causing gastric disease in humans. In 
the early years of H. pylori research, pathologists examining human gastric biopsies reported 
the presence of bacteria with a long spiral-shaped morphology. These microorganisms were 
similar to bacteria earlier reported in the stomach of pigs, cats, dogs and non-human primates 
(Salomon, 1898; Mendes et al., 1990; Queiroz et al., 1990) and have been found in 0.2 to 6% 
of gastric biopsies from humans with severe gastric complaints (Heilmann and Borchard, 
1991; Stolte et al., 1994; Svec et al., 2000; Solnick et al., 2003). They were originally referred 
to as “Gastrospirillum hominis” (McNulty et al., 1989). Analysis of the 16S rRNA gene of 
these non-H. pylori Helicobacter spp. (NHPH) resulted in their classification into the genus 
Helicobacter. They were renamed “H. heilmannii” after the German pathologist Konrad 
Heilmann who first studied the pathology associated with these helicobacters 
(Heilmann&Borchard, 1991).  Although the name H. heilmannii had at that time no official 
standing in nomenclature, for many years it was used to refer to the whole group of long 
spiral-shaped bacteria in the human stomach, which actually comprise several different 
Helicobacter species.  
 
2.1. Gastric non-H. pylori Helicobacter nomenclature, characteristics and phylogeny 
As a sequel to the renaming of “Gastrospirillum hominis” as “H. heilmannii”, further analysis 
of the 16S rRNA gene sequence resulted in the reclassification of these gastric helicobacters 
into “H. heilmannii” type 1 and “H. heilmannii” type 2. These 2 types differ by more than 3% 
in nucleotide sequence of the 16S rRNA gene. “H. heilmannii” type 1 is identical to H. suis, 
which naturally colonizes the stomach of pigs (Baele et al., 2008b; De Groote et al., 1999; 
O’Rourke et al., 2004b). H. heilmannii type 2 is more complex. It does not represent one 
single species, but rather a group of species naturally colonizing the canine and feline gastric 
mucosa, such as H. bizzozeronii, H. felis, H. salomonis, H. cynogastricus, H. baculiformis, H. 
heilmannii and H. ailurogastricus (Table 1; Haesebrouck et al., 2009; Smet et al., 2011; Baele 
et al., 2008a; Van den Bulck et al., 2006; Joosten et al., 2015). For H. ailurogastricus, H. 
cynogastricus and H. baculiformis, no information is available about their zoonotic potential 
in humans. The valid description of H. heilmannii as a species further added to the confusion 
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on the nomenclature of this complex and expanding group of microorganisms (Smet et al., 
2011). Therefore, the terms H. heilmannii (sensu lato), referring to the group of gastric NHPH, 
and H. heilmannii (sensu stricto), referring to the species, have been introduced (Haesebrouck 
et al., 2011).  
Although the porcine, feline and canine Helicobacter spp. all have a typical spiral shape, 
differences in morphology between these NHPH have been described. An overview is shown 
in Table 2. H. felis, H. cynogastricus and H. baculiformis possess periplasmic fibrils (Eaton et 
al., 1996; Van den Bulck et al., 2006, Baele et al., 2008a), while H. bizzozeronnii, H. 
heilmannii, H. ailurogastricus, H. salomonis and H. suis do not have these structures 
(Hänninen et al., 1996; Jalava et al., 1997; Baele et al., 2008b, Smet et al., 2011; Joosten et al., 
2015). H. felis, H. cynogastricus, H. bizzozeronii, H. heilmannii, H. ailurogastricus and H. 
suis are known to have very tight coils, whereas H. baculiformis and H. salomonis are rather 
slender, slightly spiral-shaped rods. These bacteria also differ from each other in cell length, 
number of spiral turns and bipolar flagella and their ability to hydrolyze biochemical 
substrates (Table 2).  
Besides the canine, feline and porcine gastric helicobacters, 3 other animal-associated 
Helicobacter spp., with a morphology more similar to that of H. pylori, have been described 
in the early 90s and the beginning of the 21st century. These include H. acinonychis from wild 
felines, H. cetorum from marine mammals and H. mustelae from ferrets (Paster et al., 1991; 
Harper et al., 2002; Eaton et al., 1993). Their presence in humans has so far not been 
described. An overview of the morphological and biochemical characteristics of H. 
acinonychis, H. cetorum and H. mustelae is presented as well in Table 2. 
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Table 2: Morphological and biochemical characteristics of gastric Helicobacter species. 
 Hh Hailuro Hfel Hbiz Hsal Hcyn Hbac Hsuis Hp Hacin Hcet Hmust 
 
Cell length (µm) 
Cell width (µm) 
 
3-6.5 
0.6-0.7 
 
3-5.5 
0.5-0.7 
 
5-7.5 
0.4 
 
5-10 
0.3 
 
5-7 
0.8-1.2 
 
10-18 
0.8-1.0 
 
10 
1 
 
2.3-6.7 
0.9-1.2 
 
2.5-5.0 
0.5-1.0 
 
1.5-2 
0.3 
 
4 
0.6 
 
2.5-5 
0.5 
Urease activity + + + + + + + + + + + + 
Nitrate production + + + + + + + - - - - + 
Alkaline phosphatase activity - + + + + + + + + + - + 
Hydrolysis of indoxylacetate - - - + + - - - - - - + 
Periplasmic fibril - - + - - + + - - - - - 
Growth at 42°C - - - + - - - - - - + + 
Flagella 
No. per cell 
Distribution 
 
4-10 
BP 
 
6-8 
BP 
 
14-20 
BP 
 
10-20 
BP 
 
10-23 
BP 
 
6-12 
BP 
 
11 
BP 
 
4-10 
BP 
 
4-8 
MP 
 
2-5 
MP 
 
1 
BP 
 
4-8 
peritrichous 
Hh = H. heilmannii (Smet et al., 2011), Hailuro = H. ailurogastricus (Joosten et al., 2015), Hfel = H. felis (Hänninen et al., 1996; Lee et al., 1988; Jalava et al., 1997), Hbiz = 
H. bizzozeronii (Hänninen et al., 1996), Hsal = H. salomonis (Jalava et al., 1997), Hcyn = H. cynogastricus (Van den Bulck et al., 2006), Hbac = H. baculiformis (Baele et al., 
2008a), Hsuis = H. suis (Baele et al., 2008b), Hp = H. pylori (Hänninen et al., 1996; Jalava et al., 1997), Hacin = H. acinonychis (Eaton et al., 1993); Hcet = H. cetorum 
(Harper et al., 2002), Hmust = H. mustelae (Paster et al., 1991). BP = bipolar, MP = monopolar. Urease, catalase, oxidase and γ-glutamyltranspeptidase activity was uniformly 
present; growth in the presence of 1% glycine was uniformly absent. Gastric Helicobacter spp. require a highly humidified micro-aerobic environment, consisting of 10% 
CO2, 5% O2 and 85% N2.   
14 
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Despite the difference in morphology among the gastric NHPH, microscopic investigation of 
biopsy samples is not an accurate method for species identification (Eaton et al., 1996). 
Analysis of the 16S rRNA gene sequence has frequently been used in the past for 
differentiation between gastric Helicobacter species (O'Rourke et al., 2004b). Though, 
sequencing of the 16S rRNA cannot distinguish between H. bizzozeronii, H. felis, H. 
salomonis, H. baculiformis, H. cynogastricus and H. heilmannii (Smet et al., 2011; Baele et 
al., 2008a; Van den Bulck et al., 2006; Dewhirst et al., 2005). For differentiation between 
those species, analyses of the urease A and B and the hsp60 gene sequences have been 
performed. The similarity of the ureAB genes from the canine and feline gastric helicobacters 
is lower than 85%, which allowed discrimination between these species (O’Rourke et al., 
2004b). However, it has been shown that the recently described H. ailurogastricus species 
from cats could not be distinghuised from its closest relative H. heilmannii by means of its 
16S rRNA and ureAB genes. This implicates that the discriminatory capacity of these gene 
sequences is not high enough for the distinction of closely related gastric Helicobacter species. 
In this respect, genome sequencing based approaches are superior compared to the traditional 
16S rRNA sequence analysis for studying phylogeny because they are based on the complete 
genome content and have a better resolution for discriminating both distantly and closely 
related bacteria (Vandamme, 2014). A phylogenetic tree based on the core genomes of all 
gastric Helicobacter spp. described so far is shown in Figure 2.        
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Figure 2: A phylogram representing the maximum-likelyhood tree of gastric Helicobacter spp.  based on 
aligned and concatenated core genes. The enterohepatic H. hepaticus species was used as outgroup. Three gastric 
cluster can be seen. One cluster comprises the porcine, canine and feline helicobacters, one comprises H. 
mustelae and one comprises H. pylori, H. acinonychis and H. cetorum (unpublished results). 
  
2.2. Animal-associated gastric Helicobacter infections in humans: clinical significance 
To date, evidence is accumulating that domestic animals constitute a reservoir for gastric 
Helicobacter spp. with zoonotic potential. A significant number of reports has revealed that 
people who have close contact with dogs, cats and pigs are more likely to be infected with an 
animal-associated gastric Helicobacter species, such as H. heilmannii (Chung et al., 2014; De 
Bock et al., 2007; Joosten et al., 2013; Meining et al., 1998). Helicobacter DNA has been 
detected in saliva from cats, dogs and pigs indicating that the oral cavity of these animals may 
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act as source of NHPH infection for humans (Ekman et al., 2013; Casagrande Proieti et al., 
2010; ShojaeeTabrizi et al., 2010). Fecal-oral transmission has also been suggested as a 
possible route for infection in cats (Ghil et al., 2009). Besides direct contact with animals, 
other routes of transmission of NHPH should not be neglected. It has been shown that H. felis 
is able to survive in water for several days highlighting the possible role for water in the 
transmission of this species (Azevedo et al., 2008). H. suis can be present on and survive in 
minced pork. This indicates that raw or undercooked pork may also constitute a source of H. 
suis infection for humans (De Cooman et al., 2013). 
H. suis, H. heilmannii, H. bizzozeronii, H. felis and H. salomonis (Table 1) have been 
associated with gastritis, gastric and duodenal ulcers and low grade MALT lymphoma in 
humans (Haesebrouck et al., 2009; Matsumoto et al., 2014; Iwanczak et al., 2012; Duquenoy 
and Le Luyer, 2009). These NHPH have microscopically been detected in 0.2-6% of humans 
with severe gastric complaints undergoing a gastroscopy. This is most probably an 
underestimation of their true prevalence since it cannot be excluded that infections with these 
agents sometimes remain unapparent or cause mild disease signs which are not often 
thoroughly examined (Haesebrouck et al., 2009). Also they are not that easily detected in 
gastric biopsy samples by microscopical examination since their colonization pattern is much 
more focal and patchy than that of H. pylori. So examination of a small biopsy sample will 
not always reveal the presence of spiral-shaped bacteria in infected human patients 
(Haesebrouck et al., 2009; Trebesius et al., 2001; De Groote et al., 2005; Iwanczak et al., 
2012; Yakoob et al., 2012). Interestingly, the prevalence of H. pylori in humans from the 
Western World is decreasing from generation to generation (Bhandari and Crowe, 2012), 
leaving a niche for possible infection with these animal-associated gastric Helicobacter spp.   
Clinical symptoms associated with gastric NHPH infections include acute or chronic 
epigastric pain, nausea, dyspepsia, reflux esophagitis, heartburn, vomiting, hematemesis, 
abdominal pain, irregular defecation frequency and consistency and dysphagia, often 
accompanied by a decreased appetite (Dieterich et al., 1998; Goddard et al., 1997; 
Heilmann&Borchard, 1991; Iwanczak et al., 2012; Joosten et al., 2013; Matsumoto et al., 
2014; Mention et al., 1999; Oliva et al., 1993; Solnick&Schauer, 2001).  
In patients undergoing an endoscopy, a variety of lesions can be observed ranging from a 
normal to slightly hyperaemic mucosa, mucosal oedema, nodular inflammation and the 
presence of ulcerations in the antrum of the stomach or in the duodenum (Haesebrouck et al., 
2009; Sykora et al., 2003; Van Loon et al., 2003; Yang et al., 1995; Yoshimura et al., 2002). 
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Histological examination of gastric biopsies is generally characterized by infiltration with 
lymphocytes and plasma cells. In some cases, lymphocytic aggregates or intestinal metaplasia 
have been described (Ierardi et al., 2001; Joosten et al., 2013; Matsumoto et al., 2014; 
Morgner et al., 2000; Yakoob et al., 2012). Compared to an H. pylori-associated gastritis, 
gastritis associated with NHPH is often less active and less severe. On the other hand, the risk 
of developing MALT lymphoma is higher with NHPH than with H. pylori (Haesebrouck et al., 
2009; Matsumoto et al., 2014; Joosten et al., 2013).  
The inflammatory effects caused by these NHPH seem not only to be restricted to the stomach. 
An exceptional high frequency (27%) of H. suis DNA was found in gastric biopsies from 
human patients with Parkinson's disease compared to a control group with no clinical 
parkinsonism.  Besides in the stomach, in our research group, H. suis DNA was detected in a 
blood sample of a patient with parkinsonism who was also diagnosed with Alzheimer’s 
disease. This patient received a triple therapy of tetracyclines, clarithromycin and a proton 
pump inhibitor to eradicate H. suis. Interestingly, the H. suis infection was cleared and the 
gastric and neurological symptoms improved remarkably (Blaecher et al., 2013). 
Subsequently to these latter findings, an in vivo H. suis infection study in mice highlighted the 
potential role of H. suis infection in neuro-inflammation (Blaecher C., 2015, personal 
communication).  
Commercial tests to diagnose infection with gastric NHPH are currently unavailable. Urea 
breath tests, used to diagnose infection with H. pylori, are often negative in patients infected 
with animal-associated gastric Helicobacter spp., such as H. heilmannii (Matsumoto et al., 
2014). This can be explained by the fact that infections with these bacteria are, in contrast 
with H. pylori infections, more often focal and predominantly found in the antrum of the 
stomach (Solnick and Schauer, 2001). Only a low number of animal-associated gastric 
Helicobacter isolates are available worldwide. Due to their fastidious nature, isolation of 
these bacteria is not an option for routine diagnostic purposes. So far, 2 gastric Helicobacter 
species, namely H. bizzozeronii (Andersen et al., 1999; Kivisto et al., 2010)  and H. felis 
(Wüppenhorst et al., 2013), have been cultured from gastric biopsies taken from infected 
human patients. Therefore, analysis of gastric biopsies by molecular microbiological methods 
and histology is at this moment the only way to determine infections with these pathogens 
(Haesebrouck et al., 2009).  
For patients with severe gastric complaints and evidence of an NHPH infection, treatment is 
necessary. There is, however, a lack of clinical trials and only few reports deal with 
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antimicrobial susceptibility tests of gastric NHPH (Vermoote et al., 2011; Van den Bulck et 
al., 2005a; Blaecher et al., 2013). Triple therapy using the combination of a proton pump 
inhibitor and two antimicrobial agents, like clarithromycin, metronidazole, amoxicillin or 
tetracycline may be effective in most cases but not always due to the presence of acquired 
resistance against antimicrobial agents among these gastric helicobacters (Schott et al., 2012; 
Kondadi et al., 2013). 
 
2.3 Helicobacter heilmannii in domestic pets and wild felines 
2.3.1 Prevalence of H. heilmannii 
H. heilmannii, formerly “Candidatus H. heilmannii” (O'Rourke et al., 2004a; Smet et al., 
2012), naturally colonizes the stomach of domesticated cats and dogs (Haesebrouck et al., 
2009; Smet et al., 2012). According to the literature, this microorganism has more frequently 
been detected in cats than in dogs (Smet et al., 2012; Takemura et al., 2009; Canejo-Teixeira 
R et al., 2014). This bacterium has also occasionally been found in the stomach of wild felines, 
including lynx, leopards, pumas, bobcats, tigers and cheetahs (Hamir et al., 2004; Mörner et 
al., 2008; Terio et al., 2005; O’Rourke et al., 2004a; Luiz de Camargo et al., 2011). The 
prevalence of NHPH ranges from 20% to 100% in the gastric mucosa of healthy pets as well 
as animals showing chronic vomiting and other symptoms of gastrointestinal discomfort  
(Haesebrouck et al., 2009; Hwang et al., 2002; Neiger et al., 1998; Van den Bulcket al., 
2005a; Amorin et al., 2015). Additionally, pet animals infected with H. heilmannii can also be 
co-infected with an additional gastric Helicobacter species, e.g.  H. felis (Haesebrouck et al., 
2009; Smet et al., 2012).  
 
2.3.2 Pathogenic significance of H. heilmannii in its natural hosts and experimentally infected 
lab animals 
In general, H. heilmannii has been associated with chronic active gastritis in pet animals 
(Haesebrouck et al., 2009). Histological changes in the lamina propria including mild 
mononuclear inflammatory infiltration, the presence of lymphoid follicles, fibrosis and 
glandular degeneration have been described in the stomach of cats naturally infected with H. 
heilmannii (Takemura et al., 2009). In cheetahs, gastritis caused by H. heilmannii was 
characterized by the infiltration of lymphocytes and plasma cells in the epithelium and lamina 
propria with gland destruction and parietal cell loss. In some cases lymphoid follicles were 
observed especially in captive animals and less frequently in wild animals (Terio et al., 2005; 
  
 20 
 Review of the Literature 
Munson et al., 2005). Terio et al. (2012) further investigated the local gastric immune 
response in cheetahs with varying degree of Helicobacter-associated gastritis. The type of 
cells involved in the host immune response was similar among all types of gastritis with the 
exception that a large number of lamina proprial activated CD79a+CD21-B cells and plasma 
cells were only seen in cheetahs with severe gastritis (Terio et al., 2012). 
To study the pathogenesis of a gastric H. heilmannii infection, experimental infection studies 
in specific pathogen free (SPF) laboratory animals have been performed (O'Rourke et al., 
2004a; Joosten et al., 2013; Nakamura et al., 2014).  Rodent animals have been shown to be 
useful models for the study of Helicobacter-related gastric disease (O’Rourke and Lee, 2003; 
Rogers and Fox, 2004). H. heilmannii has been propagated in mice for up to 28 months and 
was able to induce MALT lymphoma in the stomachs of these animals (O’Rourke et al., 
2004a). However in this mouse experiment, homogenized animal gastric tissue was used as 
inoculum. This implies that other microorganisms were inoculated together with H. 
heilmannii, which might have influenced the results (Flahou et al., 2010). Thus, to obtain 
better insights into the pathogenicity of H. heilmannii, experimental infection studies with 
pure cultures of this microorganism are essential.  A recent infection study with pure feline H. 
heilmannii strains, using a Mongolian gerbil model, showed an antrum-dominant chronic 
active gastritis with formation of large lymphocytic aggregates in the stomach of animals 
infected for 9 weeks (Joosten et al., 2013).   
Although infection with H. heilmannii has been associated with the development of severe 
gastric pathologies in its natural hosts, its clinical significance in those animals still remains 
not completely understood and is most probably strain-dependent or may be related to host 
differences (Haesebrouck et al., 2009).  
 
3. The gastric mucosa: a niche for Helicobacter 
3.1 Anatomy and physiology of the human gastric mucosa 
The gastric mucosa is the layer of the stomach which contains the glands and the gastric pits. 
It consists of the epithelium, lamina propria and muscularis mucosa (Eurell and Frappier, 
2006; Figure 3).  
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Figure 3: Schematic representation of the human gastric mucosa. In the epithelium, gastric pits lead to gastric 
glands that secrete gastric juice. The gastric glands (one is shown enlarged on the right), showing a simple or 
branched tubular morphology, contain different cell types that secrete a variety of substances, including 
hydrochloric acid (HCl), which activates the protein-digesting enzyme pepsin (adapted from Open Stax College, 
Anatomy and Physiology. OpenStax CNX. http://cnx.org/contents/14fb4ad7-39a1-4eee-ab6e-3ef2482e3e22@ 
8.24) 
 
The surface epithelium and the gastric pits of the gastric mucosa are made up primarily of 
mucous cells, which secrete a coat of mucus that functions as a protective barrier against 
pathogens (Figure 3).  
On the other hand, the gastric glands consist of different cell types (Figure 3 & 5). According 
to the different zones in the stomach, there are 3 types of gastric glands (Figure 4): cardiac 
glands (in the proximal part of the stomach), fundic (oxyntic) glands (the dominating type of 
gland), and pyloric glands (in the antrum of the stomach).  
The glands of the cardia and pylorus are composed primarily of mucus-secreting cells. The 
pyloric antrum additionally contains enteroendocrine cells secreting hormones, such as gastrin 
(G-cells) and somatostatin (D-cells) (Soybel, 2005). The glands of the fundus and the body of 
the stomach (Figures 4&5), produce most of the gastric secretions and are made up of a 
variety of secretory cells. These include HCl-secreting parietal cells, zymogen (pepsinogen)-
secreting chief cells, mucous neck cells, enterochromaffin-like cells and enteroendocrine cells 
(Figures 3 & 5). Below an overview of the main function of these cells is presented. 
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Figure 4: Schematic representation of the different gland regions (pyloric, fundic, and cardiac glands) in the 
human stomach. The fundic gland region and the pyloric gland region can be distinguished by the transition zone 
and the pylorus can be easily palpated, with a ring of muscle (pyloric sphincter) separating the stomach and the 
duodenum. 
 
Parietal cells contain an extensive secretory network named canaliculi, from which the HCl 
is secreted by active transport into the gastric lumen (Figures 3&5). When stimulated, these 
cells massively secrete H+ into the gastric lumen, at a concentration of roughly 160 mM, 
which is equivalent to a pH of 0.8. Acid facilitates the activation of pepsinogen, the digestion 
of food and absorption of iron, calcium, and vitamin B-12, and it also controls bacterial 
overgrowth and enteric infection (Schubert et al., 1990). The ability of the parietal cell to 
secrete acid is dependent on active transport. The H+, K+ -ATPase of parietal cells is the 
proton pump composed of a catalytic subunit (α-subunit) and an accessory subunit (β-subunit). 
The dephosphorylation reaction of mass adenosine triphosphate (ATP) releases energy. So the 
H+, K+ -ATPase transports protons against a huge gradient into the gastric lumen in exchange 
for K+ (Yao et al., 2003; Figure 5). Chief cells secrete pepsinogen, the inactive proenzyme 
form of pepsin. HCl is necessary for the conversion of pepsinogen to pepsin. Mucous neck 
cells secrete thin acidic mucus which is different from the alkaline mucus released by the cells 
at the surface epithelium. Enterochromaffin-like cells (ECLs) produce histamine, which is a 
powerful stimulant of acid secretion (Yao et al., 2003; Figure 5). The hormone gastrin is 
released by enteroendocrine G-cells and also stimulates acid production (Figure 5). 
 
 
duodenum 
antrum 
transition zone 
pyloric sphincter 
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Figure 5: Schematic representation of a gastric fundic gland comprising different epithelial cell types. 
(Adapted from https://www.studyblue.com/notes/note/n/37-secretion-in-gi-system/deck/11297865) 
 
The fundic gland region and the pyloric gland region can be distinguished by the transition 
zone from obliquely oriented rugae (internal surface of the stomach) to a relatively flat 
mucosa, and the pylorus can be easily palpated, with a ring of muscle separating the stomach 
and the duodenum (Soybel, 2005; Figure 4). 
 
3.2 The mucus layer covering the healthy human gastric mucosa: mucins (MUCs) and 
trefoil factors (TFFs) 
The mucus layer is the first barrier pathogens encounter and mainly consists of high 
molecular mass oligomeric secreted mucins (MUCs) and trefoil factors (TFFs) (Figure 5; 
Kaneko et al., 2003; Chen et al., 2004; Lindén et al., 2002; McGuckin et al., 2011; Ringel and 
Lohr, 2003; Kawakubo et al., 2004). Secreted mucins are produced by cells in the epithelial 
cell surface and/or the glands. Small amounts of mucins are continuously secreted to maintain 
the mucus layer whereas high amounts of mucins will be released as a response to 
environmental and/or (patho)physiological stimuli. The membrane-associated mucins, located 
underneath the mucus layer, also provide a barrier, thereby limiting access to the cell surface, 
as well as a reporting function, due to their cytoplasmic tail with signalling potential 
(McGuckin et al., 2011; Atuma et al., 2001). In the human stomach but also among several 
mammalian species, including pigs, cats and dogs, MUC1, MUC5AC and MUC6 are the 
major mucins covering the healthy gastric mucosa (Karlsson et al., 1997; Lacunza et al., 
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2009). The membrane-associated MUC1 is expressed at the surface epithelium. The secreted 
MUC5AC is also restricted to the surface epithelium, whereas the secreted MUC6 is 
expressed by the glands (Lindén et al., 2002; McGuckin et al., 2011). In addition to the 
membrane-bound form of MUC1, secreted variants of this mucin have also been reported. 
MUC5AC and MUC6 are large oligomeric mucins that occur as distinct glycoproteins.  
The intestinal mucins MUC2, MUC4, MUC13 and MUC5B are normally not expressed in the 
human gastric mucosa but their presence has been described in gastric cancer (Ho et al., 1995; 
Pinto-de-Sousa et al., 2004; Babu et al., 2006). MUC2 is the main secreted mucin making up 
the mucus layer in the intestines. MUC4 is a cell surface mucin and is mainly expressed in 
normal colon tissue. The transmembrane MUC13 is expressed in the small and large intestine 
whereas MUC5B is the predominant mucin in the human gallbladder and in a subset of 
colonic goblet cells (Van Klinken et al., 1998). 
Mucins contain in their nucleotide sequence unique tandem repeat motifs coding for regions 
with a high density of serine, threonine and proline. The tandem repeats can vary in length 
between mucins and a genetic polymorphism in the number of repeats, also called Variable 
Number of Tandem Repeats (VNTR) polymorphism, has been described. Serine and 
threonine can be O-glycosylated and most of the mucin molecular mass is due to the presence 
of carbohydrate structures (Figure 6).  
 
Figure 6: Mucin structure and glycosylation. (A) Schematic representation of structures of secreted and cell- 
membrane-associated mucins showing different domains. (B) Cartoon showing distribution and structure of gel-
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forming secreted, non-gel-forming secreted, and membrane-bound mucins. (C) Schematic representation of the 
complex glycosylated structure (bottle-brush appearance) and multimeric assembly of a gel-forming secreted 
mucin. Immediately after its synthesis and translocation into the endoplasmic reticulum, the mucin polypeptide 
chain is N-glycosylated and forms disulfide-bonded dimers through its C-terminal Cys-rich domains. The dimers 
are then transported to the Golgi complex, and the tandem repeat domains are O-glycosylated. Once the 
glycosylated dimers reach the trans-Golgi compartments, they are assembled into disulfide-bonded multimers 
through their N-terminal D-domains. The Y-shaped structures on the N-terminal D-domains and the C-terminal 
Cys-rich domains represent N-linked oligosaccharides. The squiggly lines perpendicular to the polypeptide chain 
represent O-linked oligosaccharides in the tandem repeat domains (adapted from Moran et al., 2011).  
 
Mucins can carry on the order of 100 different carbohydrate structures, which provide the 
mucins with a bottle-brush appearance and makes them act as receptors for microorganisms 
(Figure 6C; Klein et al., 1993). 
The carbohydrate structures contain an N-acetylgalactosamine (GalNAc) group linked to 
serine or threonine and are elongated by the formation of core structures, followed by type-1 
or type-2 chains. The chains can be terminated by fucose (Fuc), galactose (Gal), GalNAc, N-
acetylglucosamine (GlcNAc) or sialic acid residues in the peripheral region, which form 
histo-blood-group antigens such as A, B, H, Lewis (Le)a, Leb, Lex, Ley, sialyl(s)Lea and sLex. 
Sulfation of Gal and GlcNAc causes further diversification (McGuckin et al., 2011). In the 
human stomach, Lea and Leb are expressed by MUC1 and MUC5AC, and Lex and Ley by 
MUC6 (Lindén et al., 2002; Lindén et al., 2009). It should be noted that carbohydrate 
structures present on mucins differ between people with different histo-blood groups 
(Marionneau et al., 2001). Mucins from a healthy human stomach express low levels of sialic 
acid and sulfate and are therefore predominantly neutral.  
In humans, three TFFs, namely TFF1/presenilin (pS2), TFF2/spasmolytic polypeptide (SP), 
and TFF3/intestinal trefoil factor (ITF) are known. Trefoil factors are small, soluble peptides 
with trefoil or P domains. The trefoil domains are made up of six cysteine residues (Hoffmann 
and Hauser, 1993; Katoh, 2003). TFFs are secreted from the granules of mucus-secreting cells 
and are cross-linking with mucins to help form the gel layer in the stomach (Shirazi et al., 
2000; Clyne et al., 2004; Julia et al., 2009). TFF1 is normally found in the superficial cells of 
the body and antral mucosa of the stomach, whereas TFF2 is found in the mucus neck cells of 
the body and antral glands in the stomach. TFF3 is normally not expressed in the stomach but 
is expressed in the intestines and the salivary glands (Wong et al., 1999). Previous studies in 
humans have shown that TFF1 interacts with MUC5AC, TFF2 interacts with MUC6 and 
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TFF3 interacts with MUC2 (Clyne et al., 2004; Ruchaud-Sparagano et al., 2004; Thim and 
May, 2005). 
 
3.3 Mucin dynamics associated with Helicobacter-induced gastric pathologies 
Most mucins exhibit considerable genetic polymorphism due to variability in their numbers of 
tandem repeat peptides, which results in proteins of widely divergent lengths. The mucin 
MUC1 is constitutively expressed by the gastric mucosa and is likely the first point of contact 
between the host stomach and adherent pathogens. Several studies have 
linked MUC1 polymorphisms with susceptibility to H. pylori-induced disease, such as 
gastritis and gastric cancer (Carvalho et al., 1997; Vinall et al., 2002), suggesting a direct 
effect of MUC1 polymorphisms in the development of Helicobacter-associated pathology. 
Additionally, MUC1 limits H. pylori infection both by steric hindrance and by acting as a 
releasable decoy (Linden et al., 2009; Every et al., 2008). 
It has been shown that the expression of gastric mucins and trefoil factors as well as their 
distribution in the stomach alter in H. pylori-induced gastric pathologies (Lindén et al., 2002, 
Schmitz et al., 2009; Wang & Fang, 2003). MUC1 has been shown to be expressed early in 
the H. pylori infection process but is decreased during the metaplastic stage  (Wang and Fang, 
2003). MUC5AC is present in a normal stomach, but its expression is lost in gastric 
adenocarcinoma (Ho et al., 1995; Wang and Fang, 2003; Pinto-de-Sousa et al., 2004; Dhar et 
al., 2005; Roessler et al., 2005; Babu et al., 2006). 
On the contrary, MUC5B, which is not expressed in a healthy human stomach, has been 
found in gastric adenocarcinoma biopsies (Wang and Fang, 2003; Pinto-de-Sousa et al., 2004; 
Roessler et al., 2005; Babu et al., 2006).  
MUC6 is expressed at high levels in a normal human stomach in the mucus neck glands but is 
absent in the gastric epithelium altered by gastric cancer (Ho et al., 1995; Pinto-de-Sousa et 
al., 2004).  
As described above, the intestinal mucins MUC2, MUC4 and MUC13 are not expressed in 
the healthy gastric mucosa but have been detected in gastric adenocarcinomas and in early 
events of the carcinogenesis process, such as intestinal metaplasia (Mejías-Luque et al., 2010; 
Reis et al., 1999; Shimamura et al., 2005; Sheng et al., 2011). Intestinal metaplasia is induced 
by the loss of parietal cells during H. pylori infection. Two distinct types of mucous 
metaplasia have been described: intestinal metaplasia and spasmolytic polypeptide-expressing 
metaplasia (SPEM). SPEM might even progresses into dysplasia (Weis et al., 2013; Wang et 
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al., 2000; Houghton et al., 2004).  It has been suggested that intestinal metaplasia develops in 
the presence of pre-existing SPEM, supporting the role of SPEM as a neoplastic precursor in 
the carcinogenesis cascade (Yoshizawa et al., 2007; Goldenring et al., 2010).  
TFF1 has been shown to be lost in 50% of gastric carcinomas (Muller and Borchard, 1993; 
Wong et al., 1999), while TFF2 expression has been detected in human stomach biopsies 
showing gastritis and atrophy but not during intestinal metaplasia and gastric carcinoma (Hu 
et al., 2003; Dhar et al., 2005). On the contrary, TFF3, which is not expressed in a healthy 
stomach, was detected in the stomach as it progressed through the intestinal metaplasia stage 
to gastric cancer (Taupin et al., 2001). For the aforementioned studies, mucin and trefoil 
factor expression was characterized by both RNA expression and immunohistochemical 
stainings.  
The C57BL/6 mouse strain has been shown to develop gastric adenocarcinoma after long-
term H. felis infection. This model was used to determine whether murine mucin (Muc) and 
trefoil factors (Tffs) expression after infection was changed in a similar fashion to the changes 
seen in the human gastric mucosa after H. pylori infection (Schmitz et al., 2009). In this study, 
alterations in mucin expression, including increased expression of Muc4 and Muc5b and loss 
of Muc5ac, occurred at 4 weeks post-infection, before the development of mucous metaplasia 
or gastric dysplasia (Schmitz et al., 2009). H. felis infection in mice is often used as an animal 
model to study H. pylori-related gastric pathologies in man. Due to the lack of several 
important H. pylori virulence factors (see below), researchers must be aware that H. felis 
might not always have similar outcomes in pathogenicity compared to H. pylori. 
Extrapolation of data obtained in a H. felis infection mouse model to H. pylori infections in 
humans should therefore be done with caution.    
 
4. Virulence factors of gastric Helicobacter species 
The virulence factors involved in the pathogenesis of a H. pylori infection have been 
tremendously studied in the past (Figure 7). The genomes of H. felis, H. bizzozeronii, H. 
heilmannii, H. ailurogastricus and H. suis have recently been published (Arnold et al., 2011; 
Schott et al., 2011; Smet et al., 2012; Vermoote et al., 2011; Joosten et al., 2015). The 
availability of these genomes will now provide platforms to identify the genes that may 
contribute to these pathogens virulence and carcinogenic properties as well as for further 
comparative analyses of genomic variability, plasticity and bacterial evolution. This chapter 
will focus on the H. pylori virulence factors involved in colonization and induction of gastric 
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lesions. Absence/presence of homolog genes encoding these virulence factors in the available 
gastric NHPH genomes will be shown as well.  
 
Figure 7: Virulence factors of H. pylori involved in gastric colonization and induction of gastric lesions. 
(Adapted from https://upload.wikimedia.org/wikipedia/commons/9/9a/H_pylori_virulence_factors_en.png) 
 
4.1. Virulence factors essential for colonization of the gastric mucosa  
4.1.1. pH homeostasis 
For a long time, it was believed that the stomach was too hostile for persistent colonization by 
bacteria because of the low pH (Burne and Chen, 2000). All gastric Helicobacter species are 
able to survive the acidic environment in the stomach (Weeks et al., 2000; Pot et al., 2007). 
They possess a family of genes encoding the urease enzyme (Burne and Chen, 2000; Arnold 
et al., 2011; Schott et al., 2011; Vermoote et al., 2011; Smet et al., 2011; Figure 8). The urease 
enzyme consists of two subunits, UreA and UreB, and forms an essential component of 
Helicobacter acid resistance, by converting urea into ammonia and carbon dioxide. The 
ammonia on its turn neutralizes the hydrochloric acid of the stomach resulting in an increase 
of the pH in the stomach (Eaton et al., 1991; Tsuda et al., 1994; Karita et al., 1995). 
Downstream of the ureAB genes, the urease gene cluster contains a second operon, 
comprising ureI and the urease accessory ureEFGH genes (Akada et al., 2000). The 
UreEFGH proteins probably play a role in the subunit assembly and the regulation of urease 
activity by the incorporation of nickel (Cussac et al., 1992; Mobley et al., 1995). UreI 
functions as an acid-activated urea channel and controls the urea transport into the bacterial 
cell (Scott et al., 2000). The urease enzyme is mainly localized in the cytoplasm but is also 
, GGT 
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found on the surface of viable bacteria after autolysis of surrounding bacteria (Phadnis et al., 
1996; De Reuse et al., 2005). 
 
4.1.2 Motility and chemotaxis 
For many pathogenic bacteria, flagellum-dependent motility and chemotaxis are crucial 
factors in the process of colonization of the host organism and establishment of a successful 
colonization (Moens and Vanderleyden, 1996; Ottemann et al., 1997). All gastric 
Helicobacter spp. possess the ability to move to the epithelial cell surface of the stomach and 
thus to a more neutral pH with the assistance of highly mobile flagellae (Salama et al., 2013; 
Arnold et al., 2011; Schott et al., 2011; Vermoote et al., 2011; Smet et al., 2011; Figure 7). 
These flagellae consist of a body, hook and flagellar filament. The filaments are composed of 
two flagellins A (FlaA) and B (FlaB) which are important for motility (Josenhans et al., 1995; 
Andrutis et al., 1997). The flagellar hook (FlgE) and flagellar cap (FliD) proteins have also 
been shown to be essential in flagellar structure and motility (O’Toole et al., 1994; Kim et al., 
1999).   
In addition to motility, several in vivo studies indicated that chemotaxis is also required for 
gastric Helicobacter colonization (Foynes et al., 2000; McGee et al., 2005; Terry et al., 2005). 
These bacteria show a directed motility towards urea, bicarbonate, cholesterol, arginine and 
other amino acids, but move away from hydrochloric acid. The chemotaxis receptor TlpB is 
required for pH taxis. Helicobacter bacteria lacking this receptor are defective for 
colonization (O’Toole et al., 1994; Kim et al., 1999). Compared to H. pylori, H. heilmannii, H. 
felis, H. bizzozeronii and H. suis possess a larger number of methyl-accepting chemotaxis 
proteins, allowing them to respond to a wider spectrum of environmental signals. The high 
metabolic versatility and the ability to react to a range of environmental signals, which 
differentiate these NHPH from H. pylori, may contribute to their zoonotic nature (Arnold et 
al., 2011; Schott et al., 2011; Vermoote et al., 2011; Smet et al., 2011).  
 
4.1.3 Oxidative stress 
Next to the acidic environment, gastric helicobacters have also to counteract oxidative stress, 
resulting from the host immune response. They all possess several key components, including 
catalase (KatA), superoxide dismutase (SodB) and alkyl hydroperoxide reductase (AhpC) 
Seyler et al., 2001; Arnold et al., 2011; Schott et al., 2011; Smet et al., 2011). The neutrophil-
activating protein (NAP), present among all gastric Helicobacter species (Arnold et al., 2011; 
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Smet et al., 2011; Schot et al., 2011; Vermoote et al., 2011), has been shown to play a role in  
the induction of neutrophils to produce reactive oxygen radicals and combating oxidative 
stress resistance during H. pylori colonization (Olczak et al., 2003; de Bernard et al., 2010; 
Evans et al., 1995).  
 
4.1.4 Outer membrane proteins 
One of the very first steps in the pathogenesis of gastric infections caused by Helicobacter is 
colonization, and in particular adhesion of these bacteria to the gastric mucosa (McGuckin et 
al., 2011). 
H. pylori is equipped with a set of ca. 64 outer membrane proteins (OMPs), whose role in the 
colonization process has been well studied (Alm et al., 2000; Odenbreit et al., 2009). The H. 
pylori OMPs can be divided into 5 paralogous families. The largest family comprises the Hop 
(for Helicobacter outer membrane porin, 21 members) and Hor (for Hop related, 12 members) 
proteins. Families 2 and 3 comprise the Hof (for Helicobacter OMP family, 8 members) and 
Hom (for Helicobacter outer membrane, 4 members) proteins, respectively. Families 4 and 5 
are composed of iron-regulated OMPs (6 members) and efflux pumps OMPs (3 members), 
respectively. The function of the 10 remaining OMPs is still unkown (Oleastro and Ménard, 
2013; Figure 8). The H. pylori Hop OMPs share highly similar or identical sequences at their 
amino and carboxyl termini and include porins and adhesins involved in adhesion to the 
gastric mucosa (Alm et al., 2000; Aspholm et al., 2006b; Odenbreit, 2005; Gerhard et al., 
2001). An overview of the well-studied H. pylori adhesins and their presence in animal-
associated gastric helicobacters is given below.   
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Figure 8: Phylogenetic analysis of the large set of outer membrane proteins identified in H. pylori. The five 
major families of outer membrane proteins (OMP) are represented. Family 1 (blue) comprises 21 members 
named Hop (21 members) and Hor (12 members) proteins. Families 2 (red) and 3 (pink) comprise the Hof (8 
members) and Hom (4 members) proteins, respectively. Families 4 (green) and 5 (red) are composed of iron-
regulated OMPs (6 members) and efflux pump OMPs (3 members), respectively. The 10 other non-classified 
OMPs are not included in the phylogenetic tree. The duplicated Hop proteins (HopJ/K and HopM/N) were not 
differentiated and are each visualized as one line. The branch length index is represented below the tree and 
highlights the differences in nucleotides. (Adapted from Alm et al., 2000 and Oleastro and Ménard, 2013). 
 
The first and major adhesin identified in H. pylori is the blood group antigen binding 
adhesin A (BabA or HopS; Figure 8). BabA mediates binding of the bacterium to the human 
fucosylated Lewis b blood group antigen (Leb) and related terminal fucose residues found on 
blood group O (H antigens), A and B antigens which are expressed on MUC1 and MUC5AC 
and gastric epithelial cells in the human stomach. Leb is the dominant antigen present in the 
gastric mucosa (Boren et al., 1993; Ilver et al.,1998). The BabA adhesin has two closely 
related paralogs, BabB (HopT) and BabC (HopU), whose function has not yet been 
determined. The genes encoding these Bab proteins present extensive 5’ and 3’ homology, 
suggesting that the middle variable region of BabA most likely encodes the adhesin function 
(Pride et al., 2002).  The expression level of  BabA can be regulated by gene conversion, a 
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process by which one DNA sequence e.g. loci A replaces a homologous sequence e. g. loci B 
by recombination such that the sequences become identical after the conversion event. Gene 
conversion occurs most likely by RecA-dependent intragenomic recombination between 
complementary loci leading to chimeric babB/A and babA/B genes (Solnick et al., 2004; 
Matteo et al., 2011).  
Another mechanism involved in regulation of BabA expression at transcriptional level is 
phase variation through slipped strand mispairing (SSM) based on the number of Cytidine-
Thymidine (CT) dinucleotide repeats in the 5’ region of the babA gene. These CT repeats are 
probably the result of chromosomal translocation events (Ilver et al., 1998; Solnick et al., 
2004).  
The second most well characterized adhesin of H. pylori is the sialic acid-binding adhesin A 
(SabA or HopP; Figure 8) and binds to sialylated carbohydrate structures, such as sialyl-
dimeric lewis x (sLex), which are upregulated as part of complex gangliosides in inflamed 
gastric tissue (Mahdavi et al., 2002). SabA was postulated to contribute to the chronic 
persistence of the infection (Aspholm et al., 2006a; Mahdavi et al., 2002). SabA can also 
mediate the adherence of H. pylori to laminin (Walz et al., 2005). SabA has a closely related 
paralog SabB (HopO). The 5’ and 3’ ends of the sabA gene share the highest nucleotide 
identity with sabB and an additional OMP gene, hopQ. The OMPs encoded by these latter 
genes may also be involved in H. pylori adherence (Loh et al., 2008; Saunders et al., 2005). 
Gene conversion, resulting from intragenomic recombination between sabA and sabB and at a 
lower rate with hopQ, is involved in the regulation of the amount of SabA on the bacterial 
surface and adherence to gastric tissue (Yamaoka et al., 2006). The sabA gene can also be 
regulated at transcriptional level. Dinucleotide CT repeats present in the 5’coding region of 
sabA regulate its expression by phase variation through SSM (Yamaoka et al., 2006) and the 
sabA promoter modulates its transcriptional activity through a variable homopolymeric 
thymidine tract (Kao et al., 2012). The on/off switch of SabA expression suggests that SabA 
expression can rapidly respond to the changing conditions in the stomach (Yamaoka et al., 
2006).    
Two highly homologous OMPs, the adherence-associated lipoproteins A and B (AlpA 
(HopC) and AlpB (HopB); Figure 8), are also involved in H. pylori adherence to human 
gastric tissue sections (Odenbreit et al., 1996; Odenbreit et al., 1999; Alm et al., 2000; Alm et 
al., 1999). Both lipoproteins contribute to host laminin binding and influence gastric 
inflammation (Bernarde et al., 2010; Baik et al., 2004; Odenbreit et al., 1997). 
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The outer inflammatory protein A (OipA or HopH; Figure 8), encoded by the oipA gene, 
was initially identified as a pro-inflammatory response-inducing protein (Yamaoka et al., 
2000). It has been shown that OipA is involved in bacterial adherence to gastric epithelial 
cells in vitro and is strongly associated with increased interleukin (IL)-8 secretion of epithelial 
cells in a Type 4 secretion system (T4SS)-independent manner (Dossumbekova et al., 2006; 
Yamaoka et al., 2000; Yamaoka et al., 2002). The oipA gene does not have highly similar 
paralogs and is quite distant from other hop genes. OipA expression is regulated by phase 
variation within a CT dinucleotide repeat motif located in the 5’ coding region of the hopH 
gene. The “on” status of this adhesin has been associated with more severe gastric diseases, H. 
pylori density and severe neutrophil infiltration (Franco et al., 2008; Saunders et al., 1998).  
The HopZ (Omp1; Figure 8) OMP has been described on the surface of H. pylori bacteria 
(Peck et al., 1999). A hopZ-knockout mutant strain showed significantly reduced binding 
capacity to the gastric epithelial AGS cell line, compared to the corresponding wild-type 
strain, suggesting the role of HopZ  in adherence of H. pylori  (Yamaoka et al., 2002).  The 
expression of the hopZ gene is regulated by SSM within CT dinucleotide repeats of different 
length localized at the 5’ end of the coding region. The hopZ “off” status frequently switches 
to “on” status during infection (Kennemann et al., 2012). 
The smallest family of OMP is the Hom family constituted of four members. The most 
studied gene is homB encoding the HomB protein (Figure 8) expressed in the H. pylori outer 
membrane (Oleastro et al., 2008). This protein is associated with IL-8 secretion in vitro and 
contributes to bacterial adherence (Oleastro et al., 2008). The homB gene has a closely related 
paralog, homA. Expression of both loci can be regulated by gene conversion or phase 
variation (Oleastro et al., 2009).  
HorB, a member of the Hor family (Figure 8), has also been suggested to be involved in 
gastric epithelial cell adhesion. Disruption of the horB gene reduced H. pylori adhesion to 
gastric epithelial cells (Snelling et al., 2007).  
The animal-associated gastric Helicobacter spp. also harbour a large set of ca. 55-60 OMPs 
which is in agreement with the 64 well annotated OMP genes described in H. pylori (Joosten 
et al., 2015; Alm et al 2000). Comparative genomics between the H. pylori and the available 
NHPH genomes revealed that all canine, feline and porcine helicobacters lack the H. pylori 
Hop and Hom adhesins described above (Joosten et al., 2015). Among H. heilmannii, H. 
ailurogastricus, H. felis, H. bizzozeronii and H. suis, only a few homologs encoding members 
of the H. pylori Hop and Hor family, including HorB (probably functioning as a porin) are 
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present (Joosten et al., 2015). On the contrary, H. acinonychis and H. cetorum, the 2 most 
closest relatives of H. pylori, harbor a few homologs of known H. pylori Hop adhesins, such 
as SabB, AlpA/B and OipA (Smet et al., 2011, Arnold et al., 2011, Vermoote et al., 2011, 
Schott et al., 2011; Joosten et al., 2015). Which OMPs are involved in binding to the gastric 
mucosa by H. heilmannii, H. ailurogastricus, H. felis, H. bizzozeronii and H. suis is so far 
unknown. Interestingly, homologs of all members of the H. pylori Hof family are present and 
well conserved among all gastric helicobacters, with the exception of H. mustelae (Figure 8, 
Smet et al., 2014). In contrast to H. pylori, the genes encoding the Hof OMPs and present in 
the H. heilmannii, H. ailurogastricus, H. felis, H. bizzozeronii and H. suis genomes are 
located in a large locus. In H. pylori, H. cetorum and H. acynonichis, the hof genes are 
scattered across their genomes. The role of such hof gene locus in gastric colonization has not 
yet been investigated (Joosten et al., 2015).  
 
4.2 Virulence factors involved in the induction of gastric lesions 
4.2.1 Vacuolating cytotoxin 
The vacuolating cytotoxin (VacA; Figure 7) is one of the major virulence factors of H. pylori 
and is one of the most extensively studied toxins produced by H. pylori (Leunk et al., 1988; 
Cover et al., 1992). The VacA toxin binds to host cells after secretion through a type V 
autotransport secretion system. The induction of vacuolation in host cells, caused by VacA, 
has been observed in primary gastric epithelial cells (Garner et al., 1996; Smoot et al., 1996; 
de Bernard et al., 1997; Palframan et al., 2012). 
In addition to the induction of vacuolation, VacA exerts a variety of other effects on target 
cells, including disruption of mitochondrial functions (Kuck et al., 2001), stimulation of 
apoptosis and blockade of T-cell proliferation (Cover and Blanke, 2005). VacA is also 
important for colonization of H. pylori in vivo (Salama et al., 2001). Infection with H. pylori 
strains containing the toxigenic allelic s1 form of VacA is associated with an increased risk of 
peptic ulceration and gastric cancer (Atherton et al., 1995;Gerhard et al., 1999; Miehlke et al., 
2000; Louw et al., 2001). VacA is absent in H. heilmannii, H. ailurogastricus, H. felis, H. 
bizzozeronii, H. suis and H. acynonichis. Homologs of H. pylori VacA have only been found 
in H. cetorum (Joosten et al., 2015; Kersulyte et al., 2013). Additionally, H. pylori contains 3 
genes annotated as putative vacA paralogs because the C-terminal autotransporter domains of 
their encoded proteins show approximately 30% identity to that of VacA. These 3 VacA-like 
proteins each enhance the capacity of H. pylori to colonize the stomach (Radin et al., 2013). 
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Such vacA paralogs have also been described among the animal-associated gastric 
Helicobacter spp. (Joosten et al., 2015). 
 
4.2.2 Cytotoxin-associated gene pathogenicity island 
The Cytotoxin-associated gene pathogenicity island (CagPAI; Figure 7) consists of about 30 
genes depending on the clinical strain (Akopyants et al., 1998), in which the cytotoxin-
associated gene A (CagA) is a marker for the H. pylori CagPAI. CagA is recognized as 
another key virulence factor secreted by H. pylori (Cover et al., 1990). Cag PAI encodes a 
T4SS which mediates the injection of cytotoxin-associated effector protein A (CagA) into 
epithelial cells (Odenbreit et al., 2000; Yamazaki et al., 2003). The CagA is associated with 
the development of peptic ulcer disease, gastric cancer, and other severe H. pylori-associated 
pathologies (Bourzac et al., 2005; Salama et al., 2013).The roles of many of the proteins 
encoded within the Cag PAI are not known. The CagI has been considered as an accessory 
component of the CagA secretion system not translocated into host cells and is located in the 
bacterial inner and outer membrane (Wang et al., 2012). Besides CagI, there are other Cag-
PAI genes required for CagA delivery or localization. 
After translocation into the host cell, CagA affects cell shape, increases cell motility, 
abrogates junctional activity, and promotes an epithelial to mesenchymal transition-like 
phenotype (Buti et al., 2011). The inhibition effect of CagA on apoptosis in human epithelial 
cells has been described in some reports. It has also been shown that CagA increases 
apoptosis of human gastric adenocarcinoma cells (AGS) (Tsutsumi et al., 2003). Human 
infections with CagA-positive H. pylori strains mainly show overexpression of  pro-apoptotic 
proteins. Interestingly, this Cag PAI is absent among all known animal-associated gastric 
Helicobacter genomes. 
 
4.2.3 Gamma-glutamyltranspeptidase 
The gamma-glutamyltranspeptidase (GGT) is an important virulence factor, and is well 
conserved in the genus Helicobacter (Smet et al., 2011; Vermoote et al., 2011; Arnold et al., 
2011; Schott et al., 2011; Rossi et al., 2012; Haesebrouck et al., 2009; Wachino et al., 2010; 
Figure 7). Membrane-assocated H. pylori GGT activity plays an important role in the 
metabolism of gluthatione (Orlowski and Meister, 1970), a free thiol maintaining an optimal 
intracellular redox environment (Circu et al., 2010). The Helicobacter GGT is very efficient 
in using both glutamine and gluthatione from epithelial cells as a source of glutamate 
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(Shibayama et al., 2003; Flahou et al., 2011). As glutamine and gluthatione are important 
nutrients to maintain a healthy gastric tissue, their depletion by the GGT probably plays a role 
in damaging of gastric epithelial cells. Previous reports have shown that the H. pylori GGT is 
involved in induction of host cell apoptosis via a mitochondria-mediated pathway (Shibayama 
et al., 2001; Shibayama et al., 2003; Kim et al., 2007). Flahou and colleagues (2011) showed 
that the H. suis GGT catalyses the degradation of extracellular glutathione. The degradation 
products cause a cell-independent extracellular generation of H2O2, leading to lipid 
peroxidation and necrosis. During this process, inflammation-promoting molecules are 
released from gastric epithelial cells (Flahou et al., 2011). Additionally, the Helicobacter 
GGT has also been shown to inhibit T cell proliferation, thereby indicating its role in evasion 
of host immune response (Schmees et al., 2007; Zhang et al., 2015). The importance of H. 
pylori GGT in pathogenesis is further supported by studies demonstrating that H. pylori GGT 
upregulates COX-2 and EGF-related peptide expression in human gastric cells (Busiello et al., 
2004; Gong et al., 2010).  
 
4.2.4 Other virulence factors 
Besides VacA, cagPAI and GGT, other H. pylori virulence factors have also been associated 
with gastric disease, including NapA, PutA, PutP, AnsB, FldA, PgbA-B, HtrA, PrtC and IceA. 
Homologs encoding these virulence factors have been detected in the available H. heilmannii, 
H. felis, H. bizzozeronnii, H. ailurogastricus, H. suis, H. acinonychis and H. cetorum 
genomes (Joosten et al., 2015; Smet et al., 2011; Schott et al., 2011; Arnold et al., 2011; 
Vermoote et al., 2011; Kersulyte et al., 2013). NapA has been identified as a 
immunomodulator. The H. pylori flavodoxin protein (FldA) is an electron acceptor of the 
pyruvate oxidoreductase enzyme complex, which has been associated with MALT lymphoma 
(Chang et al., 1999).  
The ulcer-associated protein restriction endonuclease (IceA) has been shown to be induced by 
contact of the bacterium with the gastric epithelium  (Smet et al., 2011). IceA is present in 
most gastric helicobacters and has been identified as a virulence factor associated with peptic 
ulcer disease (Peek  et al., 1998; Donahue et al., 2000). There are two distinct genotypes in 
the iceA gene, iceA1 and iceA2. Only iceA1 RNA is induced following adherence (Peek et al., 
2000). The H. heilmannii strains tested so far all contained an intact iceA1 homolog (Joosten 
et al., 2015). Another virulence factor, high temperature requirement A (HtrA), is involved in 
the cleavage of E-cadherin and thus in the disruption of gastric epithelial barrier junctions, 
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facilitating intercellular entry of H. pylori (Hoy et al., 2010; Lower et al., 2011). Recently it 
has been demonstrated that H. pylori induces ectodomain cleavage of E-cadherin in polarized 
cells (Weydig et al, 2007). AnsB and L-asparaginase (DcuA) are involved in cell-cycle 
inhibition. The PgbA-B proteins play a role in plasminogen binding while collagenase (PrtC) 
is an enzyme which in charge of the degradation of collagen.  
Although a substantial number of genes encoding putative virulence factors have been 
described to be present in the NHPH genomes in general and in the H. heilmannii genome in 
particular, for the majority of these, their possible role in pathogenesis still remains unclear. 
 
5. Innate immune response upon Helicobacter adherence to the gastric 
mucosa 
Helicobacter spp. generally cause a gastric life-long infection and the induced host immune 
response does not result in eradication of the infection (Flahou et al., 2012). In contrast to the 
scarce literature about the host immune responses against NHPH, several studies describing 
the host immune response (both the innate and adaptive host responses) against H. pylori are 
available. This section therefore particularly focuses on H. pylori. More specifically, it intends 
to give an overview of the innate immune responses upon adherence of H. pylori to the gastric 
mucosa. Where possible, information about NHPH-induced innate responses is introduced as 
well. 
 
During H. pylori infection, most of the bacteria remain within the gastric mucus layer of the 
human stomach, while only 1% interacts directly with gastric epithelial cells (Dubois & Boren, 
2007). Adhesion of H. pylori to gastric epithelial cells is an essential step in the induction of 
an immune response. The initiation of innate immune responses to bacterial pathogens is 
dependent on the recognition of microbial structures or products by host pattern recognition 
receptors (PRRs). PRRs can be located either on cytoplasmic and endosomal membranes or in 
the cytosol of host cells (Akira et al., 2006). The surface-expressed PRRs, Toll-like receptors 
(TLRs), play an important role in mucosal host defense against H. pylori. Although there are 
ten known human TLRs, only TLR2, -4, -5 and -9 have been detected on gastric epithelial 
cells in the human stomach (Schmausser et al., 2004) and thus may be important for the 
recognition of H. pylori in vivo. TLR2 responds to stimulation with a wide variety of 
microbial products, while TLR4 is rather specific for Gram-negative lipopolysaccharide 
(LPS). Nevertheless, some forms of Gram-negative LPS, including the H. pylori-derived LPS, 
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have a weak affinity for this receptor and mainly act via TLR2 (Schmith et al., 2003; Figure 
9). Activation of the innate immunity via LPS-induced TLR2 has also been described for the 
canine/feline H. felis (Mandell et al., 2004).  Despite the low affinity of Helicobacter LPS to 
TLR4, there is evidence that this receptor may play a partial role in initiating dendritic cells 
(DCs) to produce cytokines in response to H. pylori (Rad et al., 2009; Figure 9).  
Another H. pylori component involved in TLR2 signalling is the neutrophil-activating protein 
(Hp-NAP). Hp-NAP is able to induce the production of IL-12 and IL-23 by human 
neutrophils and monocytes, thereby facilitating the differentiation of native T-helper (Th) 
cells into the Th1 phenotype (D’Elios et al., 2007; Figure 9). Homologs of the Hp-NAP 
coding gene, napA, are also present in the NHPH genomes (Arnold et al., 2011; Vermoote et 
al., 2011; Schott et al., 2011; Smet et al., 2013), but their role in the activation of the innate 
immunity via TLR signalling remains to be further elucidated. 
Bacterial flagellin is specifically recognized by TLR5 (Hayashi et al., 2001). Given the fact 
that H. pylori expresses 4 to 6 polar, sheated flagella, it seemed reasonable to assume that 
TLR5 is involved in H. pylori flagellin recognition (Eaton et al., 1996). However, it has been 
shown that the H. pylori flagellin molecules cannot be sensed by TLR5, because these 
molecules lack the conserved amino acids required for full TLR5 agonist activity (Andersen-
Nissen et al., 2005; Figure 9).    
In addition to TLRs, host cells may also express cytosolic pathogen recognition molecules, 
such as the nucleotide-binding oligomerization domain (NOD) proteins. These molecules 
have been shown to play an important role in host defense against bacterial pathogens, 
including H. pylori (Ferrero, 2005). H. pylori triggers NOD1 signalling via its T4SS. More 
specifically, H. pylori activates NOD1 by transfer of its peptidoglycan into the cytoplasm of 
epithelial cells via a cagPAI-dependent mechanism (Viala et al., 2004; Figure 9).  
Both H. pylori-mediated TLR2 and NOD1 signalling result in the induction of NF-κB and a 
subsequent production of pro-inflammatory cytokines, including IL-8 (Viala et al., 2004). 
Production of IL-8 in gastric epithelial cells can also be mediated in a TLR-/NOD1-
independent manner by H. pylori OMPs (Oleastro & Menard, 2013; Figure 9). OipA or HopH 
regulates IL-8 secretion through PI3/Akt and this regulation is dependent on FoxO1/3a 
inactivation. By using the BabA and SabA adhesins, H. pylori can bind via carbohydrate 
structures to gastric mucins, such as MUC1. On its turn, this mucin is able to induce IL-8 in 
gastric epithelial cells (Sheng et al., 2013; Figure 9). Also other H. pylori OMPs involved in 
attachment to gastric epithelial cells, including AlpA/AlpB and HomB, have been shown to 
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trigger gastric epithelial IL-8 secretion upon adherence (Oleastro & Menard, 2013; Ishijima et 
al., 2011; Figure 9).  
The production of pro-inflammatory cytokines by gastric epithelial cells after H. pylori 
infection facilitates a second stage in the innate immune response which involves the 
recruitement of innate immune cells (neutrophils, macrophages and DCs) to the site of 
infection. Phagocytosis mediated by macrophages and neutrophils is an important anti-
bacterial innate defense mechanism. H. pylori partially evades phagocyte-mediated killing by 
surviving inside phagosomes. This may provide a protected intracellular niche contributing to 
the persistence of infection (Allen et al., 2000; Allen et al., 2001). Additionally, H. pylori 
induces the extracellular release of ROS by phagocytes, but the bacterium is capable of 
surviving this response through its catalase and superoxide dismutase activity (Ramarao et al., 
2000). 
In response to H. pylori antigens, DCs and macrophages further amplify the inflammatory 
response by the production of cytokines, including IL-1β, TNF-α and IL-6. This leads to 
recruitment, differentiation and activation of CD4+ Th cells, which organize the adaptive 
immune response (Wilson & Crabtree, 2007; Figure 9). 
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Figure 9: Schematic representation of the innate immune response upon H. pylori adherence via pathogen-
recognition molecule (PRM) and outer membrane protein (OMP) signalling. H. pylori pathogen-associated 
molecular patterns (PAMPs) (e.g. LPS, NAP) are detected by PRMs expressed by epithelial cells, which results 
in the activation of NF-κB and the production of pro-inflammatory cytokines, such as IL-8. Additionally, H. 
pylori adhesins (including AlpA/B, HomB, BabA and SabA) can initiate IL-8 production upon adherence. The 
pro-inflammatory cytokine IL-8 recruits macrophages, neutrophils and dendritic cells to the site of infection, 
which can be further activated by PAMPs that pass through the epithelial cell barrier. These activated immune 
cells subsequently produce cytokines that facilitate the recruitment of T-helper cells, resulting in the progression 
of inflammation and the development of an adaptive immune response.  
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SCIENTIFIC AIMS OF THE STUDY 
Gastric disease in humans has not only been associated with the well-studied pathogen 
Helicobacter pylori, but also with other Helicobacter spp. naturally colonizing the stomach of 
domestic animals such as H. heilmannii. This zoonotic gastric NHPH species is highly 
prevalent in both cats and dogs. It has been associated with gastritis, gastric and duodenal 
ulcers and low grade MALT lymphoma in humans. Living in close contact with cats and dogs 
has been identified as a significant risk factor for these infections in humans. Information on 
how H. heilmannii interacts with its host still remains poor. The very fastidious nature of this 
bacterium has hampered the progress of H. heilmannii-related research. H. heilmannii was 
successfully isolated in vitro in 2011 opening new doors to investigate the role of this 
pathogen in human gastric pathology.  
 
The ultimate goal of this thesis was to identify the bacterial and host factors involved in 
colonization of the gastric mucosa by H. heilmannii.  
 
The human gastric mucosa is covered by a layer of continuously secreted mucus that washes 
away trapped particles. It is the first barrier Helicobacter encounters and consists of heavily 
glycosylated secreted mucins. The gastric epithelium underneath the mucus layer consists of 
various cell types. To obtain better insights into the interaction of H. heilmannii with the 
human gastric mucosa, experimental infection studies with this bacterium are essential. 
Rodents have been shown to be useful models for the study of Helicobacter-related human 
gastric disease. The first specific aim of this thesis was to investigate the distribution and 
expression pattern of mucins in the stomach of mice during a one year infection with H. 
heilmannii in which gastric disease progressed in severity.  
 
Adherence to the gastric mucosa is widely assumed to play not only an important role in the 
initial colonization but also in the long-term persistence of Helicobacter in the stomach which 
may last for decades or even an entire lifetime. It is well-known that the vast majority of 
Helicobacter bacteria remains in the mucus layer by adherence to mucins, while a small 
percentage binds to the epithelial cell surfaces underneath the mucus layer. Bacterial OMPs 
are directly involved in the interaction of pathogenic bacteria with their host. For H. 
heilmannii, however, nothing is known about the virulence factors that play a role in binding 
of this bacterium to the gastric mucosa. Thus, the second specific aim of this thesis was to 
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characterize the H. heilmannii OMPs involved in this process. Additionally, their role in 
gastric mucin expression during H. heilmannii colonization was investigated as well.  
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EXPERIMENTAL STUDIES 
 
1. Gastric de novo Muc13 expression and spasmolytic polypeptide-expressing 
metaplasia during Helicobacter heilmannii infection 
2. The Helicobacter heilmannii hofE and hofF genes are essential for colonization of 
the gastric mucosa and are involved in IL-1β-induced gastric MUC13 expression 
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Abstract  
Helicobacter heilmannii is a zoonotic bacterium that has been associated with gastric disease 
in humans. In this study, mRNA expression of mucins was analyzed at several time-points in 
the stomach of BALB/c mice during a one year infection with this bacterium in which gastric 
disease progressed in severity. Markers for acid production by parietal cells and mucous 
metaplasia were also examined. In the first 9 weeks post-infection, mRNA expression of 
Muc6 was clearly upregulated in both the antrum and fundus of the stomach of H. heilmannii-
infected mice. Interestingly, Muc13 was upregulated already at 1 day post-infection in the 
fundus of the stomach. Its expression level remained high in the stomach over the course of 
the infection. This mucin is, however, not expressed in a healthy stomach and a high 
expression of this mucin has so far only been described in gastric cancer. In the later stages of 
infection, mRNA expression of H+/K+-ATPase α/β and KCNQ1 decreased whereas the 
expression of Muc4, Tff2, Dmbt1 and PigR increased starting at 16 weeks post-infection 
onwards suggesting the existence of spasmolytic polypeptide-expressing metaplasia in the 
fundus of the stomach. Mucous metaplasia present in the mucosa surrounding low grade 
mucosa associated lymphoid tissue lymphoma-like lesions was also histologically confirmed. 
Our findings indicate that H. heilmannii infection causes severe gastric pathologies, 
alterations in the expression pattern of gastric mucins, such as Muc6 and Muc13, as well as a 
disruption in the gastric homeostasis by inducing loss of parietal cells resulting in the 
development of mucous metaplasia.  
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Introduction 
Helicobacter pylori is the major predisposing factor for the development of chronic active 
gastritis, peptic ulcers and gastric adenocarcinomas in humans, and approximately 15% of the 
infected individuals are estimated to develop such symptoms. This pathogen can be detected 
attached to gastric epithelial cells but is found mainly within the mucus layer and is able to 
bind to highly glycosylated mucins. MUC1, MUC5AC and MUC6 are the major mucins 
covering the healthy gastric mucosa. The membrane-associated MUC1 and secreted 
MUC5AC are expressed at the surface epithelium, whereas MUC6 is secreted by glandular 
cells (Linden et al., 2002; McGuckin et al., 2011; Linden et al., 2009; Taupin and Podolsky, 
2003). 
H. pylori infection causes alterations in the expression pattern, glycosylation and distribution 
of gastric mucins as well as a disruption in the gastric homeostasis by inducing loss of parietal 
cells (Skoog et al., 2012; Weis et al., 2013). The loss of parietal cells can lead to two distinct 
types of mucous metaplasia: intestinal metaplasia and SPEM. It has been suggested that 
intestinal metaplasia develops in the presence of pre-existing SPEM, supporting the role of 
SPEM as a neoplastic precursor in the carcinogenesis cascade (Weis et al., 2013). The 
intestinal mucins MUC2, MUC4 and MUC13 are not expressed in the healthy gastric mucosa 
but have been detected in gastric adenocarcinomas and during stages of mucous metaplasia 
(Mejias-Luque et al., 2010; Reis et al., 1999; Shimamura et al., 2005).  
Besides H. pylori, other spiral-shaped NHPH, such as H. suis in pigs and H. heilmannii (sensu 
stricto), H. felis, H. bizzozeronii and H. salomonis in cats and dogs, have been associated with 
gastric disease in humans (Haesebrouck et al., 2009; Smet et al., 2012). H. heilmannii is 
highly prevalent in healthy cats and dogs as well as in animals with chronic gastritis 
(Haesebrouck et al., 2009). In humans, this Helicobacter species has been associated with 
gastritis, gastric and duodenal ulcers and low grade MALT lymphoma. It has been detected in 
8–19% of gastric biopsies with histological evidence of NHPH infection (Haesebrouck et al., 
2009; Smet et al., 2012; O’Rourke et al., 2004a). Living in close contact with cats and dogs 
has been identified as a significant risk factor for these infections in humans (Haesebrouck et 
al., 2009). Since this species has only recently been isolated and cultured in vitro, information 
on how H. heilmannii interacts with the human stomach and causes disease still remains poor. 
Comparative genomic analyses showed that although the H. heilmannii genome contains 
several genes encoding homologues of known H. pylori virulence factors, it lacks a Cag 
pathogenicity island (CagPAI) as well as genes encoding a vacuolating cytotoxin VacA and 
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several outer membrane proteins involved in binding of H. pylori to the gastric mucosa, such 
as BabA/B, SabA, AlpA/B, OipA, HopZ, HopQ and HomB (Smet et al., 2012). Thus, factors 
that contribute to this pathogen’s colonization properties, in particular adhesion, remain to be 
identified. A recent infection study in a Mongolian gerbil model for human Helicobacter-
induced pathology showed variation in colonization capacity and virulence between different 
H. heilmannii strains isolated from the gastric mucosa of cats. These findings are most 
probably also relevant for infection with this bacterium in humans (Joosten et al., 2013). 
Unlike H. pylori, which is mainly observed at the surface epithelium and close to MUC1- and 
MUC5AC-producing cells (Linden et al., 2002; Linden et al., 2009), H. heilmannii is mostly 
found in the gastric pits as has been described for other NHPH too (Joosten et al., 2013, 
Flahou et al., 2010). This bacterium can be found in close association with parietal cells but is 
also able to bind to human mucus-secreting epithelial cells as well as to mucin samples 
containing highly glycosylated MUC5AC and MUC6 (unpublished data). Whether a H. 
heilmannii infection has an impact on the distribution and expression of the gastric MUC1, 
MUC5AC and MUC6 mucins is currently unknown. SPF inbred C57BL/6 and BALB/c mice 
have been shown to be useful models for the study of Helicobacter-related human gastric 
disease (Flahou et al., 2010). C57BL/6 have been described genetically as predominant Th1 
responders, while BALB/c mice are mainly Th2 responders (Flahou et al., 2010). It has been 
shown that infection with H. suis induces a predominant Th17/Th2 immune response in 
BALB/c mice and even in C57BL/6 mice, in the absence of a Th1 response, but with a more 
pronounced inflammation in BALB/c mice (Flahou et al., 2012). More recently, it has been 
suggested that infection with H. heilmannii also elicits a Th2 immune response (Joosten et al., 
2013). These results are in contrast to the predominant Th17/Th1 response mostly seen during 
H. pylori infection in mice (Flahou et al., 2012). Additionally, H. pylori can also elicit a Th2 
response. Typical for H. pylori strains inducing a Th2 immune response is that they lack 
genes encoding CagPAI, VacA, BabA and SabA (Crabtree et al., 2002). Therefore, in the 
present study, we used Th2-prone BALB/c mice to investigate the expression levels of Muc1, 
Muc5ac and Muc6 in the stomach at several time-points during a one year H. heilmannii 
infection in which gastric disease progressed from gastritis to MALT lymphoma-like lesions 
and mucous metaplasia. Since H. heilmannii has been found close to parietal cells in the 
gastric pits, markers for acid production by parietal cells were examined. Markers for mucous 
metaplasia (in particular the Muc2, Muc4 and Muc13 intestinal mucins) as a result of parietal 
cell loss, were included as well. Infection with the mouse adapted H. pylori SS1, a strain that 
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elicits a Th2 response, was included for the purpose of comparison (Flahou et al., 2012). This 
latter strain, created after several gastric passages in mices, is able to colonize multiple strains 
of mice contrary to its parental human strain pre-mouse (PM)SS1 (Crabtree et al., 2002).  
 
MATERIALS AND METHODS 
Animals.  
Six-week old SPF, female BALB/c mice were purchased from Harlan NL (Horst, The 
Netherlands). The animals were housed in individual filter top cages, had free access to water 
and food (an autoclaved commercial diet (TEKLAD 2018S, containing 18% protein; Harlan)) 
throughout the experiment and were monitored daily.  
The in vivo experimental protocol was approved by the Ethical Committee of the Faculty of 
Veterinary Medicine, Ghent University, Belgium (EC 2011-155; October 27, 2011). 
 
Cultivation of H. heilmannii and H. pylori strains used for infection.  
The highly virulent H. heilmannii strain ASB1.4, isolated from the stomach of a kitten with 
gastritis, was cultivated as described previously (Smet et al., 2012; Joosten et al., 2013). After 
incubation under microaerobic conditions (Smet et al., 2012), the bacteria were harvested and 
the final concentration was adjusted to 7 × 108 viable bacteria/mL. 
The mouse-adapted H. pylori SS1 strain (Crabtree et al., 2002) was grown for 3 days on blood 
agar plates (Oxoid) and further cultured overnight in Brucella broth (Oxoid) under 
microaerobic conditions. The optical density was then adjusted to 1.5, corresponding to 
approximately 1x109 viable bacteria/mL.   
 
Experimental procedure.  
For each time point tested, 6 animals were intragastrically inoculated 3 times at 2 days 
interval with 300 μL of an ASB1.4 or SS1 bacterial suspension and 3 animals with Brucella 
broth (pH 5) serving as negative control. Inoculation was performed under brief isoflurane 
anaesthesia (2.5%), using a feeding needle. At 1 day, 4 days, 1, 2, 3, 4, 9, 12, 16, 20, 24, 34 
and 52 weeks after the first inoculation, the animals were euthanized by cervical dislocation 
under deep isoflurane anaesthesia (5%). The stomach and the duodenum of each mouse were 
resected and samples were taken for histopathological examination and quantitative real-time 
(RT)-PCR analysis. 
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Histopathology and immunohistochemistry.  
A longitudinal section, starting from the end of the forestomach and comprising the antrum 
and the fundus of the stomach and part of the duodenum, was fixed in 10% phosphate 
buffered formalin and embedded in paraffin for light microscopy. From each animal, several 
consecutive paraffin slides of 5 μm were cut, deparaffinized and dehydrated. Heat-induced 
antigen retrieval (100 °C, 20 min) was then performed in citrate buffer (pH 6) and 
endogenous peroxidase activity and non-specific reactions were blocked by incubating the 
slides with 3% H2O2 in methanol (5 min) and 30% goat serum (30 min), respectively. A 
haematoxylin/eosin (H&E) staining was performed on a first slide to score the intensity of the 
gastritis according to the Updated Sydney System as described previously (Flahou et al., 
2010), but with some modifications as shown in Figure 1. On a second slide, B lymphocytes 
were visualized by immunohistochemical staining using a polyclonal rabbit anti-CD20 
antibody (1/100; Thermo Scientific, Fremont, USA). On a third slide, parietal cells were 
identified by immunohistochemical staining using a mouse monoclonal antibody against the 
hydrogen potassium ATPase (1/200; Abcam Ltd, Cambridge, UK). 
Muc13 expression was evaluated by immunohistochemical staining (one slide for each 
staining) using an in-house mouse polyclonal anti-Muc13 antibody. Incubation with primary 
antibodies directed against CD20 and Muc13 was followed by incubation with a biotinylated 
goat anti-rabbit IgG antibody (1/500; DakoCytomation, Heverlee, Belgium). Incubation with 
primary antibody against the hydrogen potassium ATPase and Muc13 was followed by a 
biotinylated goat anti-mouse IgG antibody (1/200; DakoCytomation). To reduce the 
background caused by secondary antibody binding to endogenous mouse IgG, mouse sections 
were further processed with Envision + System-HRP (DAB) (DakoCytomation). After 
rinsing, the sections were incubated with a streptavidin-biotin-HRP complex 
(DakoCytomation) and the color was developed with diaminobenzidine tetrahydrochloride 
(DAB) and H2O2. 
To highlight lymphoepithelial lesions, paraffin slides were stained with a monoclonal mouse 
anti-cytokeratin antibody (1/50; DakoCytomation) and further processed using an 
EnVisionTM+ system for use with mouse primary antibodies (DakoCytomation). 
Finally, a periodic acid-Schiff (PAS)-Alcian blue staining was performed for the differential 
staining of glycoproteins. 
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DNA extraction and quantification of colonizing Helicobacter spp. in the stomach and 
duodenum.  
Samples from the fundus and the antrum of the stomach and from the duodenum of each 
animal were harvested into 1 mL RNA later (Ambion, Austin, TE, USA) and stored at -70 °C 
until RNA- and DNA-extraction. Tissue samples were then homogenized (MagNALyser, 
Roche, Mannheim, Germany) and RNA and DNA were separated (Joosten et al., 2013). The 
number of colonizing H. heilmannii and H. pylori per mg gastric tissue was determined in the 
DNA samples using quantitative RT-PCRs specific for the detection of H. heilmannii and H. 
pylori (Joosten et al., 2013, Flahou et al., 2012). Helicobacter standards were generated as 
described previously (O’Rourke et al., 2004b).  One μL of DNA template was suspended in a 
10 μL reaction mixture consisting of 3.5 μL HPLC water, 5 μL SensiMix™ SYBR No-ROX 
(Bioline Reagents Ltd, UK) and 0.25 μL of both primers (TABLE S1, Integrated DNA 
technologies). Standards and DNA samples were run in duplicate on a CFX96™ RT-PCR 
System with a C1000 Thermal Cycler (Bio-Rad, Hercules CA, USA). For quantification of H. 
heilmannii and H. pylori DNA in the tissue samples, the Bio-Rad CFX Manager (version 1.6) 
software was used. 
 
Real Time (RT)-PCR for gene expression.  
The total RNA concentration in each sample was utilized for first strand cDNA synthesis 
using iScript™ cDNA Synthesis Kit (Bio-Rad). Quantitative RT-PCR was carried out for 
measuring gene expression levels of murine gastric mucins (Muc1, Muc2, Muc4, Muc5AC, 
Muc5B, Muc6 and Muc13), trefoil factors (Tff1 and Tff2), Dmbt1, PigR, H+/K+-ATPase, 
Kcnq1 and Ckb. The housekeeping genes PPIa, H2afz and HPRT were included as reference 
genes. Primer sequences are shown in Table S1. Reactions were performed in 10 μL volumes 
containing 1 μL cDNA, 0.05 μL of both primers (TABLE S1), 3.9 μL HPLC water and 5 μL 
SensiMix™ SYBR No-ROX. The experimental protocol for PCR reaction (40 cycles) was 
performed on a CFX96™ RT-PCR System with a C1000 Thermal Cycler (Bio-Rad). Control 
reactions without the reverse transcriptase step were implemented to exclude DNA 
contamination of the RNA samples. No-template-control reaction mixtures were included and 
all samples were run in duplicate. Results are shown as fold changes of mRNA expression in 
infected animals relative to mRNA expression levels in control animals. Fold changes were 
calculated using the ΔΔCT method (Livak and Schmittgen, 2001) with mean of Ct-values 
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from three uninfected mice as control. Fold changes ≥4 were accepted as up-regulation and 
≤0.25 as down regulation. 
 
Statistical analysis.  
Statistical analysis was performed using SPSS Statistics 21 software (IBM) package. Gastritis 
scores were analyzed using the non-parametric Mann-Whitney U test to compare groups. 
Gene expression was compared between different infected groups and controls using a 
Bonferoni post hoc test (ANOVA). For correlation between different variables, Spearman’s 
rho correlation coefficients were calculated. Differences were considered statistically 
significant at p ≤ 0.05.  
 
RESULTS 
Induction of inflammation by and colonization capacity of H. heilmannii ASB1 and H. 
pylori SS1.  
In none of the non-infected control animals, gastric lymphoid lesions were present. For all 
these animals, histomorphology was considered to be normal, with only minor inflammatory 
cell infiltration in the gastric mucosa. Inflammation in ASB1.4- and SS1-infected mice was 
characterized by mononuclear and polymorphonuclear cell infiltration in the lamina propria 
mucosae, the tunica submucosa or both, depending on the individual animal. At all time-
points, inflammation was observed mainly in the fundus. The fundic inflammation scores of 
each individual animal are shown in Figure 1A. No statistically significant difference between 
inflammation scores for mice inoculated with ASB1.4 or SS1 at a certain time-point was 
demonstrated. From 24 weeks post-infection onwards, large lymphoid aggregates of 
mononuclear and/or polymorphonuclear cells were mainly seen in a narrow zone in the 
fundus near the forestomach/stomach transition zone (Figure 1B & 1C) of both H. heilmannii- 
and H. pylori-infected mice. In mice infected with ASB1.4 and SS1 for at least 34 weeks, B-
cell containing germinal centers were seen in those large lymphoid aggregates (Figures 1F & 
1G). In several mice infected with ASB1.4 and SS1 for 52 weeks, numerous lymphoepithelial 
MALT-lymphoma like lesions could be detected in the gastric mucosa (Figures 1H & 1I). 
These were most abundant in a narrow zone in the fundus near the forestomach/stomach 
transition zone. In all Helicobacter-infected mice, mild signs of inflammation were detected 
in the antrum of the stomach and the duodenum at 52 weeks post-infection (Figures 1D & 
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1E). However, inflammation could also be noted in the junction between antrum and fundus 
of mice infected with H. heilmannii for 52 weeks (data not shown). 
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Figure 1: Gastric inflammation in H. heilmannii- and H. pylori-infected BALB/c mice. 
(A) Fundic inflammation was scored on a scale of 0 to 4 (0: no infiltration with mononuclear and/or 
polymorphonuclear cells; 1: mild diffuse infiltration with mononuclear and/or polymorphonuclear cells or the 
presence of one small (50–200 cells) aggregate of inflammatory cells; 2: moderate diffuse infiltration with 
mononuclear and/or polymorphonuclear cells and/or the presence of 2–4 inflammatory aggregates; 3: marked 
diffuse infiltration with mononuclear and/or polymorphonuclear cells and/or the presence of at least five 
inflammatory aggregates; 4: diffuse infiltration of large regions with large aggregates of mononuclear and/or 
polymorphonuclear cells). Individual animals are depicted as symbols around the mean (lines).  (B&E) H&E 
staining of the fundus, antrum and the duodenum of a Helicobacter-infected BALB/c mouse. A large infiltrate of 
mononuclear cells (arrow) at the forestomach/stomach transition zone of a mice infected with H. heilmannii 
ASB1.4 (B) and H. pylori SS1 (C) at 52 weeks post-infection. Bar = 30 µm.  A mild lymphocytic infiltration of 
the lamina muscularis mucosae in the antrum (D) and duodenum (E) of a mouse infected with H. heilmannii 
ASB1.4 for 52 weeks (arrows). Bar = 30 µm. (F&G) CD20 staining of the forestomach/stomach transition zone 
of a mouse infected with H. heilmannii ASB1.4 (F) and H. pylori SS1 (G) at 52 weeks post-infection, showing B 
lymphocytes (brown) in germinal centers of lymphoid follicles (arrow). Bar = 30 µm.  (H&I) Cytokeratin 
staining of the forestomach/stomach transition zone of a mouse infected with H. heilmannii ASB1.4 (H, Bar = 30 
µm.) and H. pylori SS1 (I, Bar = 10 µm.) at 52 weeks post-infection showing numerous lymphoepithelial lesions 
(arrows).  
 
Throughout the experiment, all control animals were negative for Helicobacter DNA in 
quantitative RT-PCR. At all time-points, Helicobacter DNA was found in both the antrum 
and fundus of the stomach from all infected animals. H. pylori and H. heilmannii DNA was 
found in the duodenum from 3 and 12 weeks post-infection onwards, respectively (Figures 
2A, 2B & 2C). In general, ASB1.4 colonized the stomach of mice at a significantly higher 
level compared to SS1 (P = 0.002 for antrum at 4, 20, 24 and 34 weeks post-infection; P =
0.004 for antrum at 12, 16 and 52 weeks post-infection; P=0.026 for antrum at 9 weeks post-
infection; P = 0.009 for fundus at 12 weeks post-infection; P = 0.002 for fundus at 16, 20, 24 
and 34 weeks post-infection). The amount of ASB1.4 and SS1 DNA was much lower in the 
duodenum compared to the stomach and only at 3 weeks post-infection, a significant 
difference between H. heilmannii and H. pylori was seen (P=0.015; Figure 2C).  
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Figure 2: Colonization capacity of H. heilmannii ASB1.4 and H. pylori SS1 after experimental infection. 
Colonization capacity is shown as log10 values of bacteria per mg tissue, detected with quantitative RT-PCR in 
the antrum (A) and the fundus (B) of the stomach and the duodenum (C). Animals in which no Helicobacter 
* 
* 
* 
* * 
* * 
* 
* 
* 
* * * * 
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DNA could be detected in the gastro-intestinal tract were set as 0. Helicobacter DNA was found in the 
duodenum from 3 weeks post-infection onwards. Individual animals are depicted as figures around the mean 
(lines). Statistical significant differences between animals infected with H. heilmannii ASB1.4 and H. pylori SS1 
are indicated by * (Mann-Whitney U test, p < 0.05).  
 
Changes in Muc1, Muc5AC, Muc5B and Muc6 expression during H. heilmannii 
colonization.  
No change in mRNA expression of Muc1 and Muc5AC was seen in the stomach during the 
whole experiment (data not shown). In the first 9 weeks post-infection, quantitative RT-PCR 
showed a clear upregulation in mRNA expression of Muc6 both in the antrum (ASB1.4: 7.43 
± 2.08; SS1: 6.39 ± 2.5) and fundus (ASB1.4: 5.88 ± 2.66; SS1: 6.86 ± 3.01) of Helicobacter-
infected mice compared to the control group (Figures 3A & 3B and Supplementary figures 1A 
& 1B). In addition, a significant positive correlation was observed between Muc6 expression 
and Helicobacter colonization in the antrum of ASB1.4-infected mice (Figure 3C).  
Also in this early stage of infection, Muc5B was abnormally expressed in the stomach of mice 
infected with both species (Figure 4A & 4B and Supplementary figures 1C & 1D). This 
mucin is normally not expressed in a healthy stomach (Schmitz et al., 2009). Compared to the 
control animals with mRNA expression level set to 1, the antral fold difference between 
Muc5B and Muc5AC was 6.02 ± 2.27 for ASB1.4- and 5.68 ± 2.81 for SS1-infected mice. 
The fundic fold difference between Muc5B and Muc5AC was 2.88 ± 1.63 and 3.84 ± 1.53 for 
ASB1.4- and SS1-infected animals, respectively.  
Alterations in mucin mRNA expression were also evaluated in the duodenum. The mRNA 
expression level of Muc1 was significantly increased at 4 weeks post-infection in the 
duodenum of H. heilmannii-infected mice (P=0.036) and H. pylori-infected mice (P = 0.047) 
(Supplementary figure 1G). A significantly increased expression of Muc5AC was seen at 4 (P 
= 0.032) and 16 (P = 0.026) weeks post-infection in the duodenum of H. heilmannii-infected 
mice (Supplementary figure 1H).  
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Figure 3: Muc6 expression in the stomach of Helicobacter-infected and control mice.  
Expression level of Muc6 in the antrum (A) and fundus (B) of the stomach of ASB1.4- and SS1-infected 
BALB/c mice is shown. Data are presented as fold change in gene expression normalized to 3 reference genes 
and relative to the negative control group which is considered as 1. Data obtained from the time points 1 day, 4 
days, 1, 2, 3, 4, and 9 weeks are pooled and designated as “early stage of infection”. Data obtained from the time 
points 12, 16, 20 and 24 weeks are pooled and designated as “mid-stage of infection”. Data obtained from the 
time points 34 and 52 weeks are pooled and designated as “late stage of infection”. Data are shown as means + 
standard deviation. Significant differences in expression level between the infected groups and the negative 
control group at a certain time frame are indicated by * p<0.05 or *** p<0.001 (ANOVA). (C) Correlation 
analysis between Muc6 mRNA expression and the number of colonizing Helicobacter bacteria in the antrum of 
the stomach of BALB/c mice. Time-points 4 days, 1 week, 2, 4 and 9 weeks were taken into account. Correlation 
was measured by Spearman’s Rho (ρ; p<0.05). 
 ρ = 0.433; p=0.020 
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Figure 4: Muc5B expression in the stomach of Helicobacter-infected and control mice. Expression of Muc5B in 
the antrum (A) and fundus (B) of the stomach of ASB1.4- and SS1-infected BALB/c mice is shown. Data are 
presented as fold change in gene expression normalized to 3 reference genes and relative to the negative control 
group which is considered as 1. Data obtained from the time points 1 day, 4 days, 1, 2, 3, 4, and 9 weeks are 
pooled and designated as “early stage of infection”. Data obtained from the time points 12, 16, 20 and 24 weeks 
are pooled and designated as “mid-stage of infection”. Data obtained from the time points 34 and 52 weeks are 
pooled and designated as “late stage of infection”. Data are shown as means + standard deviation. Significant 
differences in expression level between the infected groups and the negative control group at a certain time 
frame are indicated by * p<0.05 or *** p<0.001 (ANOVA). Significant differences in expression level between 
groups inoculated with H. heilmannii ASB1 or H. pylori SS1 of different time frames are indicated by # p<0.05 
or ### p<0.001 (ANOVA). 
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H. heilmannii infection stimulates Muc13 expression.  
The transmembrane Muc13 is only expressed at very low levels in a healthy stomach. Under 
healthy conditions, this cell-surface mucin is mainly expressed in the glycocalyx of 
enterocytes and goblet cells in the small and large intestine particularly at the luminal surface 
(Sheng et al., 2011). Interestingly, mRNA expression of Muc13 was significantly increased at 
day 1 until 9 weeks post-infection (P<0.001) in the fundus of the stomach of both H. 
heilmannii- and H. pylori-infected mice compared to the control group (ASB1: 6.08 ± 0.84; 
SS1: 5.91 ± 1.21) (Figure 5B & Suplementary figure 2B). Its mRNA expression level was 
also high in the antrum (ASB1.4: 9.61 ± 4.08; SS1: 10.09 ± 4.38) and fundus (ASB1.4: 5.77 ± 
4.33; SS1: 7.17 ± 3.67) of the stomach in the late stage of infection (Figures 5A & 5B, 
Supplementary figure 2A & 2B). A significant positive correlation was observed between 
Muc13 expression and Helicobacter colonization in the fundus of H. heilmannii- and H. 
pylori-infected mice in the first 9 weeks post-infection (Figures 5C & 5D). Although H. 
heilmannii DNA could not be found in the duodenum during the first weeks of infection, the 
Muc13 expression level was significantly increased here too at 1 (8.67 ± 1.89; P<0.001) and 2 
(6.97 ±3.09; P<0.001) weeks post-infection (Supplementary figure 2C).  
Immunohistochemical staining showed an apical membrane and cytoplasmic Muc13 staining 
(brown) in mucus-secreting epithelial cells of the stomach of Helicobacter infected mice but 
not in the non-infected controls (Figure 5E & 5F).   
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Figure 5: Muc13 expression in the stomach of Helicobacter-infected and control mice.  
Expression of Muc13 in the antrum (A) and fundus (B) of the stomach of ASB1.4- and SS1-infected BALB/c 
mice is shown. Data are presented as fold change in gene expression normalized to 3 reference genes and relative 
to the negative control group which is considered as 1. Data obtained from the time points 1 day, 4 days, 1, 2, 3, 
4, and 9 weeks are pooled and designated as “early stage of infection”. Data obtained from the time points 12, 
16, 20 and 24 weeks are pooled and designated as “mid-stage of infection”. Data obtained from the time points 
34 and 52 weeks are pooled and designated as “late stage of infection”. Data are shown as means + standard 
deviation. Significant differences in expression level between the infected groups and the negative control group 
at a certain time frame are indicated by * p<0.05 or *** p<0.001 (ANOVA). Significant differences in 
expression level between groups inoculated with H. heilmannii ASB1 or H. pylori SS1 of different time frames 
are indicated by # p<0.05 or ### p<0.001 (ANOVA).(C & D) Correlation analysis between Muc13 mRNA 
expression and the number of colonizing Helicobacter bacteria in the stomach of BALB/c mice. Time-points 4 
days, 1 week, 2, 4 and 9 weeks were taken into account. Correlation was measured by Spearman’s Rho (ρ, 
ρ = 0.331; p=0.049 ρ = 0.316; p=0.025 
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p<0.05). (E &F) Immunohistochemical analysis of Muc13 expression (brown) in the fundus of the stomach of a 
control mouse (E; Bar = 30 µm) and a mouse infected with H. heilmannii ASB1.4 for 4 weeks (F; Bar = 30 µm). 
 
H. heilmannii induces reduced expression of markers for gastric acid secretion by 
parietal cells in the fundus of the stomach.  
To determine whether Helicobacter colonization has an impact on gastric acid secretion, 
expression of different markers was analyzed (Jain et al., 2006). Quantitative RT-PCR 
analysis showed a clear down-regulation in the expression of  H+/K+-ATPase α and β proton 
pump subunits in the fundus of H. heilmannii- and H. pylori-infected mice at 52 weeks post-
infection (Figures 6A & 6B). Compared to the control animals with mRNA expression level 
set to 1, the mean relative expression of H+/K+-ATPase α was 0.24 ± 0.14 and 0.2 ± 0.07 for 
ASB1.4- and SS1-infected animals, respectively. The H+/K+-ATPase β relative mean 
expression was 0.23 ± 0.15 and 0.22 ± 0.14 for ASB1.4- and SS1-infected animals, 
respectively. The KCNQ1 potassium channel, which co-localizes with the proton pump at the 
apical membrane, has been proposed to be responsible for K+ conductance associated with 
acid secretion (Grahammer et al., 2001). Its expression level was normal until 34 weeks post-
infection, but was significantly downregulated (ASB1.4: 0.2 ± 0.11; SS1: 0.23 ± 0.07) at 52 
weeks post-infection in the fundus of Helicobacter-infected mice compared to the control 
group (Figure 6C). Reduction in the fundic expression of H+/K+-ATPase α and β proton pump 
subunits and the KCNQ1 potassium channel suggests reduced gastric acid secretion by 
parietal cells. A loss of parietal cells could clearly be visualized by immunohistochemical 
staining in the fundus close to the forestomach/stomach transition zone of the stomach of 
ASB1.4- and SS1-infected mice (Figure 6D, 6E & 6F). Quantification of parietal cells in 5 
randomly chosen High Power Fields in the fundus of the stomach of animals infected for 52 
weeks also showed a clear reduction of parietal cells in ASB1.4- and SS1-infected mice 
compared to the controls (Figure 6G). 
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Figure 6:  Analysis of parietal cells in the fundus of the stomach of Helicobacter-infected and control mice.  
Expression levels of Atp4a (A), Atp4b (B) and Kcnq1 (C) in the fundus of the stomach of H. heilmannii 
ASB1.4- and H. pylori SS1-infected mice are shown. Data are presented as fold change in gene expression 
normalized to 3 reference genes and relative to the negative control group which is considered as 1. Significant 
differences in expression level between the infected groups and the negative control group at a certain time point 
are indicated by * p<0.05 or *** p<0.001 (ANOVA).  
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 (D, E & F) Immunohistochemical staining for the hydrogen potassium ATPase. (D) ATPase staining of the 
fundus of a sham-inoculated mouse. (E & F) Loss of parietal cells (arrows) was seen in the fundus of the 
stomach of a mouse infected with H. heilmannii ASB1.4 for 52 week, (Bar = 30 µm). 
(G) The mean numbers of parietal cells in the fundus of the stomach from mice infected with Helicobacter for 52 
weeks and control mice are shown. The number of parietal cells in each stomach was determined by counting 
ATPase-positive cells in 5 randomly chosen High Power Fields at the level of the gastric pits. Significant 
differences between Helicobacter-infected and control animals are indicated by *** (ANOVA, p < 0.001). 
 
Markers for metaplastic progression are upregulated in the fundus of the stomach in 
response to chronic infection with H. heilmannii.  
Loss of parietal cells can lead to mucous metaplasia. To investigate whether metaplastic 
lineages were found in the stomach, mRNA expression of different markers for metaplastic 
progression was analyzed (Weis et al., 2013). From 16 weeks post-infection onwards, Muc4 
expression was upregulated in the fundus of the stomach of Helicobacter-infected animals 
compared to the controls and its expression remained high until the end of the study at 52 
weeks post-infection (Figure 7A). The mRNA expression level of Dmbt1, which has a 
function in epithelial cell differentiation and gastric mucosal protection (Conde et al., 2007), 
was highly increased between 20 and 52 weeks post-infection in the fundus of H. heilmannii- 
and H. pylori-infected mice (Figure 7B). Similar results were found for the polymeric 
immunoglobulin receptor (PIgR), which is involved in the transport of immunoglobulin A 
across mucosal membranes, from the basolateral aspect of epithelial cells to the luminal 
surface. PIgR is highly expressed in intestinal epithelial cells but is not present in the normal 
gastric mucosa (Gologan et al., 2008). During this in vivo experiment, its expression level was 
highly upregulated from 20 weeks post-infection onwards in the fundus of mice infected with 
both species (Figure 7C). Expression of Tff2 was significantly increased at 52 weeks post-
infection in the fundus (ASB1.4: 6.49 ± 3.32, SS1: 3.44 ± 1.49) (Supplementary figure 1F). 
Muc4, Dmbt1, PIgR and Tff2 have been described to be related to SPEM with chronic 
inflammation (Weis et al., 2013; Nomura et al., 2004). A PAS Alcian blue staining showed at 
34 and 52 weeks post-infection evidence for mucous metaplasia in which metaplastic 
columnar glands, mainly initiating from the transition zone junction between the forestomach 
and glandular epithelium along the lesser curvature (Figure 7G) and to a lesser extent in the 
antrum (Figure 7E) and fundus (Figure 7D) of the stomach of Helicobacter-infected mice. 
Quantification of blue-stained metaplastic cells in 5 randomly chosen High Power Fields in 
the forestomach/stomach transition zone also highlighted the presence of mucous metaplasia 
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in the stomach of animals infected for 52 weeks with ASB1.4 and SS1 but not in the non-
infected controls (Figure 7H). 
 
 
Figure 7: Determination of mucous metaplasia in the fundus of the stomach of Helicobacter-infected.  
mRNA expression levels of Muc4 (A), Dmbt1 (B) and PigR (C) in the fundus of the stomach of H. heilmannii 
ASB1.4- and H. pylori SS1-infected mice are shown. Data are presented as fold change in gene expression 
normalized to 3 reference genes and relative to the negative control group which is considered as 1. Data are 
shown as means + standard deviation. Significant differences in expression level between the infected groups 
and the negative control group at a certain time point are indicated by * p<0.05 or *** p<0.001 (ANOVA).  
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(D) PAS-Alcian Blue staining of the the forestomach/stomach transition zone of a sham-inoculated mouse. PAS-
Alcian Blue staining of the antrum (E) and the fundus (F) of the stomach of a mouse infected with H. heilmannii 
ASB1 for 24 weeks. (G) PAS-Alcian Blue staining of the forestomach/stomach transition zone of a mouse 
infected with H. heilmannii ASB1 for 52 weeks. (7E & 7F: Bar = 10 µm; 7D & 7G: Bar = 30 µm). Metaplastic 
columnar cells, mainly initiating from the transition zone junction between the forestomach and glandular 
epithelium along the lesser curvature (G) and to a lesser extent in the antrum (E) and fundus (F) of the stomach 
of Helicobacter-infected mice, are indicated in blue. 
(H) The mean numbers of metaplastic cells in the forestomach/stomach transition zone of the mice infected with 
Helicobacter for 52 weeks and control mice are shown. The number of metaplastic cells was determined by 
counting blue cells in 5 randomly chosen High Power Fields after staining with PAS Alcian blue. Significant 
differences between Helicobacter-infected and control animals are indicated by *** (ANOVA, p < 0.001). 
 
Discussion 
In BALB/c mice infected with H. heilmannii ASB1.4 and H. pylori SS1 for 52 weeks, 
MALT-lymphoma-like lesions were observed in a narrow zone in the fundus near the 
forestomach/stomach transition zone. These pathological lesions might eventually lead to 
gastric MALT lymphoma (O’Rourke et al., 2004a). The risk to develop MALT lymphoma has 
been suggested to be higher in humans suffering from a NHPH gastritis than those infected 
with H. pylori (Flahou et al., 2010). Gastric MALT lymphoma is characterized by a strong 
proliferation of B-lymphocytes which may be dependent on Th2-type cytokines (Flahou et al., 
2010, Flahou et al., 2012). Experimental NHPH infections have indeed been shown to evoke a 
Th2-polarized response (Joosten et al., 2013, Flahou et al., 2012), suggesting that Th2-prone 
BALB/c mice (Enno et al., 1998) infected with NHPH can be seen as a critical model for the 
development of MALT lymphoma induced by NHPH.  
It has been demonstrated that H. pylori strains mainly stimulate Th1 responses both in humans 
and in mouse models (Robinson et al., 2005). However, as an exception, the H. pylori strain 
SS1 does not cause a significant upregulation of IFN-γ expression, a signature Th1 marker, in 
either in BALB/c or in C57BL/6 mice. Nevertheless, in common with other NHPH, it elicits a 
Th2 response in mice (Crabtree et al., 2002; Thompson et al., 2004). This may explain the 
development of MALT lymphoma-like lesions in the stomach seen in this and other studies 
(Thompson et al., 2004). Typical for H. pylori strains inducing MALT lymphoma is that they 
lack genes encoding major virulence factors such as a functional CagPAI, Bab and Sab 
adhesins (Thiberge et al., 2010). Compared to its parental strain (PMSS1), H. pylori SS1 
indeed lacks a functional CagPAI (Crabtree et al., 2002). This strain also doesn’t bind to the 
glycan structures Leb and sLex expressed by human gastric mucins (unpublished data). 
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Binding to Leb and sLex has been shown to be mediated by the H. pylori BabA and SabA 
adhesins, respectively (Linden et al., 2002; Linden et al., 2009), suggesting that SS1 doesn’t 
express these adhesins. These virulence factors as well as a functional Cag PAI are also 
absent in H. heilmannii and other NHPH (Smet et al., 2013; Vermoote et al., 2011; Schott et 
al., 2011; Arnold et al., 2011).  
In this study, H. heilmannii ASB1.4 and H. pylori SS1 colonized both the antrum and fundus 
of the stomach but with a higher colonization density seen in the antrum. This is similar to 
what has been described in human patients. Indeed, in humans infected with NHPH, 
colonization mainly occurs in the antrum of the stomach but these bacteria may be found in 
the fundus as well, which has also been described for H. pylori (Haesebrouck et al., 2009). In 
the present study, H. heilmannii-infected BALB/c mice showed higher colonization rates in 
the antrum and fundus of the stomach compared to H. pylori-infected mice. This indicates that 
the capacity of ASB1.4 to persist in the stomach of BALB/c mice is higher than that of SS1 
which showed a reduction in colonization during the later stages of infection. This latter 
finding has also been reported by Schmitz et al. (2009). DNA from H. heilmannii ASB1.4 and 
H. pylori SS1 was also found in the duodenum. Since both species have been linked to 
duodenal ulcer disease (Haesebrouck et al., 2010), it remains to be elucidated whether they 
are able to colonize the duodenum or whether the qRT-PCR just picked-up DNA from 
bacteria colonizing the stomach.    
The expression of MUC1, MUC5AC and MUC6 in the human gastric epithelium in relation 
to H pylori colonization has been previously investigated showing that H. pylori interacts with 
epithelial cells that produce MUC1 and MUC5AC by binding to Leb and sLe
x expressed by 
these mucins. This indicated that MUC1 and MUC5AC, but not MUC6, plays a role in the 
colonization of H pylori to the gastric mucosa (Linden et al., 2002; Linden et al., 2009). On 
the contrary, in this study, a clear upregulation of Muc6 but not Muc5AC and Muc1 was seen 
in the stomach of H. heilmannii ASB1.4-infected BALB/c mice in the first 9 weeks post-
infection. The pathway regulating gastric MUC6 expression in response to H. heilmannii 
infection in the human stomach as well as the bacterial factors involved are unknown and 
need further investigation. During this early stage of infection, the increased expression of 
Muc6 in the antrum was also positively correlated with the number of H. heilmannii  bacteria.  
Since Muc6 is expressed by the glands and, unlike H. pylori (Linden et al., 2002), NHPH are 
mainly localized in the deep glands of the gastric mucosa (Haesebrouck et al., 2009; Flahou et 
al., 2010; Flahou et al., 2012), the potential role of Muc6 in H. heilmannii colonization is 
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suggested and needs to be further unraveled. Whether Muc6 plays a role in colonization of H. 
pylori strains lacking the BabA and SabA adhesins, such as the SS1 strain, needs also further 
investigation. 
Another interesting finding seen during H. heilmannii ASB1.4 as well as H. pylori SS1 
infection was the increased mRNA expression of Muc13 in the stomach. MUC13 has been 
shown to be highly expressed in human gastric cancer (Sheng et al., 2011) but an increased 
mRNA expression in the early stages of Helicobacter colonization has so far never been 
described. The positive correlation found between the increased Muc13 expression and the 
increased number of Helicobacter bacteria in the fundus of the stomach during the first 9 
weeks of infection, suggests a potential role for Muc13 in Helicobacter colonization. The 
expression level of Muc13 remained upregulated until 52 weeks post-infection. It has been 
described that a sustained elevation in expression of cell-surface mucins may promote the 
transition from chronic inflammation to cancer (Sheng et al., 2011). How Muc13 influences 
the Helicobacter colonization process is unknown and needs further investigation. 
In this study, mRNA expression of several markers for gastric acid secretion by parietal cells 
was significantly reduced at 52-weeks post-infection in the fundic epithelium of H. 
heilmannii-infected mice suggesting loss of parietal cell function. A clear loss of parietal cells 
was indeed shown by immunohistochemical staining. Parietal cell loss might eventually lead 
to the development of mucous metaplasia (Weis et al., 2013). Markers for metaplastic 
progression into SPEM were indeed found to be upregulated in the fundic region of the 
stomach during later stages of infection with H. heilmannii ASB1.4 and H. pylori SS1. 
Mucous metaplasia in a narrow zone of the fundus near the limiting ridge of the stomach of 
H. heilmannii-infected mice was histologically confirmed. MALT-lymphoma-like lesions 
were also seen in this region. In gastric cancer, intestinal metaplasia present in the mucosa 
surrounding low-grade MALT-lymphomas has been described (Lamarque et al., 2006). 
However, in our study, evidence for intestinal metaplasia, such as de novo expression of 
Muc2 as described in H. pylori infection (Mejias-Luque et al., 2010), was not seen. It remains, 
therefore, to be determined whether SPEM may further differentiate into intestinal metaplasia 
and in worst case scenario into dysplasia in mice kept for longer than 1 year after 
experimental infection with H. heilmannii.      
Taken together the results of histopathology and quantitative RT-PCR, the present 
experimental infection study in BALB/c mice illustrates that infection with H. heilmannii 
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induced severe gastric pathology that progressed into MALT lymphoma like lesions and 
SPEM as well as changes in the expression of Muc6 and Muc13 in the stomach.  
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TABLE S1: List of primers used in quantitative RT-PCR for gene expression. 
Primer* Sequence Reference 
Hh_FWQ 5’-CTT TCT CCT GGT GAA GTG ATT CTC-3’ 1 
Hh_RVQ 5’-GCT GTA CCA GAG GCA ATG TCC AAG-3’ 1 
Hp_F1 5’- AAA GAG CGT GGT TTT CAT GGC G -3’ 2 
Hp_R1 5’- GGG TTT TAC CGC CAC CGA ATT TAA -3’ 2 
H2afz-F 5’-GGT ATC ACC CCT CGT CAC TT-3’ 2 
H2afz-R 5’-TCA GCG ATT TGT GGA TGT GT-3’ 2 
HPRT-F 5’-CAG GCC AGA CTT TGT TGG AT-3’ 2 
HPRT-R 5’-TTG CGC TCA TCT TAG GCT TT-3’ 2 
PPIA-F 5’-AGC ATA CAG GTC CTG GCA TC-3’ 2 
PPIA-R 5’-TTC ACC TTC CCA AAG ACC AC-3’ 2 
Muc1-F 5’-GGT TGC TTT GGC TAT CGT CTA TTT-3’ This study 
Muc1-R 5’-AAA GAT GTC CAG CTG CCC ATA-3’ This study 
Muc2-F 5’-GTC TGC CAC CTC ATC ATG GA-3’ This study 
Muc2-R 5’-CAG GCA AGC TTC ATA GTA GTG CTT-3’ This study 
Muc4-F 5’-TCT TTC TGT CTC AAC TGT TGA ATC AGA-3’ This study 
Muc4-R 5’-CGT GGC CAG GAT GTC AAA C-3’ This study 
Muc6-F 5’-TGC TCC CAG AAT GAG TAC TTC GA-3’ This study 
Muc6-R 5’-CAG AGG TGG AAC TGT GAA ACT CAG T-3’ This study 
Muc13-F 5’-GCC AGT CCT CCC ACC ACG GTA-3’ This study 
Muc13-R 5’-CTG GGA CCT GTG CTT CCA CCG-3’ This study 
Muc5b-F 5’-CAG ATC CAT CCA TCC CAT TTC T-3’ This study 
Muc5b-R 5’-TAT CTG ACT ACC ACT TGT TGA TGT GAC T-3’ This study 
Tff1-F 5’-ATG CTG GCC TTC GGC AGC CTT GCC-3’ This study 
Tff1-R 5’-GCA ACC TCT CTC CGT GCA CTG CTG-3’ This study 
Tff2-F 5’-TTG GGA CTG CAT GCT CTG GTA GAG-3’ This study 
Tff2-R 5’-AGG GAC CCC AGC GAC GCT AGA GTC-3’ This study 
H+, K+-ATPase α-F 5-TGC TGC TAT CTG CCT CAT TG-3’ 3 
H+, K+-ATPase α-R 5’-GTG CTC TTG AAC TCC TGG TAG-3’ 3 
H+, K+-ATPase β-F 5’-AAC AGA ATT GTC AAG TTC CTC-3’ 3 
H+, K+-ATPase β-R 5’-AGA CTG AAG GTG CCA TTG-3’ 3 
Dmbt1 F 5’-ACC TCC TCA CGG TGC TAC AG-3’ 3 
Dmbt1 R 5’-GCT TCT TCA CAT CCT CCA CTG-3’ 3 
PigR F 5’-GAT TTG GGA GGC AAT GAC AAC-3’ 3 
PigR R 5’-GCT TTC TTG GAT TCT TCT GGC-3’ 3 
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Kcnq1 F 5’-AGA TGC GGT GAA CGA GTC-3’ 3 
Kcnq1 R 5’-CAG GAG GCG ATG GTC TTC-3’ 3 
Ckb F 5’-GAT CTG AGC AGC CAC AAC-3’ 3 
Ckb R 5’-GTC TAC GCC AGT CTG AAT G-3’ 3 
Nmyc F 5’-ACC TCC GGA GAG GAT ACC TTG AG-3’ 3 
Nmyc R 5’-CAT AGT TGT GCT GCT GAT GGA TGG-3’ 3 
*Primers used for measuring mRNA expression of Muc5AC were purchased from QIAGEN Cat.no.:Qt01196006 
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Figure. S1: mRNA expression levels of Muc6, Muc5B and Tff2 in the stomach and Muc1 and Muc5AC in the duodenum of H. heilmannii ASB1.4- and H. pylori SS1-
infected mice. Expression levels of Muc6 in the antrum (A) and fundus (B), Muc5B in the antrum (C) and fundus (D), Tff2 in the antrum (E) and fundus (F) and Muc1 (G) 
and Muc5AC (H) in the duodenum are shown. Data are presented as fold change in gene expression normalized to 3 reference genes and relative to the negative control group 
which is considered as 1. Data are shown as means + standard deviation. Significant differences in expression level between groups inoculated with H. heilmannii ASB1 and 
H. pylori SS1 at a certain time-point are indicated by # (Mann-Withney U test, p<0.05).  Significant differences in expression level between the infected groups and the 
negative control group at a certain time point are indicated by * for the ASB1.4-infected mice and + for SS1-infected mice (Mann-Withney U test, p<0.05).  
   
Figure S2: mRNA expression level of Muc13 in the stomach and duodenum of H. heilmannii ASB1.4- and H. pylori SS1-infected mice. Expression levels of Muc13 in the 
antrum (A) and fundus (B) of the stomach and the duodenum (C) are shown. Data are presented as fold change in gene expression normalized to 3 reference genes and 
relative to the negative control group which is considered as 1. Data are shown as means + standard deviation. Significant differences in expression level between groups 
inoculated with H. heilmannii s.s. ASB1.4 and H. pylori SS1 at a certain time-point are indicated by # (Mann-Withney U test, p<0.05).  Significant differences in expression 
level between the infected groups and the negative control group at a certain time point are indicated by * for the ASB1.4-infected mice and + for SS1-infected mice (Mann-
Withney U test, p<0.05). 
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Abstract 
Helicobacter heilmannii is a zoonotic bacterium associated with gastric disease in humans. 
We recently showed that H. heilmannii binds to human gastric mucins and epithelial cells and 
highlighted a potential role for the murine Muc13 mucin in gastric Helicobacter colonization. 
The aims of this study were to investigate the role of the H. heilmannii hof gene locus 
encoding HofH/F/E/G/C/D in adhesion to the gastric mucosa and induction of increased 
gastric Muc13 expression.  
Bacterial hof gene and host gene expression experiments, Helicobacter binding assays and 
experimental infection studies in mice were performed. H. pylori and its ΔhofF mutant were 
included for comparison.  
H. heilmannii strains lacking HofE or HofF showed a clear decrease in binding to gastric 
mucins and epithelial cells as well as a lower gastric colonization level in the stomach of 
Balb/c mice at 4 and 9 weeks post-infection compared to the H. heilmannii wildtype strain. 
Interestingly, H. heilmannii ΔhofE and ΔhofF and H. pylori ΔhofF did not induce an 
increased expression of MUC13 in human gastric epithelial cells and of Muc13 in the 
stomach of mice. Finally, we demonstrated that IL-1β is induced in the stomach as a response 
to Helicobacter colonization which on its turn is involved in the expression of 
MUC13/Muc13 in the gastric epithelium.  
These novel results in Helicobacter research identified H. heilmannii HofE and HofF as 
adhesins and suggest an important  role of H. heilmannii HofE and HofF and H. pylori HofF 
in IL-1β-induced gastric MUC13/Muc13 expression. 
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Introduction 
Helicobacter pylori colonizes the stomach of more than half of the human population. 
Infection with this agent causes a wide variety of gastric disorders, including gastritis, ulcers 
and cancer (Montecucco et al., 2001). However, gastric disease in humans has also been 
associated with other, long spiral-shaped NHPH naturally colonizing the stomach of 
domesticated animals, such as cats, dogs and pigs (Haesebrouck et al., 2009). One of the most 
predominant Helicobacter species in the feline stomach is H. heilmannii (Haesebrouck et al., 
2009; Smet et al., 2012). This Helicobacter species is highly prevalent in healthy cats as well 
as animals showing chronic vomiting (Haesebrouck et al., 2009). Most likely, transmission of 
H. heilmannii to humans occurs through direct or indirect contact between cats and humans 
(Haesebrouck et al., 2009). In humans, this pathogen has been associated with gastritis, peptic 
and duodenal ulcers and MALT lymphoma. The risk of developing MALT lymphoma is 
higher after infection with a NHPH species, such as H. heilmannii, than with H. pylori 
(Haesebrouck et al., 2009; Liu et al., 2014; Joosten et al., 2013; O’Rourke et al., 2004; Van 
Den Bulck et al., 2005; Baele et al., 2009).  
Information on how H. heilmannii colonizes the human gastric mucosa still remains scarce. 
The human gastric mucosa is covered by a layer of continuously secreted mucus that washes 
away trapped particles. It is the first barrier Helicobacter encounters and consists of heavily 
glycosylated secreted mucins (MUC) (Linden et al., 2002; McGuckin et al., 2011). In a 
healthy human stomach, MUC1, MUC5AC and MUC6 are the major mucins covering the 
gastric mucosa. The membrane-associated MUC1 and secreted MUC5AC are expressed by 
the surface epithelium, whereas MUC6 is secreted by glandular cells (Linden et al., 2002; 
McGuckin et al., 2011; Sheng et al., 2012). In a recent one-year experiment, Balb/c mice 
experimentally infected with H. heilmannii developed severe gastric pathologies that 
progressed into MALT-lymphoma like-lesions and SPEM as well as changes in the 
expression pattern of gastric mucins (Liu et al., 2014). Of particular interest was the increased 
expression of the murine Muc13 mucin already in the early stages of H. heilmannii 
colonization. This novel phenomenon was also observed during H. pylori infection (Liu et al., 
2014). Human MUC13 and murine Muc13 are transmembrane mucins that are most abundant 
in the intestinal tract. In the healthy stomach, the expression level is very low (Sheng et al., 
2011). The positive correlation between the increased Muc13 expression and the increased 
number of H. heilmannii and H. pylori bacteria in the stomach of mice during the acute stage 
of infection highlights a potential role for Muc13 in Helicobacter colonization (Liu et al., 
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2014).  
Adherence to the gastric mucosa is widely assumed to play an important role in the initial 
colonization of Helicobacter in the stomach (McGuckin et al., 2011). The vast majority of H. 
pylori remains in the mucus layer by adherence to mucins, while a small percentage binds to 
the epithelial cell surfaces underneath the mucus layer (Linden et al., 2002; Appelmelk et al., 
2000). More recently, we showed that H. heilmannii also binds to human mucin samples as 
well as to gastric epithelial cells (Smet et al., 2014). In general, H. pylori and H. heilmannii 
have a higher binding capacity to mucins at pH2 and to epithelial cells at pH7 (unpublished 
results; Skoog et al., 2012). H. pylori is equipped with a large set of OMPs, which role in the 
adhesion process has been well-studied. The H. pylori OMPs BabA/B (HopS/T), SabA 
(HopP), AlpA/B (HopB/C), OipA (HopH), HopZ, HopQ and HomB have been identified as 
adhesins (Oleastro et al., 2013; Ilver et al., 1998; Mahdavi et al., 2002; Alm et al., 2000; 
Kavermann et al., 2003; Odenbreit et al., 1999). Based on the available genome sequence of 
H. heilmannii, this microorganism also harbours a large set of OMPs which is in agreement 
with the approximately 64 well annotated OMPs described in H. pylori (Alm et al., 2000). 
Interestingly, it lacks all H. pylori OMPs identified as adhesins so far, indicating that other 
OMPs might be involved in binding (Smet et al., 2013). H. heilmannii contains a ca. 10kb 
locus encoding homologs of 6 H. pylori Hof OMP proteins (HofH/F/E/G/C/D, Fig. 1). This 
hof locus is also present in other zoonotic NHPH, such as H. felis (Figure 1, Smet et al., 2014).  
 
 
Figure 1: Schematic representation of the hof gene locus of the H. heilmannii ASB1 strain (above; 9780 bp; 
EMBL genome accession number CDMK00000000) and H. felis CS1 (ATCC49179) strain (below; 9451 bp; 
NCBI genome accession number NC_014810). Blast comparisons between these two genomic regions showed 
an overall nucleotide identity of 78%. This locus harbors the hofH (1470 bp (ASB1); 1476 bp (CS1)), hofF 
(1530 bp (ASB1); 1539 bp (CS1)), hofE (1356 bp (ASB1); 1341 bp (CS1)), hofG (1479 bp (ASB1); 1485 bp 
(CS1)), hofC (1704 bp (ASB1); 1689 bp (CS1)) and hofD (1410 bp (ASB1); 1365 bp (CS1)) genes. A N-
terminal signal sequence was predicted by the bioinformatics tools SignalP 3.0 and Phobius for HofF, HofE and 
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HofG. The DNA fragments encoding the N-terminal signal sequences for these Hof OMPs are highlighted as 
blue rectangles. 
 
On the contrary, the hof genes of H. pylori are scattered across its genome (Smet et al., 2013; 
Schott et al., 2011). A signature tagged mutagenesis approach by Kavermann and his 
colleagues (2003) showed that the H. pylori HofF protein is essential for gastric colonization. 
They even suggested that this OMP might have a function as adhesin (Kavermann et al., 
2003).  
The main aim of the present study was to obtain better insights in the role of the H. heilmannii 
hof gene locus in gastric colonisation and its relationship to the increased gastric Muc13 
expression seen in mice during Helicobacter colonization. In order to colonize the stomach, H. 
pylori is able to regulate the expression of its omp genes in response to environmental host 
factors (Skoog et al., 2012; de Vries et al., 2001; Huang et al., 2011; Wen et al., 2003). We 
therefore defined the H. heilmannii hof gene expression patterns in response to different 
conditions reflecting the gastric environment. Subsequently, the role of these Hof proteins in 
adherence to the gastric mucosa and in gastric human MUC13 and murine Muc13 expression 
was studied. An H. pylori wildtype and ΔhofF mutant strain were included for the purpose of 
comparison. Expression and mutational analyses of the hof genes, the Helicobacter binding 
assays and the experimental infection study in mice identified H. heilmannii HofE and HofF 
as adhesins and confirmed the role of H. pylori HofF in gastric colonization. These analyses 
also revealed the importance of H. heilmannii HofE and HofF and H. pylori HofF in IL-1β-
induced gastric MUC13/Muc13 expression.  
 
Materials and Methods 
Helicobacter strains and growth conditions.  
The highly virulent H. heilmannii ASB1 wildtype (wt) strain, isolated from the gastric mucosa 
of a kitten with severe gastritis, was cultivated biphasically on Brucella agar plates at pH5 
under microaerobic conditions at 37°C (Smet et al., 2012). The H. pylori SS1 strain (Liu et al., 
2014), the H. pylori STM138ΔhofF strain and its corresponding P1 wildtype strain 
(Kavermann et al., 2003) were all grown microaerobically on blood agar plates (Oxoid) at 
37°C (Liu et al., 2014; Kavermann et al., 2003). The SS1 strain is a mouse-adapted strain and 
used in this study for in vivo purposes only. The STM138ΔhofF is able to colonize rodents as 
shown before and was used in in vitro and in vivo experiments, while its parental P1 strain 
was only enclosed in the in vitro cell experiments (Kavermann et al., 2003).   
  
 104 
 Experimental Study 2 
 
In vitro exposure of H.heilmannii to different conditions reflecting the host environment. 
Liquid cultures of H. heilmannii ASB1wt (optical density at 600 nm (OD600): 0.5-1.0) were 
exposed to different pH environments, high temperature or H2O2. To induce acid stress, the 
pH in the Helicobacter growth medium was adjusted to 2 (pH in the gastric lumen) using 
concentrated hydrochloric acid. To simulate pH conditions in the gastric glands and surface 
epithelium under the mucus layer, H. heilmannii was exposed to pH7 using buffered 
conditions. Oxidative stress was simulated by adding 1% H2O2 to the growth medium. All 
these cultures were incubated microaerobically at 37°C. To cause temperature stress, another 
gastric environmental stress condition, bacterial cultures were incubated microaerobically at 
42°C instead of 37°C. All experiments were performed in triplicate. Bacterial samples were 
harvested after 30 min and 1h of incubation at pH2, 42°C or in the presence of H2O2. Samples 
from bacterial cultures that were exposed to pH7 were collected after 24h. Samples at normal 
growth conditions (pH5) and prior to exposure to the different environmental conditions were 
included as controls. From all collected samples, Helicobacter RNA was extracted as 
described before (Liu et al., 2014). 
 
Co-cultivation of Helicobacter with gastric mucins and epithelial cells.  
Mucin samples containing MUC6 and MUC5AC were collected from one tumor sample 
(labelled as human 1) and two samples with normal histology (labelled human 2 and 3). The 
samples with normal histology were obtained after informed consent and approval of the local 
ethical committee (Lund University Hospital, Lund, Sweden), whereas the mucins from the 
tumor sample was from our well characterized mucin library, and the sample was collected in 
1983 at the IMIM-Hospital del Mar, Barcelona, Spain (before the hospital had an ethics 
comitté). Rinsed and frozen human stomach tissue pieces were drenched in 10 mM sodium 
phosphate buffer (pH 6.5) containing 0.1 mM phenylmethylsulphonylfluorid (PMSF). The 
tissue was placed into five volumes of extraction buffer (6M guanidinium chloride, 5mM 
ethylenediaminetetraacetic acid (EDTA), 10mM sodium phosphate buffer (pH 6.5)) 
containing 0.1 mM PMSF, dispersed using a Dounce homogenizer (four strokes with a loose 
pestle) and stirred slowly at 4°C overnight. The insoluble material was removed by 
centrifugation at 23,000 × g for 50 min at 4°C (Beckman JA-30 rotor). Supernatants were 
dialyzed against ten volumes of extraction buffer for 24h and filled up to 26 ml with 
extraction buffer. Cesium chloride was added to the samples to give 1.39 g/ml starting density 
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by gentle stirring. The samples were centrifuged at 40,000 × g for 90h at 15°C. The fractions 
were collected from the bottom of the centrifuge tubes with a fraction collector. The dialyzed 
purified mucin samples were diluted in PBS to get 100 µg/ml concentration. H. heilmannii 
ASB1wt was harvested from biphasic Brucella agar plates and cultured in Brucella broth 
containing 20% fetal bovine serum (FBS) at a starting concentration of OD600= 0.25 in the 
presence of dialyzed mucin. As a control for normal proliferation, bacteria were cultured with 
phosphate buffered saline (PBS) without mucin. Bacteria were grown in 96-well plates for 
24h at 37oC under microaerophilic conditions. Thereafter, the bacterial culture was treated 
with RNAprotect Bacteria Reagent (Qiagen) according to the manufacturer’s instructions and 
further used for RNA extraction (Liu et al., 2014). 
For co-cultivation of Helicobacter with epithelial cells, human gastric epithelial MKN7 
(Riken Cell Bank, Japan) cells, grown as described before (Linden et al., 2002) were seeded 
in antibiotic free medium (pH7) at a concentration of 104 cells/ml on cover slips in 24-well 
plates and incubated overnight at 37°C. Then, cells were washed and 500 µl of a bacterial 
suspension (H. heilmannii ASB1wt at a concentration of 5x108 viable bacteria/ml cell culture 
medium (pH7)) was added to the cells and further incubated for 24h at 37°C under 
microaerobic conditions. Helicobacter strains incubated in the absence of cells were included 
as control. After 3 washing steps, the epithelial cells with bound bacteria were detached from 
the surface of the microtitre plates and further used for RNA extraction (Liu et al., 2014).  
 
Quantitative RT- PCR for hof gene expression.  
The bacterial RNA concentration was determined by measuring the optical density at 260 nm 
with a spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). Each sample was 
DNase treated. The cDNA was synthesized from 1 µg RNA using the iScript™ cDNA 
Synthesis Kit (Bio-Rad). Quantitative RT-PCR was carried out for measuring gene expression 
levels of H. heilmannii  hofC, hofD, hofE, hofF, hofG and hofH. The H. heilmannii atpA and 
efp genes were included as housekeeping genes. Primer sequences are shown in Table S3. The 
quantitative PCR reactions were performed as described before (Liu et al., 2014). No-
template-control reaction mixtures were included and all samples were run in duplicate. The 
Ct-values were normalized to the geometric mean of the Ct-values from the reference genes 
(H. heilmannii atpA and efp). Results were expressed as fold changes of hof mRNA 
expression in bacteria exposed to different environmental conditions, mucins or epithelial 
cells relative to hof mRNA expression levels in control bacterial cultures. Fold changes were 
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calculated using ΔΔCT method (Livak et al., 2001) with mean of Ct-values from three normal 
bacterial cultures as control.  
 
Creation of mutants by chromosomal insertion mutagenesis.  
Analysis of the H. heilmannii Hof proteins using the SignalP bio-informatic tool showed that 
only HofE, HofF and HofG contain a signal sequence. Based on this finding and the results of 
the hof gene expression studies, H. heilmannii ΔhofE, ΔhofF and ΔhofG mutants were 
constructed as described previously (Kondadi et al., 2013). Briefly, deletion was introduced 
by allelic exchange using vector pUC119 in which ~300 bp of the 5’ –end and 3’ –end of the 
target gene and the chloramphenicol resistance gene from pUOA14 was cloned (Viera and 
Messing, 1991; Sambrook and Russel, 2001). The constructed deletion vector was then 
transferred into E. coli TOP10 cells. H. heilmannii ASB1wt was used for electroporation with 
1 µg deletion vector. Mutants were selected (Josenhans et al., 1999) on Brucella agar plates 
(pH 5; 20% FCS; Vitox; 10 mg/ml chloramphenicol) and the site of recombination was 
verified by PCR and sanger ABI 3730xd sequencing. The expression of the hof genes present 
in the locus was verified in these mutants under normal growth and different environmental 
conditions (stress, co-incubation with mucins or cells) by RT-PCR as described above.  
 
In vitro Helicobacter binding assays to human gastric mucins.  
The H. heilmannii ASB1wt and its mutants ASB1ΔhofE, ASB1ΔhofF and ASB1ΔhofG 
cultured for 24h, were harvested and resuspended in 1% Blocking Reagent for ELISA (Roche, 
Stockholm, Sweden), containing 0.05% Tween 20 (blocking buffer). Human samples, 
obtained as described above, were diluted in 4M Guanidinium chloride to 4 mg/ml and coated 
on 96-well plates (PolySorp; Nunc A/S, Roskilde, Denmark) overnight at 4°C. The wells were 
then washed with PBS containing 0.05% Tween 20 and blocked for 1h with blocking buffer. 
After discarding the blocking buffer, the bacteria with an OD600 of 0.1 were diluted 1:10 in 
blocking buffer containing 10 mM citric acid (pH2 and pH5) and added for 1h to the wells. 
Thereafter, the 96-well plates were washed and incubated with rabbit anti-H. pylori serum 
(1:1000 dilution in blocking buffer) for 1h at room temperature. Subsequently, the plates were 
washed and incubated with horseradish peroxidase conjugated anti-rabbit IgG (1:10,000 
dilution in blocking buffer) for 1h at room temperature. After the final washing steps, binding 
was visualized by the addition of 3,3’,5,5’,-TetraMethylBenzidine substrate (Sigma-Aldrich, 
Diegem, Belgium), with absorbance read at 450 nm. 
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In vitro Helicobacter binding assays to human gastric epithelial cells.  
The human gastric epithelial cell line MKN7 and the murine gastric surface mucous GSM06 
cell line were cultured at 37°C with 5% CO2 as described before (Linden et al., 2002; Goso et 
al., 1997). 
For the in vitro binding assays with H. heilmannii ASB1wt and its mutants ASB1ΔhofE, 
ASB1ΔhofF and ASB1ΔhofG, the cell medium was changed to antibiotic free medium. 
MKN7 cells and GSM06 cells were seeded at a concentration of 104 cells/ml on cover slips in 
24-well plates and incubated overnight at 37°C. Then, cells were washed and 500 µl of a 
bacterial suspension of 108 viable bacteria/ml cell medium (pH7) was added to the cells and 
further incubated for 1h at 37°C under microaerobic conditions. Visualization of bacteria 
adhering to gastric epithelial cells at pH7 was done by scanning electron microscopy (SEM). 
For this purpose, coverslips were fixed in 500 µl HEPES fixative (2% paraformaldehyde) and 
prepared for SEM by routine techniques. The mean number of binding bacteria per cell was 
calculated by counting spiral-shaped and coccoid Helicobacter bacteria attached to 10-20 at 
random selected cells. 
 
In vitro MUC13 expression and cytokine analysis.  
Confluent MKN7 cells with low MUC13 expression (Linden et al., 2002) grown in 6 well 
microtitre plates were inoculated with 108 viable ASB1wt, ASB1ΔhofE, ASB1ΔhofF, 
ASB1ΔhofG, P1 and STM138ΔhofF for 24h under microaerobic conditions. Uninfected cells 
were included as controls. Total RNA was extracted from the cell pellet and cDNA was 
synthesized. For the measurement of MUC13 mRNA, RT-PCR was performed (Liu et al., 
2014; Sheng et al., 2012). Human GADPH was included as housekeeping gene. Primers used 
in these assays are listed in Table S3. Subsequently, the cell culture supernatant was used to 
quantify cytokine production using a multi-analyte ELISArryTM (IL-1α, IL-1β, IL-2, IL-4, IL-
6, IL-8, IL-10, IL-12, IL-17α, IFNγ, TNFα, GM-CSF; Sabbiosciences). To identify which 
cytokine is involved in the activation of MUC13 expression, uninfected MKN7 cells were 
treated with 20 or 40 ng/ml of one of the human recombinant pro-inflammatory cytokines Il-
1β, IL-6, IL-8 and tumor necrosis factor (TNF)-α (Mejias-Luque et al., 2008). Total RNA 
extracted from the cells was then screened for MUC13 expression as described above. 
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Animals and experimental procedure.  
Six-week old SPF, female Balb/c mice, purchased from Harlan NL (Horst, The Netherlands) 
were housed in individual filter top cages, had free access to water and food (an autoclaved 
commercial diet (TEKLAD 2018S, containing 18% protein; Harlan) throughout the 
experiment and were monitored daily. The in vivo experimental protocol was approved by the 
Ethical Committee of the Faculty of Veterinary Medicine, Ghent University, Belgium 
(EC2014_106, September 2014). 
The final concentration of H. heilmannii ASB1wt and its mutants ASB1ΔhofE, ASB1ΔhofF, 
ASB1ΔhofG was adjusted to 7 × 108 viable bacteria/ml. For H. pylori SS1 and STM138ΔhofF, 
a concentration of 1 × 109 viable bacteria/ml was used. In total, 90 animals were included and 
divided in 6 Helicobacter-infected groups of 13 animals (ASB1wt, ASB1ΔhofE, ASB1ΔhofF, 
ASB1ΔhofG, SS1 or STM138ΔhofF) and 1 control group of 12 animals. The Helicobacter-
infected animals were intragastrically inoculated 3 times at 2 days interval with 300 μL of a 
Helicobacter suspension. The control group was inoculated with Brucella broth (pH 5). At 4 
(acute stage of infection) and 9 (chronic stage of infection) weeks post-infection, animals (5 
animals from each group at 4 weeks post-infection; 8 animals from each Helicobacter-
infected group and 7 animals from the control group at 9 weeks post-infection) were 
euthanized by cervical dislocation under deep isoflurane anaesthesia (5%). The stomach from 
each mouse was resected and samples were taken for histopathological examination and 
quantitative RT-PCR analysis. 
 
Histopathology and quantification of colonizing Helicobacter spp.  
A longitudinal section, starting from the end of the forestomach and comprising the antrum 
and the fundus of the stomach and part of the duodenum, was fixed in 10% phosphate 
buffered formalin and embedded in paraffin for histopathological examination as previously 
described (Liu et al., 2014). A haematoxylin/eosin (H&E) staining was performed on a 
paraffin slide of 5µm to score the intensity of the gastritis according to the Updated Sydney 
System, but with some modifications (Liu et al., 2014; Flahou et al., 2010). DNA from the 
antrum and fundus of the stomach was extracted (Joosten et al., 2013) and the number of 
colonizing H. heilmannii ASB1wt, ASB1ΔhofE, ASB1ΔhofF and ASB1ΔhofG and H. pylori 
SS1 and STM138ΔhofF per mg gastric tissue (antrum and fundus of the stomach) was 
determined in the DNA samples using H. heilmannii- and H. pylori specific qPCRs based on a 
short fragment of the ureAB gene cluster (Liu et al., 2014; Joosten et al., 2013). For 
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quantification of H. heilmannii and H. pylori DNA in the tissue samples, the Bio-Rad CFX 
Manager (version 1.6) software was used. 
 
Quantification of host gene expression levels.  
Total RNA extracted from the stomach samples was utilized for first strand cDNA synthesis 
using iScript™ cDNA Synthesis Kit (Bio-Rad) (Liu et al., 2014). Quantitative RT-PCR was 
carried out for measuring gene expression levels of murine gastric mucins (Muc1, Muc5AC, 
Muc6 and Muc13), the human IL-8 related mouse proteins (Mip-2, Kc and Lix), IL-1β and 
TNF-α. The murine housekeeping genes PPIa, H2afz and HPRT were included as reference 
genes. Primer sequences are shown in Table S3. The quantitative PCR reactions were 
performed as described before (Liu et al., 2014). No-template-control reaction mixtures were 
included and all samples were run in duplicate. The Ct-values were normalized to the 
geometric mean of the Ct-values from the housekeeping genes. Results are shown as fold 
changes of mRNA expression in infected animals relative to mRNA expression levels in 
control animals. Fold changes were calculated using ΔΔCT method (Livak et al., 2001) with 
mean of Ct-values from 5 or 7 uninfected mice as controls. 
 
Statistical analysis.  
Statistical analysis was performed using SPSS Statistics 21 software (IBM) package. Gastritis 
scores, the number of colonizing bacteria in the murine stomach and cytokine production in 
the cell culture supernatant were analyzed using the non-parametric Mann-Whitney U test to 
compare groups. Bacterial and host gene expression was compared between different in vitro 
conditions or infected groups and controls using a Bonferoni post hoc test (ANOVA). 
Differences were considered statistically significant at p ≤ 0.05.  
 
Results 
The effect of pH, temperature, H2O2, gastric mucins and gastric epithelial cells on the 
expression of the H. heilmannii hof genes located in a 10kb locus. 
As the pH in the stomach varies from pH2 in the gastric lumen to pH7 at surface epithelium 
and in the glands, we hypothesized that the effect of pH can modulate expression of H. 
heilmannii omp genes involved in gastric colonization. At pH2, mRNA expression of only 
hofE was decreased after 30 min and 1h of incubation (p=0.002; Figure 2A & Table S1). 
Interestingly, the mRNA expression levels of hofE, hofF and hofG were increased after 24h 
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growth at pH7 (p<0.05; Fig. 2B & Table S1).  
The effect of exposure to 42°C (a gastric environmental stress condition) for 30 min and 1h 
on the expression of the hof genes, showed that all genes, with the exception of hofC, were 
downregulated (p<0.05; Figure 2A & Table S1). On the contrary, exposure of H. heilmannii 
to H2O2 to mimic oxidative stress did not induce statistically significant changes in expression 
of the hof genes (Figure 2A & Table S1).  
It has been shown that mucins can alter the expression of genes involved in binding of H. 
pylori to the gastric mucosa (Skoog et al., 2012). Incubation of H. heilmannii with mucins 
resulted in an increase (p<0.01) in mRNA expression of hofC, hofD, hofE, hofF and hofG as 
shown in Figure 2B and Table S1. Subsequently, H. heilmannii hof gene expression was also 
studied during co-incubation of this bacterium with human gastric epithelial cells. Adhesion 
to MKN7 cells did not cause statistically significant changes in the expression of H. 
heilmannii hofC, hofD, hofE, hofF, hofG and hofH (Figure 2B & Table S1).  
 
 
 
 
  
 111 
 Experimental Study 2 
Figure 2: H. heilmannii hof gene expression in response to exposure at pH2, 42°C and H2O2 for 30 min (A) 
and pH7, a gastric mucin sample at pH2 (Human 2 obtained from a gastric tumor and on which H. 
heilmannii binds to) and MKN7 cells at pH7 (B) for 24h (B). Each experiment was repeated at least 3 
times. Expression levels of hofH, hofF, hofE, hofG, hofC and hofD from the ASB1 wildtype (wt) strain are 
shown. Data are presented as fold change in gene expression normalized to two reference genes (atpA and efp 
genes for H. heilmannii) and relative to the results for H. heilmannii grown under normal in vitro conditions 
(pH5) or in the absence of mucins and cells (3). Data are shown as means + standard deviation. Significant 
differences in expression level between H. heilmannii grown under the different environmental conditions (acid, 
temperature, H2O2, mucins and cells) and normal in vitro H. heilmannii growth (pH5) or H. heilmannii grown 
without mucins or cells are indicated by * p<0.05 (ANOVA).  
 
A clear reduction in binding of H. heilmannii ΔhofF, ΔhofE and ΔhofG mutants to 
human gastric mucins and epithelial cells.  
Genomic analysis of the H. heilmannii ASB1wt hof gene locus revealed that only HofE, HofF 
and HofG had a predicted signal sequence (Figure 1). Based on this finding and the results of 
the above hof gene expression analyses, the genes encoding HofE, HofF and HofG were 
selected for further analyses. H. heilmannii strains lacking HofE, HofF or HofG were 
developed by chromosomal insertional mutagenesis. The mRNA expression pattern of the 
other hof genes residing in the hof locus of the H. heilmannii ASB1ΔhofE, ASB1ΔhofF and 
ASB1ΔhofG mutants was also examined under normal growth (pH5), different stress 
conditions and in co-culture with gastric mucins and epithelial cells. Results are shown in 
Table S1. 
Under normal growth conditions (pH5 for 24h), only the expression of hofE in the ΔhofF 
mutant was decreased (p=0.001). At pH7, the expression pattern of most of the hof genes in 
the different mutant strains was comparable to their expression in the wildtype strain. Only 
the hofH gene was overexpressed (p=0.002) in ASB1ΔhofE whereas expression of hofG did 
not reach statistical significance in ASB1ΔhofF (Table S1).  
However, under acid, high temperature and oxidative stress, the hofE gene in ASB1ΔhofF and 
the hofF gene in ASB1ΔhofE were increased (p=0.001 for hofE and hofF; Table S1). 
Additionally, exposure at 42°C also changed the expression pattern of hofH and hofG in the 
mutants (p=0.001 for hofH; p=0.003 for hofG) compared to their expression pattern in the 
wildtype strain (Table S1). 
In response to gastric mucins, expression of the hof genes in the mutant lacking HofE did not 
reach statistical significance, whereas only hofG was upregulated in the ASB1ΔhofF mutant 
(p=0.001; Table S1). Co-culture of ASB1ΔhofE, ASB1ΔhofF and ASB1ΔhofG with MKN-7 
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cells showed a similar hof gene expression pattern in the different mutants compared to its 
expression pattern in ASB1wt (Table S1). 
Subsequently, the binding ability of the H. heilmannii ASB1ΔhofE, ASB1ΔhofF and 
ASB1ΔhofG mutants to gastric mucins and epithelial MKN7 and GSM06 cells was 
investigated. Mucin binding was investigated at pH2 and pH5, with pH2 representing the 
environment present at the luminal side of the mucus layer, and pH5 the environment closer 
to the cell surface. A weak binding to the gastric mucin samples was found for the H. 
heilmannii ASB1wt strain at pH2 and pH5 (Figures 3A & 3B). The level of binding at pH2 
was lower with the ASB1ΔhofE, ASB1ΔhofF and ASB1ΔhofG mutants compared to the 
wildtype strain, and a similar trend was present at pH5 (p<0.05, Figures 3A & 3B).   
H. heilmannii ASB1wt strongly binds to human MKN7 cells (Figures 3C & 3D) and murine 
GSM06 cells (Figures 3C & 3H). A lower number of ASB1ΔhofE, ASB1ΔhofF and 
ASB1ΔhofG mutant bacteria bound to the human-derived MKN7 cells and mouse-derived 
GSM06 cells than the H. heilmannii ASB1wt strain at pH7 (p<0.05; Figures 3C to 3K). 
Reduction in binding was more pronounced for the ASB1ΔhofE mutant (Figure 3C).  
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Figure 3: In vitro binding capacity of H. heilmannii and its Δhof mutants to gastric mucins and mucus-
secreting epithelial cells.  
In vitro binding of ASB1wt, ASB1ΔhofE,  ASB1ΔhofF and ASB1ΔhofG to different human gastric mucin 
samples (Human 1 obtained from a healthy stomach; Human 2 and human 3 obtained from a gastric tumor) at 
pH2 (A) and pH5 (B). Binding was quantified by measuring the OD at 450 nm. Subsequently, scanning electron 
microscopy was performed for visualization of binding at pH 7 of H. heilmannii ASB1wt (D), ASB1ΔhofF (E), 
ASB1ΔhoGF (F) and ASB1ΔhofE (G) to MKN7 cells and ASB1wt (H), ASB1ΔhofF (I), ASB1ΔhofG (J) and 
3C 
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ASB1ΔhofE (K) to GSM06 cells. Bars: 10µm. The mean number of H. heilmannii and its mutants binding 
MKN7 cells and GSM06 cells at pH7 was calculated (C). Significant differences in binding between the 
wildtype strain and a mutant strain are indicated by * p<0.05 (Mann-Withney U test).  
 
H. heilmannii HofE and HofF and H. pylori HofF play a role in MUC13 expression in 
human gastric epithelial cells.  
We recently suggested a potential role for Muc13 in gastric Helicobacter colonization in mice 
(Liu et al., 2014). Therefore, human MUC13 mRNA expression was examined after co-
culture of H. heilmannii and gastric epithelial MKN7 cells for 24h. The H. pylori P1 strain 
was included for comparison. For both Helicobacter species, mRNA expression of MUC13 
was increased (Fold change for ASB1wt 7.66±2.51 (p=0.003) and for P1 4.21±0.39 (p=0.001); 
Figure 4A). To investigate the role of the H. heilmannii HofE, HofF and HofG proteins in 
MUC13 expression, MKN7 cells were also incubated with the ASB1ΔhofE, ASB1ΔhofF and 
ASB1ΔhofG mutant strains. The H. pylori STM138ΔhofF strain was included for comparison. 
Only ASB1ΔhofE, ASB1ΔhofF and STM138ΔhofF were unable to increase MUC13 
expression significantly. The other strains induced an upregulation of MUC13 expression 
(p=0.003 for ASB1wt; p=0.004 for P1; p=0.013 for ASB1ΔhofG; Figure 4A).  
 
IL-1β is associated with increased MUC13 expression in human gastric epithelial cells.  
In the stomach, the activation of mucin expression can be regulated by inflammatory 
cytokines induced in response to Helicobacter colonization of the gastric mucosa (Mejias-
Luque et al., 2008). Therefore, the supernatant of Helicobacter-infected and uninfected 
MKN7 cells was screened for cytokine production (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, 
IL-12, IL-17α, IFNγ, INFα, GM-CSF) using ELISA assays. Only an increased IL-8 
production was detected in the supernatant of cells infected with H. heilmannii and H. pylori 
wildtypes and their mutant strains (Figure 4B; p<0.05) and no difference in IL-8 production 
was seen between Helicobacter wildtype- and mutant-infected cells (data not shown). To 
identify whether this pro-inflammatory cytokine was involved in the activation of MUC13 
expression, uninfected MKN7 cells were treated with human recombinant IL-8. MUC13 
expression was not induced by IL-8. Subsequently, uninfected MKN-7 cells were treated with 
other inflammatory cytokines, including IL-1β, IL-6 and TNF-α. Interestingly, IL-1β was able 
to increase MUC13 significantly (p=0.025; Figure 4C). Additionally, IL-8 mRNA expression 
was also analyzed in the cells after cytokine treatment. Expression of this cytokine was 
induced by IL-1β and TNF-α (p=0.001 for IL-1β; p=0.012 for TNF-α; Figure 4D).    
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Figure 4: Human MUC13 expression during incubation of H. heilmannii ASB1wt ASB1ΔhofF, 
ASB1ΔhofE and ASB1ΔhofG and H. pylori P1 and STM138ΔhofF to gastric epithelial cells for 24h (A).  
Data are presented as fold change in gene expression normalized to 1 reference gene and relative to the results 
for uninfected cells. Data are shown as means + standard deviation. Significant differences in expression level 
between Helicobacter-infected gastric cells and uninfected gastric cells are indicated by * p<0.05 (ANOVA). (B) 
  
 116 
 Experimental Study 2 
Presence of Human IL-8 in cell culture media measured at OD450nm at 24h after inoculation with ASB1wt, 
ASB1ΔhofF, ASB1ΔhofE, ASB1ΔhofG, P1 and STM138ΔhofF. The concentration of IL-8 (pg/ml) was 
calculated using a standard curve. Significant difference between infected and uninfected cells are indicated by * 
p<0.05 (ANOVA). Human MUC13 (C) and IL-8 (D) expression measured after treatment with IL-1β, IL-6, IL-8 
or TNF-α (20 ng/ml or 40 ng/ml) for 24h. Significant difference between cytokine-treated and untreated cells are 
indicated by * p<0.05 (ANOVA).   
 
Significantly reduced induction of inflammation and colonization by H. heilmannii 
ΔhofF and ΔhofE and H. pylori ΔhofF in the stomach of mice.  
To confirm the role of HofE, HofF and HofG in H. heilmannii colonization, the ASB1wt, 
ASB1ΔhofE, ASB1ΔhofF and ASB1ΔhofG strains were studied in a mouse model. The 
rodent-adapted H. pylori SS1 and STM138ΔhofF strains were included for comparison. 
Inflammation in the stomach of all mice was scored. For all control animals, the 
histomorphology was considered to be normal, with only minor inflammatory cell infiltration 
in the gastric mucosa. The results of the mice at 9 weeks post-infection are shown in Figure 
5A. A statistically significant difference (p<0.05) was demonstrated between the 
inflammation scores of ASB1-infected mice on the one hand and ASB1ΔhofE- or 
ASB1ΔhofF-infected mice on the other hand. A similar difference was seen between mice 
infected with SS1 or STM138ΔhofF. On the contrary, no difference in inflammation was seen 
between ASB1- and ASB1ΔhofG-infected mice (Figure 5A). The histomorphology in the 
stomach of the ASB1ΔhofE-, ASB1ΔhofF- and STM138ΔhofF-infected mice was comparable 
to that of the control animals (Figures 5C, 5D & 5G). Inflammation in ASB1-,  ASB1ΔhofG- 
and SS1-infected mice was characterized by mononuclear and polymorphonuclear cell 
infiltration in the lamina propria mucosae, the tunica submucosa or both, depending on the 
individual animal (Figures 5B, 5E & 5F). Throughout the experiment, all control animals 
were negative for Helicobacter DNA in quantitative RT-PCR assays. At 4 and 9 weeks post-
infection, Helicobacter DNA was found in both the antrum and the fundus of the stomach 
from all infected animals with a higher amount seen in the antrum (Figures 6A & 6B). The 
ASB1ΔhofE, ASB1ΔhofF and STM138ΔhofF mutants showed a clear and lower colonization 
capacity compared to the H. heilmannii and H. pylori wildtype strains (p=0.002 for 
ASB1ΔhofE and ASB1ΔhofF; p=0.004 for STM138ΔhofF; Figures 6A & 6B). The 
ASB1ΔhofG mutant colonized the stomach at an equal capacity as the ASB1wt strain (Figure 
6). In general, H. heilmannii colonized the antrum of the stomach at a higher level than H. 
pylori (p=0.002; Figure 6A).  
  
 117 
 Experimental Study 2 
 
 
Figure 5: Gastric inflammation in H. heilmannii ASB1wt-, ASB1ΔhofF-, ASB1ΔhofE-, ASB1ΔhofG-, and H. 
pylori P1- and STM138ΔhofF-infected Balb/c mice. (A) Gastric inflammation was scored on a scale of 0 to 4 (0: 
no infiltration with mononuclear and/or polymorphonuclear cells; 1: mild diffuse infiltration with mononuclear 
and/or polymorphonuclear cells or the presence of one small (50–200 cells) aggregate of inflammatory cells; 2: 
moderate diffuse infiltration with mononuclear and/or polymorphonuclear cells and/or the presence of 2–4 
inflammatory aggregates; 3: marked diffuse infiltration with mononuclear and/or polymorphonuclear cells and/or 
the presence of at least five inflammatory aggregates; 4: diffuse infiltration of large regions with large aggregates 
of mononuclear and/or polymorphonuclear cells). Individual animals are depicted as symbols around the mean 
(lines). (B-G) H&E staining of the antrum of the stomach from a Helicobacter-infected Balb/c mouse. 
Inflammation in ASB1- (B),  ASB1ΔhofG- (E) and SS1(F)-infected mice was characterized by mononuclear and 
polymorphonuclear cell infiltration in the lamina propria mucosae, the tunica submucosa or both. The 
histomorphology in the stomach of the ASB1ΔhofE- (C), ASB1ΔhofF- (D) and STM138ΔhofF(G)-infected mice 
was comparable to the control animals showing only minor inflammatory cell infiltration in the gastric mucosa. 
Bar = 30 µm. 
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Figure 6: Colonization capacity of H. heilmannii ASB1wt, ASB1ΔhofF, ASB1ΔhofE, ASB1ΔhofG and H. pylori 
SS1 and STM138ΔhofF after experimental infection. Colonization capacity is shown as log10 values of bacteria 
per mg tissue, detected with quantitative RT-PCR in the antrum (A) and the fundus (B) of the stomach. Animals 
in which no Helicobacter DNA could be detected in the stomach were set as 0. Individual animals are depicted 
as figures around the mean (lines). Statistical significant differences between animals infected with Helicobacter 
and control animals are indicated by * (H. heilmannii) or $ (H. pylori) (Mann-Whitney U test, p < 0.05).  
 
The H. heilmannii HofE and HofF and H. pylori HofF proteins play a role in IL-1β-
induced Muc13 expression in the stomach of mice.  
Changes in mRNA expression of mucins in the stomach of control and Helicobacter-infected 
mice were investigated. No changes in Muc1 expression were seen in the stomach during the 
whole experiment (Table S2). mRNA expression of Muc5AC was decreased (p<0.05) in the 
antrum of the stomach of SS1- and STM138ΔhofF-infected mice at 9 weeks post-infection 
(Table S2). Muc6 was upregulated at 9 weeks post-infection in the fundus of all infected 
animals compared to the uninfected controls (p<0.05; Table S2). The mRNA expression of 
Muc13 was increased at 4 weeks post-infection in the antrum of ASB1- and ASB1ΔhofG-
infected mice (p<0.05; Figure 7A, Table S2) and at 9 weeks post-infection in both the antrum 
and fundus of ASB1-, ASB1ΔhofG-, and SS1-infected mice (p<0.05; Figure 7A, Table S2). 
Interestingly, no significant change in Muc13 expression was seen in the stomach of 
ASB1ΔhofE-, ASB1ΔhofF- and STM138ΔhofF-infected mice during the whole experiment at 
either time point (Figure 7A, Table S2). Gene expression of Mip-2, Kc and Lix, the human 
IL-8 related mouse proteins, was increased in the stomach of most Helicobacter-infected 
groups at 4 and 9 weeks post-infection (p<0.05; Figures 7B to 7E). Upregulation of Mip-2 
was restricted to the fundus (p<0.05; Figures 7C &,7E, Table S2) whereas expression of Kc 
and Lix was induced in both the antrum and fundus of the stomach (p<0.05; Figures 7B to 7E, 
Table S2). Also the ASB1ΔhofE mutant stimulated Mip-2, Kc and Lix expression, although 
only in the fundus of the stomach (p<0.05; Figures 7C & 7E, Table S2). The mRNA 
expression of the pro-inflammatory cytokines IL-1β and TNF-α was significantly increased 
(p<0.05) in the antrum of the stomach of ASB1wt-, ASB1ΔhofG- and SS1-infected mice at 4 
and 9 weeks post-infection (Figures 7B & 7D, Table S2). 
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Figure 7: Expression of Muc13 (A), the human IL-8 related mouse genes (Mip-2, Kc and Lix), IL-1β, and TNFα  
in the stomach of H. heilmannii ASB1wt-, ASB1ΔhofF-, ASB1ΔhofE-, ASB1ΔhofG-, and H. pylori P1- and 
STM138ΔhofF-infected and control Balb/c mice. Expression in the antrum (4 weeks A&B; 9 weeks (A&C)) and 
fundus (4 weeks (A&D); 9 weeks (A&E)) of the stomach at 4 and 9 weeks post-infection is shown. Data are 
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presented as fold change in gene expression normalized to 3 reference genes and relative to the results for the 
negative-control group. Data are shown as means + standard deviation. Significant differences in expression 
level between the infected groups and the negative-control group at a certain time-point are indicated by * 
p<0.05 (ANOVA). 
 
Discussion 
Upon exposure to low pH and high temperature, expression of most of the H. heilmannii 
genes residing in the hof locus and in particular hofE, was decreased. The corresponding Hof 
OMPs contain predicted transmembrane beta-barrrel sheets which can act as diffusion 
channels that allow small molecules to pass across the outer membrane (Smet et al., 2014). 
This reduced expression of the H. heilmannii hof genes might thus lead to a decrease in the 
permeability of the outer membrane and in this way limit the accessibility of damaging agents 
to the periplasm and beyond. Similar findings have been described for several H. pylori Hop 
proteins (de Vries et al., 2001; Huang et al., 2011; Wen et al., 2003; Merell et al., 2003; Shan 
et al., 2015; Giannakis et al., 2009).  
Adherence to the gastric mucosa is assumed to play an important role in the initial 
colonization of gastric helicobacters (McGuckin et al., 2011) and it can be expected that this 
event is associated with increased expression of genes playing a role in adhesion. However, in 
the present study, expression of none of the hof genes was changed during adhesion of H. 
heilmannii to human gastric epithelial MKN7 cells. On the other hand, contact of the 
bacterium with human gastric mucins resulted in an upregulation of almost all hof genes 
examined and exposure to pH7 significantly increased the expression of hofE, hofF and hofG. 
This may suggest that H. heilmannii modifies the expression of its hof genes upon contact 
with mucins and as a reaction to changing pH conditions when it moves away from the acidic 
lumen of the stomach towards the gastric mucosa. The enhanced expression of these genes at 
pH7, which resembles the pH close to the gastric epithelium (Skoog et al., 2012), may 
indicate that the HofE, HofF and HofG OMPs play a role in adhesion of H. heilmannii to 
gastric epithelial cells. These are also the only Hof proteins, encoded by the H. heilmannii hof 
gene locus, that carry a predicted known N-terminal signal sequence, which may promote 
their translocation into the outer membrane after enhanced synthesis (Odenbreit et al., 1999; 
Carlsson et al., 2006). Therefore, ΔhofE, ΔhofF and ΔhofG mutants were created for further 
investigating the role of HofE, HofF and HofG in adhesion and colonisation.  
A complementation test to verify the phenotype of the mutants as frequently used in H. pylori 
research, is currently unavailable for H. heilmannii due to its very fastidious nature. Further 
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studies, including the identification of a suitable locus for the integration of the target gene, 
the selection of a suitable promoter and the evaluation of several marker genes (i.e: 
chloramphenicol, erythromycin and kanamycin resistant cassettes), are essential to set up such 
an assay. 
The hof gene expression pattern in the created mutants was first analysed to verify if the lack 
of a certain hof gene had an impact on the expression of other hof genes in that same locus. 
Under normal growth conditions, only the expression of hofE in the ΔhofF mutant was 
decreased, indicating that the presence of the hofF gene is essential for a normal hofE 
expression. Protein analyses are necessary to examine whether translation of hofE mRNA in 
this mutant results in a functional HofE protein. Compared to the H. heilmannii wildtype 
strain, exposure of these mutants to different stress conditions and mucins induced a change in 
the expression of the other hof genes in the ΔhofF and ΔhofE mutants suggesting that 
disruption of hofE and hofF may have an impact on the expression of the other genes in the 
hof locus.  
In general, binding to the gastric mucin samples was rather low for the H. heilmannii wildtype 
strain. Mucins can carry in the order of 100 different carbohydrate structures, which provide 
the mucins with a bottle-brush appearance and make them act as receptors for microorganisms 
(McGuckin et al., 2011). The absence of carbohydrates having a strong binding ability with H. 
heilmannii in the used mucin samples, might explain the low binding capacity of this 
pathogen.  
The ability to bind to mucins was, however, even lower for the H. heilmannii ΔhofE, ΔhofF 
and ΔhofG mutant strains compared to the wildtype strain. Similarly, the capacity to adhere to 
gastric epithelial cells was also lower for these mutant strains, compared to the wildtype strain. 
These results confirm that HofE, HofF and HofG are involved in the attachment of H. 
heilmannii to gastric mucins and epithelial cells.  
The role of these Hof proteins in colonization of the gastric mucosa by H. heilmannii was 
further investigated in vivo. The well-studied mouse-adapted H. pylori SS1 strain (Liu et al., 
2014; Crabtree et al., 2002) and a H. pylori ΔhofF mutant (Kavermann et al., 2003) were 
included for comparison. The H. heilmannii ΔhofE and ΔhofF mutants colonized the stomach, 
in particular the antrum of the stomach, at a clearly lower level than the H. heilmannii 
wildtype strain. The previously shown role of H. pylori HofF in gastric colonization was also 
confirmed (Kavermann et al., 2003). These findings, together with the results of the cell 
binding experiments described above, demonstrate that both H. heilmannii HofE and HofF are 
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essential in gastric Helicobacter colonization, in particular adherence to the gastric mucosa. It 
remains to be elucidated whether deletion of both hofE and hofF would result in a complete 
loss of adhesion of the H. heilmannii ΔhofFΔhofE mutant to the gastric mucosa. A similar 
phenomenon has been described for the alpA and alpB genes in H. pylori (Odenbreit et al., 
1999; Senkovich et al., 2011). These genes, both encoding OMP Hop adhesins, are located 
closely together in a locus. Deletion of this gene locus in H. pylori resulted in a complete loss 
of binding to human gastric tissue sections (Oleastro and Menard, 2013; Senkovich et al., 
2011). 
On the contrary, the H. heilmannii ΔhofG mutant colonized the murine stomach at a 
comparable level as the H. heilmannii wildtype strain. Although our in vitro studies showed 
that HofG plays a role in adherence to human gastric epithelial MKN7 cells, this OMP is 
apparently not an essential colonization factor in our mouse model. It remains to be 
determined whether it is involved in gastric colonization in human patients.   
In the present study, the pathway regulating gastric MUC13 expression as a response to 
Helicobacter colonization was further investigated. A schematic representation of the 
presumptive cascade of events involved in gastric MUC13 expression that occur during 
adhesion of H. heilmannii to epithelial cells is shown in Figure 8. An increased expression of 
MUC13 in response to colonization of H. heilmannii and H. pylori to human gastric epithelial 
cells was shown. This finding confirms the recently suggested role of murine Muc13 in 
gastric Helicobacter colonization (Liu et al., 2014). However, it remains to be further 
elucidated whether attachment of these helicobacters to the cell surface is essential for the 
induction of MUC13 expression. How human MUC13 and murine Muc13 influence the 
Helicobacter colonization process in vivo has not yet been unraveled. Analyses of the 
stomach of Helicobacter-infected Muc13-/- mice might shed more light on this. 
The activation of gastric MUC13 expression can be regulated by inflammatory cytokines 
induced in response to Helicobacter colonization of the gastric mucosa as has been described 
for other membrane-associated mucins (Mejias-Luque et al., 2008). In this study, an increased 
IL-8 production was found in the supernatant of human gastric epithelial cells infected with H. 
heilmannii or H. pylori. Therefore, the role of IL-8 as well as other pro-inflammatory 
cytokines in MUC13 expression was further investigated in vitro. Interestingly, MUC13 
expression was induced by IL-1β (Figure 8) and not by IL-8. IL-1β also caused increased IL-8 
mRNA expression in these human gastric epithelial cells (Figure 8). Previous in vivo 
experiments showed that mRNA levels of IL-1β were clearly upregulated in the stomach of 
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rodents suffering from gastritis induced by H. heilmannii and H. pylori (Joosten et al., 2013; 
unpublished data). Also in our mice experiment, IL-1β expression was significantly increased 
in the antrum of the stomach of H. heilmannii ASB1wt- and H. pylori SS1-infected animals. 
These findings suggest that IL-1β is induced in the stomach as a response to Helicobacter 
colonization and on its turn plays a role in the expression of MUC13 and IL-8 in the gastric 
epithelium. The signal transducers regulating the IL-1β-induced MUC13 and IL-8 expression 
pathway in the stomach have not yet been identified (Figure 8). IL-1β plays a crucial role in 
the development of gastric pathologies (Joosten et al., 2013). To be active, pro-IL-1β must be 
cleaved by the inflammasome, an intracellular multiprotein oligomer implicated in the 
activation of inflammatory processes (Semper et al., 2014; Figure 8). It has recently been 
shown that H. pylori-induced IL-1β secretion is mediated by the nucleotide-binding 
oligomerization domain-like receptor family, pyrin domain containing 3 (NLRP3) 
inflammasome which requires the H. pylori vacuolating cytotoxin A (VacA) and cag 
pathogenicity island (Semper et al., 2014). H. heilmannii lacks both VacA and cagPAI (Liu et 
al., 2014). How the inflammasome is activated by H. heilmannii is so far unknown (Figure 8).   
 
Figure 8: A schematic representation of the hypothetical cascade of events involved in gastric MUC13 
expression that occur during adhesion of H. heilmannii to epithelial cells.  
Shown is the involvement of HofE and HofF OMPs in adhesion of H. heilmannii to gastric epithelial cells and 
the induction of the IL-1β-induced transmembrane MUC13 expression (A). Inflammatory cells responsible for 
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IL-1β and TNF-α secretion are attracted to the site of Helicobacter infection (B). The signaling pathways 
regulating IL-1β-induced MUC13 and IL-1β- and TNF-α-induced IL-8 expression in the stomach during 
Helicobacter infection remains to be further elucidated. 
 
In gastric epithelial cells, IL-8 expression was also increased by TNF-α. This cytokine can be 
secreted by immune effector cells which are attracted upon Helicobacter infection, as shown 
before (Sheng et al., 2013; Fusunyan et al., 1998; Figure 8). Additionally, expression of TNF-
α was significantly increased in the antrum of the stomach of animals infected with H. 
heilmannii ASB1wt or H. pylori SS1. From these results, it can be concluded that expression 
of IL-8 in the stomach can be regulated by both the IL-1β and TNF-α signaling pathways as 
has also been shown in intestinal epithelial cells (Sheng et al., 2013; Fusunyan et al., 1998). 
How TNF-α induces gastric IL-8 expression upon H. heilmannii infection remains to be 
further studied (Figure 8). 
The role of H. heilmannii HofE, HofF and HofG and H. pylori HofF in the stimulation of 
MUC13 expression was examined in vitro and in vivo. H. heilmannii ΔhofE and ΔhofF and H. 
pylori ΔhofF did not induce an increased expression of MUC13 in human gastric epithelial 
cells and of Muc13 in the stomach of mice. As described above, these mutants also showed a 
clear and reduced gastric colonization capacity in vivo, suggesting that colonization is 
essential for gastric Muc13 expression. Additionally, these Helicobacter mutants did not 
upregulate expression of IL-1β mRNA neither in the murine stomach. Whether these outer 
membrane proteins play a role in the activation of the inflammasome for IL-1β expression 
remains elusive (Figure 8). The above novel findings in Helicobacter research highlight the 
importance of H. heilmannii HofE and HofF and H. pylori HofF in induction of IL-1β and 
human MUC13 and murine Muc13 expression in the stomach (Figure 8).  
Infection with H. heilmannii, H. pylori and their mutants all induced a significant increase in 
IL-8 expression both in vitro and in vivo. This may suggest that the Helicobacter Hof OMPs 
and human MUC13 and murine Muc13 do not play a major role in IL-8 production in the 
stomach. This is in contrast to what has been described in the intestinal tract where MUC13 
increases IL-8 expression in human intestinal epithelial cells in response to a Campylobacter 
infection (Sheng et al., 2012). Additionally, H. heilmannii ΔhofE and ΔhofF and H. pylori 
ΔhofF did not induce a significant change in expression of TNF-α highlighting that the 
increased expression of the human IL-8 related MIP-2, KC and Lix proteins demonstrated in 
the stomach of mice infected with these mutants is regulated by another signalling pathway. 
Expression of IL-8 can indeed be regulated by multiple signalling pathways (Hoffmann et al., 
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2002).  
Taken together, the results of the bacterial hof genes and host genes expression experiments, 
the Helicobacter binding assays and the experimental infection studies in Balb/c mice 
illustrate the importance of the H. heilmannii hof locus, in particular genes encoding HofE 
and HofF, in adhesion to the gastric mucosa as well as the role of H. heilmannii HofE and 
HofF and H. pylori HofF in human MUC13 and murine Muc13 expression.   
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Table S1: The hof gene expression patterns of H. heilmannii ASB1wt, ASB1ΔhofE, ASB1ΔhofF and 
ASB1ΔhofG in response to exposure at pH2, 42°C and H2O2 for 30 min and pH7, mucins and cells for 24h. 
Data are presented as fold change (± standard deviation) in gene expression normalized to two reference genes 
and relative to the results for H. heilmannii grown under normal in vitro conditions (pH 5). 
pH2_30min 
 hofH hofF hofE hofG hofC hofD 
ASB1wt 0.82±0.032 0.84±0.07 0.5±0.09* 0.7±0.015 1.11±0.14 1.11±0.06 
ASB1ΔhofE 0.58±0.052 2.29±0.41* - 1.02±0.14 2.52±0.27 2.37±0.44 
ASB1ΔhofF 0.92±0.19 - 3.67±0.16* 0.85±0.14 0.86±0.18 1.18±0.29 
ASB1ΔhofG 0.85±0.15 0.56±0.02 1.07±0.17 - 1.02±0.07 1.25±0.22 
42°C_30min 
 hofH hofF hofE hofG hofC hofD 
ASB1wt 0.38±0.03* 0.59±0.05* 0.39±0.06* 0.24±0.02* 1.06±0.09 0.48±0.07* 
ASB1ΔhofE 1.04±0.15 1.87±0.08 - 0.94±0.04 0.71±0.11 0.52±0.03 
ASB1ΔhofF 0.96±0.09 - 1.54±0.43 1.09±0.05 0.71±0.03 0.54±0.09 
ASB1ΔhofG 0.78±0.07 1.60±0.07 1.37±0.12 - 1.4±0.07 0.77±0.10 
H2O2_30min 
 hofH hofF hofE hofG hofC hofD 
ASB1wt 0.93±0.06 1.23±0.15 0.89±0.01 1.06±0.29 1.25±0.03 0.88±0.02 
ASB1ΔhofE 0.77±0.09 2.44±0.10* - 1.03±0.19 1.73±0.21 1.58±0.11 
ASB1ΔhofF 1.09±0.32 - 5.11±0.48* 0.89±0.02 0.84±0.02 1.19±0.04 
ASB1ΔhofG 1.22±0.19 0.64±0.05 0.77±0.06 - 1.61±0.12 0.83±0.06 
pH7_24h 
 hofH hofF hofE hofG hofC hofD 
ASB1wt 2.14±1.46 4.06±2.07* 3.89±1.79* 2.29±0.25* 1.53±0.36 2.17±0.74 
ASB1ΔhofE 4.86±2.32* 2.88±0.18* - 2.64±0.23* 1.81±0.08 1.75±0.01 
ASB1ΔhofF 1.5±0.06 - 3.09±0.07* 2.04±0.29 1.72±0.15 1.79±0.16 
ASB1ΔhofG 1.34±0.10 2.86±0.4* 2.95±0.12* - 1.59±0.01 1.16±0.31 
mucin co-cultures_24h 
 hofH hofF hofE hofG hofC hofD 
ASB1wt 1.9±1.5 2.7±0.18* 3.37±0.15* 3.68±0.13* 4.75±1.48* 2.57±0.12* 
ASB1ΔhofE 1.54±0.09 0.87±0.09 - 1.25±0.04 1.01±0.04 1.31±0.12 
ASB1ΔhofF 1.10±0.32 - 0.71±0.19 3.08±0.03* 0.58±0.04 1.58±0.28 
MKN7 cells_24h 
 hofH hofF hofE hofG hofC hofD 
ASB1wt 1.06±0.35 1.15±0.15 1.26±0.09 1.03±0.31 1.15±0.30 1.41±0.26 
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ASB1ΔhofE 2.15±0.57 0.78±0.26 - 0.74±0.16 1.59±0.5 0.89±0.27 
ASB1ΔhofF 1.42±0.4 - 0.83±0.03 0.77±0.01 0.71±0.15 0.93±0.05 
ASB1ΔhofG 1.13±0.12 0.67±0.04 0.61±0.09 - 1.15±0.31 0.5±0.07 
* Significant differences in expression level between H. heilmannii grown under different environmental 
conditions and normal in vitro H. heilmannii growth are indicated by * p<0.05 (ANOVA). 
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Table S2: Expression of gastric mucins, the human IL-8 related mouse genes (Mip-2, Kc and Lix), IL-1β 
and TNFα in the stomach of H. heilmannii ASB1wt-, ASB1ΔhofF-, ASB1ΔhofE-, ASB1ΔhofG-, and H. 
pylori P1- and STM138ΔhofF-infected and control Balb/c mice. Data are presented as fold change (± 
standard deviation) in gene expression normalized to 3 reference genes and relative to the results for the 
negative-control group.  
antrum 4 weeks post-infection 
 ASB1wt ASB1ΔhofE ASB1ΔhofF ASB1ΔhofG SS1 STM138ΔhofF 
Muc1 1.05±0.1 0.73±0.08 0.87±0.12 1.12±0.13 0.68±0.2 0.87±0.15 
Muc5ac 1.02±0.54 0.79±0.19 1.06±0.17 0.49±0.08 1.08±0.46 0.87±0.32 
Muc6 0.93±0.04 0.83±0.11 0.92±0.14 1.11±1.04 0.87±0.36 0.93±0.19 
Muc13 3.19±0.97* 2.01±0.63 2.15±0.83 3.93±1.72* 1.34±0.78 1.11±0.16 
KC 3.87±1.41* 1.29±0.30 1.29±0.49 9.47±2.27* 0.84±0.19 1.05±0.11 
Lix 6.63±5.89* 1.04±0.18 1.89±1.81 3.9±0.46* 1.30±0.6 1.4±0.25 
MIP-2 2.84±2.55 1.13±0.35 1.10±0.55 2.14±0.69 1.27±1.07 1.31±0.25 
TNF-α 4.16±2.68* 0.84±0.15 1.11±0.35 3.96±0.79* 1.65±0.71 1.51±0.72 
IL-1β 8.13±5.5* 1.41±0.17 1.49±1.14 7.92±2.09* 2.35±0.7* 2.18±1.02 
fundus 4 weeks post-infection 
 ASB1wt ASB1ΔhofE ASB1ΔhofF ASB1ΔhofG SS1 STM138ΔhofF 
Muc1 1.11±0.72 1.30±0.66 1.37±0.79 1.35±0.54 1.23±0.40 1.33±0.70 
Muc5ac 2.66±2.03 2.37±1.15 1.69±1.27 1.81±1.24 4.5±3.44 4.07±3.39 
Muc6 1.34±0.89 1.69±0.51 1.44±0.87 1.46±1.06 2.15±0.37 2.09±1.04 
Muc13 1.78±1.14 1.82±0.62 1.75±0.90 0.71±0.13 0.78±0.36 1.19±0.78 
KC 2.13±1.04 1.87±0.67 1.62±0.70 1.30±0.29 1.01±0.31 1.73±0.73 
Lix 1.39±0.29 2.37±0.68 2.57±0.80 0.87±0.27 1.78±0.69 2.35±0.83 
MIP-2 3.18±2.27 4.18±2.24* 4.84±4.03* 5.86±6.34* 11.45±6.93* 8.85±7.07* 
TNF-α 0.82±0.62 0.85±0.51 0.87±0.27 0.83±0.22 0.68±0.26 0.65±0.35 
IL-1β 1.55±0.45 1.37±0.29 1.32±0.21 1.43±0.1 1.95±0.82 1.49±0.36 
antrum 9 weeks post-infection 
 ASB1wt ASB1ΔhofE ASB1ΔhofF ASB1ΔhofG SS1 STM138ΔhofF 
Muc1 2.21±0.37 0.57±0.47 1.60±0.28 1.18±0.19 1.06±0.21 0.83±0.15 
Muc5ac 0.85±0.41 2.94±2.46 1.01±0.29 0.48±0.24* 0.49±0.19* 0.55±0.20* 
Muc6 1.32±0.33 1.06±0.38 2.86±3.57* 0.49±0.15* 1.94±2.37* 0.60±0.14* 
Muc13 6.66±2.29* 0.75±1.05 2.22±1.70 3.78±1.33* 2.55±0.96* 1.03±0.31 
KC 12.5±3.94* 0.57±0.79 3.7±3.31* 5.86±2.3* 2.77±3.96* 0.78±0.31 
Lix 5.23±2.13* 0.40±0.6 2.5±2.83 4.07±1.63* 0.73±0.33 0.39±0.23 
MIP-2 1.29±0.62 0.56±0.22 0.72±0.42 0.47±0.28 0.46±0.19 0.46±0.14 
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TNF-α 9.56±2.51* 1.95±0.84 2.17±0.54 8.37±3.09* 5.2±4.08* 1.65±1.4 
IL-1β 5.1±2.97* 0.86±0.51 1.19±0.59 5.04±0.55* 1.73±0.95 1.18±0.61 
fundus 9 weeks post-infection 
 ASB1wt ASB1ΔhofE ASB1ΔhofF ASB1ΔhofG SS1 STM138ΔhofF 
Muc1 1.29±0.38 1.29±0.86 2.44±1.20 2.06±1.02 2.69±1.61 2.22±0.68 
Muc5ac 1.44±0.94 1.80±1.32 1.60±1.01 2.17±1.97 2.24±1.96 1.58±1.02 
Muc6 2.12±0.31* 3.12±1.57* 2.62±0.58* 2.42±1.46* 2.81±1.56* 2.80±1.66* 
Muc13 2.14±0.25* 1.3±0.25 2.02±0.79 2.12±1.16* 3.03±0.89* 2.02±0.80 
KC 2.27±0.35* 2.73±1.27* 4.76±3.30* 2.79±1.62* 2.81±1.02* 3.21±1.27* 
Lix 1.19±0.85 4.98±2.05* 4.10±2.36* 4.25±2.34* 4.77±2.21* 7.19±3.02* 
MIP-2 1.61±1.89 1.70±1.77 1.25±2.00 2.62±3.43 6.04±4.16* 6.30±4.11* 
TNF-α 1.31±0.46 0.85±0.42 0.87±0.46 1.31±0.64 1.15±0.66 1.14±0.3 
IL-1β 0.96±0.39 0.55±0.13 0.53±0.25 0.96±0.35 1.01±0.3 0.77±0.53 
* Significant differences in expression level between the infected groups and the negative-control group at a 
certain time-point are indicated by * p<0.05 (ANOVA).  
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Table S3: List of primers used in quantitative RT-PCR for gene expression. 
Primer* Sequence Reference 
H2afz-F (m) 5’- GGT ATC ACC CCT CGT CAC TT-3’ 1 
H2afz-R (m) 5’- TCA GCG ATT TGT GGA TGT GT-3’ 1 
HPRT-F (m) 5’- CAG GCC AGA CTT TGT TGG AT-3’ 1 
HPRT-R (m) 5’- TTG CGC TCA TCT TAG GCT TT-3’ 1 
PPIA-F (m) 5’- AGC ATA CAG GTC CTG GCA TC-3’ 1 
PPIA-R (m) 5’- TTC ACC TTC CCA AAG ACC AC-3’ 1 
Muc1-F (m) 5’- GGT TGC TTT GGC TAT CGT CTA TTT-3’ 1 
Muc1-R (m) 5’- AAA GAT GTC CAG CTG CCC ATA-3’ 1 
Muc6-F (m) 5’- TGC TCC CAG AAT GAG TAC TTC GA-3’ 1 
Muc6-R (m) 5’- CAG AGG TGG AAC TGT GAA ACT CAG T-3’ 1 
Muc13-F (m) 5’- GCC AGT CCT CCC ACC ACG GTA-3’ 1 
Muc13-R (m) 5’- CTG GGA CCT GTG CTT CCA CCG-3’ 1 
KC-F (m) 5’- GCT GGG ATT CAC CTC AAG AA -3’ 2 
KC-R (m) 5’- TCT CCG TTA CTT GGG GAC AC -3’ 2 
MIP2-F (m) 5’- TGC CTG AAG ACC CTG CCA AGG-3’ 2 
MIP2-R (m) 5’- GTT AGC CTT GCC TTT GTT CAG-3’ 2 
Lix-F (m) 5’- CTC AGT CAT AGC CGC AAC CGA GC-3’ 2 
Lix-R (m) 5’- CCG TTC TTT CCA CTG CGA GTG C-3’ 2 
HH_FWQ (Hh) 5’- CTT TCT CCT GGT GAA GTG ATT CTC -3’ 1 
HH_RVQ (Hh) 5’- GCT GTA CCA GAG GCA ATG TCC AAG-3’ 1 
Hpyl_F1 (Hp) 5’- AAA GAG CGT GGT TTT CAT GGC G-3’ 1 
Hpyl_R1 (Hp) 5’- GGG TTT TAC CGC CAC CGA ATT TAA-3’ 1 
GADPH_F (h) 5’- CCT GTA CGC CAA CAC AGT GC-3’ 3 
GADPH_R (h) 5’- ATA CTC CTG CTT GCT GAT CC-3’ 3 
MUC13_F (h) 5’- AGC CCT TTC TGC GTT GCT TCC A-3’ 3 
MUC13_R (h) 5’- CAC TCA GGG GCC CCA CCA CT-3’ 3 
IL8_F (h) 5’- AAG AGA GCT CTG TCT GGA CC-3’ 3 
IL8_R (h) 5’- GAT ATT CTC TTG GCC CTT GG-3’ 3 
atpA-HH-F (Hh) 5’- CCT TGA AGA GGG CTG TAT CG-3’ This study 
atpA-HH-R (Hh) 5’- ACG GGG ACT TTC ATG AGT TG-3’ This study 
efp-HH-F (Hh) 5’- GTT CAT GGA CAC GGA AAC CT-3’ This study 
  
 137 
 Experimental Study 2 
efp-HH-R (Hh) 5’- ACT TGA GAG CCA TCG AGC AT-3’ This study 
hofH-HH-F (Hh) 5’- ACC TAC ATT TGG AGC GAT GC-3’ This study 
hofH-HH-R (Hh) 5’- CCT TGG GTT TTC CCA CTT CT-3’ This study 
hofC-HH-F (Hh) 5’- ACG ACA CCA CAC AGG TCA AA-3’ This study 
hofC-HH-R (Hh) 5’- GGA GCT GAA CAC TTG GAA GG-3’ This study 
hofD-HH-F (Hh) 5’- ATC TGC GTC TAG CGA CTG GT-3’ This study 
hofD-HH-R (Hh) 5’- TAG GGG TTG ACC TTC CAG TG-3’ This study 
hofE-HH-F (Hh) 5’- GCT ACA CCG AAG GCT TTG AG-3’ This study 
hofE-HH-R (Hh) 5’- GCC CTG CTT GTT CTT AGT CG-3’ This study 
hofF-HH-F (Hh) 5’- GCA GAT TGT GTG CAA GGC TA-3’ This study 
hofF-HH-R (Hh) 5’- CAT AAC GTC CGC CTC TGA AT-3’ This study 
hofG-HH-F (Hh) 5’- AAT TAT CCG GGG CTT ACC AC-3’ This study 
hofG-HH-R (Hh) 5’- GGA CCC GCT CAT AAA ATC AA-3’ This study 
efp-HP-F (Hp) 5’- GAT GAG CGA GCT CAA AAA GG -3’ This study 
efp-HP-R (Hp) 5’- GGG CTT GAC ATG CTG GTA TT -3’ This study 
Urel-HP-F (Hp) 5’- CCA GCG ACT GGG TTA TTG TT -3’ This study 
Urel-HP-R (Hp) 5’- GGA TAA AAT CGC AGC AGG AA -3’ This study 
hofH-HP-F (Hp) 5’- CAT TAG GGT TGC GCC TTT TA -3’ This study 
hofH-HP-R (Hp) 5’- CGC CAA AGA GAT TCC CAA TA -3’ This study 
hofC-HP-F (Hp) 5’- ACA CTT GGG ATC CGT TCT TG -3’ This study 
hofC-HP-R (Hp) 5’- TAA GCA CCA CCA ACC ACA AA -3’ This study 
hofD-HP-F (Hp) 5’- AAC CTC GTT TAG CCA TGG TG -3’ This study 
hofD-HP-R (Hp) 5’- AAG CCT TCA ACC CCT TGA GT -3’ This study 
hofE-HP-F (Hp) 5’- TCC ACC AAC GCT TTG ACT -3’ This study 
hofE-HP-R (Hp) 5’- ACC ATA CCA GCC AAT CCT TG -3’ This study 
hofF-HP-F (Hp) 5’- AGG GCT TTA CCC TAC CGA AA -3’ This study 
hofF-HP-R (Hp) 5’- AAG GCT CCC GTC TAA ATG GT -3’ This study 
hofG-HP-F (Hp) 5’- CGA TTG CAG CCA TTC CTT AT -3’ This study 
hofG-HP-R (Hp) 5’- AGC CCC CAA TGA AAT TCT CT -3’ This study 
m: mouse; h: human; Hh: H. heilmannii; Hp: H. pylori; *Primers used for measuring mRNA expression of 
Muc5AC were purchased from QIAGEN Cat.no.:Qt01196006 
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Gastric de novo Muc13 expression and spasmolytic polypeptide-expressing metaplasia 
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GENERAL DISCUSSION 
 
...”What we know is a drop, what we don't know is an ocean!”... by Isaac Newton 
 
Gastric NHPH species from domestic animals have been associated with disease in humans. 
Some distinct features, such as the association with gastric MALT lymphoma, indicate that 
these zoonotic bacteria should not be considered as a “light” version of H. pylori. Information 
on how NHPH species colonize the stomach and cause disease is still scarce. The recent 
successful in vitro isolation of several of these species, including H. heilmannii, has opened 
new perspectives for understanding the pathogenesis of NHPH-associated gastric pathology in 
humans.  
 
Effect of a H. heilmannii infection on the expression of gastric mucin-types 
Several gastric Helicobacter species are able to colonize the mucus niche of the human gastric 
mucosa. The main components of the mucus layer are heavily glycosylated mucins which 
interact with Helicobacter (Kaneko et al., 2003; Chen et al., 2004; Shirazi et al., 2000). Three 
mucin types are highly expressed in a healthy gastric mucosa. The membrane-bound MUC1 
mucin is detected in mucous cells of the surface epithelium and in the pyloric and fundic 
glands of the stomach (Ho et al., 1995; Peterson, 1991; Reis et al., 1998). Secreted MUC5AC 
is found in the foveolar epithelium of both antrum and fundus (Ho et al., 1995; Audie et al., 
1993) whereas secretion of MUC6 is limited to mucous neck cells of the fundic and pyloric 
glands (Ho et al., 1995; Bartman et al., 1998; De Bolos et al., 1995). One of the hallmarks of 
human gastric pathologies are the alterations in mucin distribution and expression in the 
stomach (Skoog et al., 2012; Weis et al., 2013). It has been reported that a H. pylori infection 
changes gastric mucin expression in humans (Ho et al., 1995; Wang and Fang, 2003; Babu et 
al., 2006; Beil et al., 2000; Byrd et al., 2000; Morgenstern et al., 2001; Fichman et al., 2004; 
Kim et al., 2003). This has also been confirmed by experimental H. pylori infections in 
Rhesus monkeys and rodents (Linden et al., 2008; Navabi et al., 2013). Both animal models 
have been shown to be suitable to study Helicobacter-related gastric pathology in humans 
(O’Rourke and Lee, 2003). On the contrary, when we started our studies, no information was 
available about mucin expression and distribution in the stomach of NHPH infected patients 
and only few studies dealt with the gastric mucin dynamics in animals experimentally infected 
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with animal-associated gastric Helicobacter species. Furthermore, these were limited to H. 
felis (Nomura et al., 2004; Kurt-Jones et al., 2007; Schmitz et al., 2009).   
In the first chapter of this thesis, we describe the impact of a H. heilmannii infection on the 
distribution and expression of mucins in the stomach of mice. In this study, H. pylori was 
included for comparison. In the first 9 weeks post-infection, expression of the gland mucin 
Muc6 was significantly increased in both the antrum and the fundus of the stomach of H. 
heilamnnii- and H. pylori-infected mice. Expression of gastric Muc1 and Muc5AC was 
unaffected. During this acute stage of infection, these animals developed gastritis particular in 
the fundus of the stomach. Similar findings have been reported in H. pylori-associated 
gastritis in humans (Beil et al., 2000; Byrd et al., 2000; Matsuzwa et al., 2003; Van den Brink 
et al., 2000). Although it has been shown that H. pylori interacts with MUC1 and MUC5AC 
by binding to sLex and Leb, respectively, expression of MUC5AC and MUC1 seems not to be 
affected by a H. pylori infection (Marques et al., 2005; Kang et al., 2008). Unpublished results 
of recent in vitro mucin binding assays showed that H. heilmannii does not adhere to sLex and 
Leb. Mucins can carry on the order of 100 different carbohydrate structures (Klein et al., 
1993). Whether MUC1 and/or MUC5AC carry other glycans, that could interact with H. 
heilmannii, remains to be further studied.  
Gastric glands of H. pylori-infected patients have a low degree of colonization with this 
bacterium (Kawakubo et al., 2004), although increased expression of MUC6 was seen in these 
patients, as was also shown in our in vivo experiment. This finding may be attributed to the 
involvement of α1,4-linked N-acetylglucosamine, present on MUC6, in the clearance of H. 
pylori from the glands. This carbohydrate structure has a strong antibacterial activity against 
H. pylori by inhibiting its biosynthesis of cholestryl-α-D-glucopyranoside (Kawakubo et al., 
2004). It has therefore been suggested that MUC6 plays a role in the host defense against H. 
pylori infection (Kawakubo et al., 2004). Reduced MUC6 expression will increase gastric 
mucosal susceptibility to H. pylori infection. Indeed, a decrease in expression or even loss of 
MUC6 has been described in more severe gastric pathologies, including intestinal metaplasia 
and adenocarcinoma (Byrd et al., 2000; Zheng et al., 2006).  
On the contrary, in our study, the increased Muc6 expression in the first 9 weeks post-
infection was positively correlated with the increased number of H. heilmannii bacteria. 
Unlike H. pylori which is mainly found at the surface epithelium, H. heilmannii can 
additionally be seen more deeply in the glands of the gastric mucosa (unpublished results). 
From 9 weeks post-infection onwards, expression of Muc6 was found to adopt the normal 
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expression pattern as in the uninfected animals. These findings suggest a potential role of 
Muc6 in the initial colonization of the gastric mucosa by H. heilmannii rather than a role in 
host defense as shown for H. pylori.  
 
Effect of a H. heilmannii infection on the expression of non-gastric mucin-types 
During our in vivo experiment, significantly increased expression of non-gastric mucin-types, 
including Muc5B, Muc4 and Muc13, was found in the murine stomach in response to H. 
heilmannii and H. pylori infection.  
In humans, MUC5B is predominantly found in both saliva and the respiratory tract. MUC5B 
is not expressed in the healthy human stomach but its expression has been shown to be 
upregulated in human gastric adenocarcinomas (Schmitz et al., 2009). In our study, the 
mRNA expression of murine Muc5B remained high in the stomach as gastric disease 
progressed in severity during later stages of heilmannii and H. pylori infection. This 
resembles what has been seen in human gastric disease pointing out the role of MUC5B in 
disease progression. Expression of this mucin in the human stomach is regulated by IL-1β and 
IL-17A in an NF-κB dependant manner (Fujisawa et al., 2011). Furthermore, MUC5B is able 
to bind SabA expressing H. pylori strains at neutral pH (Linden et al., 2008). The upregulation 
of MUC5B seen in the human stomach may thus also allow for increased binding of 
Helicobacter. H. heilmannii, however, lacks the SabA adhesin. Whether this bacterium is also 
able to bind MUC5B via other adhesins remains to be further determined.  
Besides MUC5B, also MUC4, a transmembrane mucin which is normally expressed in the 
intestines, plays a crucial role in the progression to gastric malignancies, such as mucous 
metaplasia (Schmitz et al., 2009). A number of studies, including our own H. heilmannii 
experimental infection study in mice, show that the loss of parietal cells leads to the evolution 
of SPEM, a gastric fundic metaplastic lineage consisting of TFF2-expressing mucous cells 
with Brunner's gland or deep antral gland morphology (Nomura et al., 2004; Wang et al., 
1998; Goldenring et al., 2000). Gastric MUC4 expression has been shown to be a marker for 
SPEM (Weis et al., 2013). The molecular mechanisms for its involvement in this type of 
metaplastic progression may be related to the epidermal growth factor (EGF)-like domain of 
MUC4 that is known to interact with the receptor tyrosine kinase ErbB2 and alter epithelial 
cell growth (Schmitz et al., 2009; Jonckheere et al., 2004). Furthermore, MUC4 has been 
shown to be upregulated by IL-6, via the gp130/STAT3 pathway and the transforming growth 
factor b (TGFb), in H. pylori-infected gastric epithelial cells, highlighting the role of these 
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signal transducers in gastric tumorigenesis (Mejias-Luque et al., 2008). Increasing evidence in 
humans and rodent models suggests that intestinal metaplasia, another mucous metaplastic 
lineage and associated with intestinal MUC2 expression in the stomach, develops in the 
presence of pre-existing SPEM. This supports the concept that SPEM is a neoplastic precursor 
in the carcinogenesis cascade (Yoshizawa et al., 2007; Nam et al., 2009; Goldenring et al., 
2010). In our study, intestinal metaplasia was not observed. Further studies are necessary in 
which H. heilmannii-infected mice are followed during more than a year to determine if 
SPEM will further differentiate into intestinal metaplasia and eventually dysplasia, an early 
stage in the development of cancer. MUC13, another transmembrane mucin, is normally 
expressed on the apical surface of all cells in glands and villi of the small intestine. It is also 
expressed by enterocytes and goblet cells throughout the large intestine where both cell-
surface (highest in the surface epithelium) and cytoplasmic localization has been described 
(Sheng et al., 2011). Additionally, this cell-surface mucin is abundantly present in the trachea 
and kidneys (Williams et al., 2001) whereas in the normal stomach, its expression level is 
very low (Williams et al., 2001; Maher et al., 2011; Sheng et al., 2011). MUC13 contains a N-
terminal signal peptide followed by a large serine-threonine rich tandem repeat domain. The 
central region of MUC13 includes three EGF-like domains (EGF1, EGF2 and EGF3), 
suggesting that MUC13 plays an important role in the signalling cascade. Additionally, a sea 
urchin sperm protein enterokinase arginine (SEA) module is present between EGF1 and 
EGF2, providing a cleavage site which separates MUC13 into an extracellular α subunit and a 
transmembrane β subunit (Williams et al., 2001; Shimamura et al., 2005). In the intestines, 
MUC13 plays an essential role in limiting tissue injury after exposure to environmental toxins 
through inhibition of apoptosis and the maintenance of intestinal epithelial barrier function 
(Sheng et al., 2011). It has been suggested that the protective role of MUC13 in inflammation 
is most likely due to cytoplasmic domain signalling (Moehle et al., 2006; Sheng et al., 2011). 
On the contrary, polymorphisms that impair MUC13 expression and signalling could lower 
this level of protection (Moehle et al., 2006). It should therefore be noted that sustained 
elevation of MUC13 may promote the transition from chronic inflammation to cancer (Kufe, 
2009). Indeed, aberrant expression of MUC13 has been described in ovarian, pancreatic, 
gastric and colorectal cancers (Maher et al., 2011; Walsh et al., 2007; Shimamura e al., 2005; 
Chauhan et al., 2007). In pancreatic cancer, increased MUC13 expression has been correlated 
with tumorigenic characteristics including repression of p53 and the upregulation of ErbB2, 
p21-activated kinase 1 (PAK1), extracellular signal-regulated kinase (ERK), Akt and 
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metastasin. Conversely, suppression of MUC13 resulted in the suppression of these 
tumorigenic characteristics (Chauhan et al., 2007). Based on these findings, MUC13 may be 
involved in cancer pathobiology and could be a potential diagnostic/prognostic biomarker of 
cancer as well as a target for antibody guided therapy for cancer treatment (Byrd et al., 2004; 
Packer et al., 2004).  
In our in vivo experiment, aberrant murine Muc13 expression was noticed already in the early 
stage of infection in the stomach of H. heilmannii and H. pylori-infected mice and its 
expression remained high when chronic inflammation evolved into MALT-lymphoma-like 
lesions. This latter finding provides further evidence for the role of MUC13 in cancerogenesis 
as described above. However, the increased expression of Muc13 in the first 9 weeks post-
infection was positively correlated with the increased number of H. heilmannii and H. pylori 
bacteria in the stomach. This finding, which is novel in Helicobacter research in general, 
suggests an additional role for Muc13 in the initial colonization of the gastric mucosa by 
Helicobacter.   
 
Pathways involved in gastric MUC13 expression 
The pathway regulating gastric MUC13 expression was further investigated in the second 
chapter of this thesis.   
In the intestines, MUC13 expression is regulated by IL-22 through the activation of the signal 
transducers STAT3 and cytokine receptor-associated JAK1, which play crucial roles in 
epithelial proliferation, differentiation, and apoptosis (Begue et al., 2011; Heneghan et al., 
2013; Okamoto et al., 2011). IL-22, expressed by innate and adaptive immune system cells, is 
a key cytokine for gut epithelial homeostasis and mucosal repair, underlining the protective 
role of MUC13 in inflammation in the intestines (Fernandes et al., 2014).  
In our study, however, we found that gastric MUC13 expression is induced by the pro-
inflammatory cytokine IL-1β. This cytokine enables H. heilmannii and H. pylori to colonize 
the gastric mucosa by inhibiting acid secretion (Joosten et al., 2013; El-Omar, 2001; Semper 
et al., 2014). Secretion of IL-1β induced by H. pylori depends on the activation of the 
inflammasome, an intracellular multiprotein oligomer implicated in the activation of 
inflammatory processes (Semper et al., 2014; Koch et al., 2015). Inflammasome activation in 
dendritic cells by H. pylori infection requires the nucleotide-binding oligomerization domain-
like receptor family, pyrin domain containing 3 (NLRP3) as well as induction of toll-like 
receptor 2 (TLR2) signalling (Koch et al., 2015). Furthermore, it has been shown that pro-IL-
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1β expression is induced by H. pylori LPS, while the urease B subunit of H. pylori is required 
for NLRP3 inflammasome licensing (Koch et al., 2015). Additionally, another study 
highlighted the involvement of the H. pylori cagPAI and VacA virulence factors in 
inflammasome activation (Semper et al., 2014). Both these virulence factors are, however, 
absent in H. heilmannii and it is currently unknown how this bacterium triggers secretion of 
IL-1β. Screening of a H. heilmannii transposon mutant library for its ability to activate the 
inflammasome may help to identify the virulence factors involved in this process. 
It has previously been shown that the intestinal mucin-type MUC2 is activated by IL-1β 
through the NF-κB signalling pathway in gastric epithelial cells (Mejias-Luque et al., 2010). 
Whether NF-κB or other signal transducers are involved in the activation of gastric IL-1β-
induced MUC13 expression remains to be further elucidated.  
Based on the findings described above, it is clear that MUC13 expression in the 
gastrointestinal tract can be regulated by different signalling pathways. 
Another remarkable difference between gastric and intestinal epithelial cells is the 
involvement of MUC13 in IL-8 signalling in response to inflammation. MUC13 increases IL-
8 production in the supernatant of human intestinal epithelial cells in response to a 
Campylobacter infection (Sheng et al., 2013). In the stomach, IL-8 is also secreted in the 
supernatant of epithelial cells infected with H. pylori (Lee et al., 2013) and H. heilmannii (our 
study). However, we demonstrated that the expression of this cytokine is not regulated by 
MUC13. Gastric IL-8 expression seems to be induced by the transmembrane mucin MUC1, as 
shown before (Sheng et al., 2013).  
 
Adhesion of H. heilmannii to the gastric mucosa 
A critical step in gastric Helicobacter colonization is adhesion to the gastric mucosa. For H. 
pylori, it has been described that the majority of the bacteria resides in the mucus layer by 
binding to mucins while only a small percentage adheres to the gastric epithelium underneath 
the mucus layer (McGuckin et al., 2011). H. heilmannii is also able to bind to human gastric 
mucins and epithelial cells, although to a lesser extent than H. pylori (Joosten et al., 2015). 
The fact that man is not the natural host for H. heilmannii might explain the lower binding 
capacity to the human gastric mucosa. Indeed, H. heilmannii adhered to a higher extend to the 
feline than to the murine mucosal surface epithelium. The latter resembles the human gastric 
mucosa (Joosten et al., 2015). The ability of H. pylori and H. heilmannii to bind to gastric 
mucins and epithelial cells is pH dependent. Binding to gastric mucins and epithelial cells was 
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the highest at pH2 and pH7, respectively (Joosten et al., 2015). This is consistent with the 
physiological pH gradient in the stomach ranging from pH 1-2 in the gastric lumen (where 
most mucins reside) to pH 6-7 at the epithelial cell surface (Linden et al., 2008; Skoog et al., 
2011). In addition, unpublished results of recent in vitro assays showed that the binding 
pattern of H. heilmannii to human gastric mucins is distinctly different from that of H. pylori. 
Binding of H. heilmannii was higher to mucins from healthy individuals and in particular to a 
mucin sample containing high amounts of N-terminal acetylgalactosamine β1-4N-
acetylglucosamine (LacdiNAc). This structure is involved in the termination of glycan side 
chains, which has been suggested to prevent more complex glycosylation (Kenny et al., 
2012). The availability of less complex glycan structures may be beneficial for H. heilmannii 
adhesion, as there would then be less steric hindrance to interfere with binding to other 
possible ligands. Alternatively, LacdiNac might be a ligand itself that H. heilmannii can bind 
to. Binding assays using ELISA with this carbohydrate structure immobilized on polystyrene 
96-well microtiter plates may clarify this matter.  
In the human stomach, the expression of LacdiNac is absent in cardiac glands. It is expressed 
at the surface of the fundic mucosa and in the distal part of the pyloric glands. This 
carbohydrate structure seems to be co-localized with MUC5AC, but has also been found 
deeper into the glands, suggesting that other mucin types may express LacdiNac as well 
(Rossez et al., 2014). It remains thus to be further elucidated, for instance by double 
immunostaining, which other mucin-types carry LacdiNac . 
Bacterial OMPs are directly involved in the interaction of pathogenic bacteria with their host 
(Galdiero et al., 2012). H. pylori is equipped with a large set of OMPs, which role in the 
adhesion process has been well-studied. The H. pylori OMPs BabA/B (HopS/T), SabA 
(HopP), AlpA/B (HopB/C), OipA (HopH), HopZ, HopQ and HomB have been identified as 
adhesins (Oleastro and Menard, 2013). The Bab and Sab adhesins are involved in adhesion to 
gastric mucins (Oleastro and Menard, 2013; Ilver et al., 1998; Mahdavi et al., 2002) whereas 
the other identified H. pylori adhesins have been described to play a role in binding to gastric 
mucus-secreting epithelial cells (Oleastro and Menard, 2013). In silico analyses of the H. 
heilmannii genome (Smet et al., 2013) revealed the presence of 53 OMPs which is in 
agreement with the number of OMPs found in H. pylori. Comparative genomics between the 
H. heilmannii and H. pylori genomes showed that only few of these H. heilmannii OMPs can 
be classified among the 5 OMP families (Hop, Hor, Hom, Hof, iron-regulated OMPs and 
efflux pump OMPs) described in H. pylori (Joosten et al., 2015). Only homologs of the H. 
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pylori Hof OMPs seem to be well conserved in H. heilmannii but also among other gastric 
NHPH. (Joosten et al., 2015). H. heilmannii lacks all H. pylori adhesins described so far 
(Joosten et al., 2015) indicating that both species harbour a different repertoire of adhesins. In 
the second chapter of this thesis, we identified the H. heilmannii HofE and HofF OMPs as 
adhesins involved in binding to the gastric mucosa albeit with a higher affinity for epithelial 
cells than mucins.  
Mucins can carry in the order of 100 different carbohydrate structures. The absence of 
carbohydrates having a strong binding affinity for H. heilmannii might explain the low 
binding capacity of this pathogen to the mucin samples used in our study. The use of 
carbohydrate-based micro-array platforms may allow to identify interactions of H. heilmannii 
HofE and HofF with specific, known carbohydrate structures.  
Epithelial cells can carry extracellular matrix (ECM) molecules (e.g. laminin, type IV 
collagen, fibronectin and vitronectin) which also can act as receptors for bacterial pathogens 
(Senkovich et al., 2011). H. pylori is able to bind to several host ECM molecules, in particular 
laminin, which is present on gastric epithelial cells. Binding to laminin is mediated by the 
AlpA/AlpB Hop adhesins of H. pylori (Senkovich et al., 2011). Whether H. heilmannii is able 
to adhere to ECM molecules and whether its HofE/F adhesins are involved remains thus to be 
further elucidated. 
To further characterize the complete adhesin repertoire of H. heilmannii, the OMP expression 
pattern of this microorganism in response to adherence to the gastric mucosa at different pH 
environments should be studied as well. This can be enabled through whole transcriptome 
analyses, chromosome insertional mutagenesis approaches and in vitro binding assays. OMPs 
that are altered in expression in relation to adherence can potentially play a role in the 
adhesion process as has been described before (Skoog et al., 2012). 
It has previously been shown that H. pylori OMPs, such as the OipA, AlpA/B, HomB, BabA 
and SabA adhesins albeit via mucin binding or by direct adherence to gastric epithelial cells, 
are involved in the induction of expression of IL-8 in the gastric epithelium (Oleastro & 
Menard, 2013; Sheng et al., 2013). In chapter 2, however, it was found that the H. heilmannii 
HofE and HofF adhesins do not play a major role in IL-8 production, but are essential for the 
activation of IL-1β which on its turn induces expression of MUC13 in the gastric epithelium. 
Also the H. pylori HofF protein was shown to be involved in IL-1β-induced MUC13 
expression. Whether this OMP plays a role in H. pylori adherence to the gastric mucosa is 
currently unknown. 
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Further unravelling the involvement of these Helicobacter Hof outer membrane proteins in 
IL-1β-induced gastric MUC13 signalling is essential for understanding the exact role of this 
mucin in the host innate immune response during initial Helicobacter colonization.   
 
Final conclusions and future perspectives 
In conclusion, the results described in this thesis clearly demonstrate that both an acute and 
chronic H. heilmannii infection in mice induce changes in the distribution and expression of 
mucins in the stomach, in particular Muc6 and Muc13 which were shown to be involved in H. 
heilmannii colonization. Whether H. heilmannii is able to bind to carbohydrate structures 
present on MUC6 and MUC13 remains to be further elucidated. This can, for instance, be 
done by performing first in vitro adhesion studies with immobilized MUC6 and MUC13. If H. 
heilmannii indeed binds to MUC6 and/or MUC13, the carbohydrates present on these mucins 
can then be released by reductive β-elimination and analysed by liquid chromatography-mass 
spectrometry. Finally, in vitro binding assays with the characterized carbohydrates may allow 
to identify the receptors for the H. heilmannii adhesins. 
One of the very first steps in the pathogenesis of gastric Helicobacter infections is adhesion of 
these bacteria to the gastric mucosa. Here, we identified two novel H. heilmannii adhesins, 
HofE and HofF, which also seem to be involved in MUC13 signalling.  
Modulating adhesin gene expression is essential for H. heilmannii to adapt its adherence 
properties accordingly to maintain infection in its host. This can be facilitated by bacterial 
genome plasticity, as has been shown for H. pylori (Kang and Blaser, 2006). Genome 
plasticity, caused by high mutation and recombination events, results in high sequence 
diversity and population heterogeneity among bacterial strains (Moreli et al., 2010). H. pylori 
and H. heilmannii have numerous simple sequence repeats in their genomes which can 
contribute to genome plasticity (Janulczyk et al., 2010; unpublished results). In H. pylori, 
expression of genes encoding adhesins can be altered through phase variation via slipped-
strand mispairing of these simple sequence repeats or via gene conversion (Aberg et al., 
2014). How H. heilmannii employs genetic variation to regulate adhesin gene expression has 
not yet been investigated. Therefore, future studies are needed to unravel the genetic 
mechanisms regulating hofE and hofF gene expression and to investigate the impact of these 
mechanisms on gastric MUC13 expression. Such studies may include a screening of available 
H. heilmannii genomes to identify the presence of simple sequence repeats in hofE and hofF 
which may result in slipped-strand mispairing. It should also be elucidated whether hofE and 
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hofF genes share a high nucleotide identity at their 5’ and 3’ end which could allow 
homologous recombination between these genes. This latter phenomenon is called gene 
conversion. If simple sequence repeats are found in the coding sequence or promoter region, 
amplified fragment polymorphisms analyses can be performed to investigate whether hofE 
and hofF gene expression is controlled by phase variation through slipped strand mispairing 
of these simple sequence repeats. An intragenic repeat length in frame with the coding 
sequence will result in protein expression (ON status) while a repeat length out of frame 
causes a frameshift and will switch off the protein (OFF status). Intergenic simple sequence 
repeats might influence transcription by changing the spacing of promoter elements. In case 
hofE and hofF share a high nucleotide homology at their 5’ and 3’ end, fluctuation assays can 
then be carried out to investigate whether expression is determined by gene conversion.  
Subsequently, H. heilmannii strains showing differences in length of the identified simple 
sequence repeats in hofE and hofF or in which gene conversion has occurred may be further 
screened for adhesin expression at RNA and protein level. The ones displaying distinct HofE 
and HofF expression can then be analyzed for their ability to induce MUC13 expression in 
gastric epithelial cells. 
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SUMMARY 
Helicobacter pylori is by far the most explored Helicobacter species in humans. Infection 
with this agent has been associated with a variety of gastric pathologies such as gastritis, 
ulcers and cancer. 
Besides H. pylori, gastric disease in humans has been associated with other spiral-shaped 
Non-Helicobacter pylori Helicobacter species (NHPH) naturally colonizing the stomach of 
animals such as H. heilmannii. This zoonotic agent, highly prevalent in cats and dogs, has 
been associated with gastritis, gastric and duodenal ulcers and Mucosa-associated lymphoid 
tissue (MALT) lymphoma in humans. The risk of developing MALT lymphoma is higher 
after infection with NHPH than with H. pylori. H. heilmannii has been described in 8-19% of 
gastric biopsy samples of humans with severe gastric complaints and with histological 
evidence of a NHPH infection. However, this is most probably an underestimation of its true 
prevalence since diagnosis of infections with this agents is difficult and it can also not be 
excluded that H. heilmannii infections sometimes remain unapparent or cause only mild 
disease signs which are often not thoroughly examined. The prevalence of H. pylori in 
humans from the western world is decreasing, leaving a niche for possible infection with 
NHPH. Living in close contact with cats and dogs has been identified as a significant risk 
factor for these infections in humans. 
Initially, information on the pathogenesis of human gastric disease associated with an H. 
heilmannii infection was scarce. This was mainly due to its fastidious nature, hampering 
isolation and cultivation under laboratory conditions. The first successful in vitro isolation of 
H. heilmannii from feline stomachs was done in 2011, opening new doors to investigate the 
role of this pathogen in human gastric pathology. 
 
The human gastric mucosa is covered by a layer of continuously secreted mucus that washes 
away trapped particles. It is one of the first barriers Helicobacter encounters and consists of 
heavily glycosylated secreted mucins. The gastric epithelium underneath the mucus layer 
consists of various cell types.  
For H. pylori, it is known that infection with this pathogen causes alterations in the expression 
pattern and distribution of gastric mucins as well as a disruption of the gastric mucosa by 
inducing epithelial cell loss. Loss of parietal cells can lead to mucous metaplasia which is 
characterized by the presence of non-gastric mucin types. 
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Similar to H. pylori, H. heilmannii is able to bind to human gastric mucins as well as to 
gastric epithelial cells. Both species are mainly observed close to the surface epithelium, but 
H. heilmannii can additionally be seen in close association with acid-secreting parietal cells 
located in the gastric glands.  
At the onset of this thesis, no information was available about the mucin dynamics in the 
stomach during infection with H. heilmannii and how this bacterium is able to adhere to the 
human gastric mucosa which is essential to initiate and maintain infection.  
 
In our first study, we investigated the expression pattern and distribution of mucins in the 
stomach of mice at several time points during a one-year infection with H. heilmannii, by 
which gastric disease progressed from gastritis to MALT-lymphoma-like lesions. Markers for 
acid production by parietal cells and mucous metaplasia were also examined. A mouse-
adapted H. pylori strain was included for comparison which has been shown to induce MALT 
lymphoma-like lesions in mice.  
In the first 9 weeks post-infection, the mRNA expression of Muc6 was clearly upregulated in 
both the antrum and fundus of the stomach of H. heilmannii- and H. pylori-infected mice. 
Interestingly and novel in Helicobacter research, Muc13 was upregulated already at 1 day 
post-infection in the fundus of the stomach of H. heilmannii and H. pylori-infected mice. Its 
expression level remained high in the stomach over the course of the infection. Muc13 is, 
however, not expressed in a healthy stomach, and a high expression of this mucin was so far 
only described in gastric cancer. Additionally, the increased expression of both Muc6 and 
Muc13 at this acute stage of infection was positively correlated with the increased number of 
H. heilmannii bacteria in the stomach, highlighting a role for these mucins in the initial 
colonization of the gastric mucosa by H. heilmannii. In H. pylori-infected mice, an increased 
number of H. pylori bacteria was positively correlated with an increased Muc13 expression 
but not with an increased Muc6 expression. 
In the later stages of H. heilmannii infection, mRNA expression of H+/K+ ATPase α/β and 
KCNQ1 (markers for acid production) decreased, whereas the expression of Muc4, Tff2, 
Dmbt1 and PigR (markers for mucous metaplasia) increased starting at 16 weeks post-
infection, suggesting the existence of spasmolytic polypeptide-expressing metaplasia in the 
fundus of the stomach of H. heilmannii-infected mice. Mucous metaplasia present in the 
mucosa surrounding low-grade MALT lymphoma-like lesions was also histologically 
confirmed. Similar findings were seen in mice infected with H. pylori. In conclusion, this 
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study described that H. heilmannii infection causes severe gastric pathologies and alterations 
in the expression pattern of gastric mucins, such as Muc6 and Muc13. An infection with this 
agent also induces a disruption of the gastric homeostasis by causing loss of parietal cells, 
resulting in the development of mucous metaplasia. 
 
A critical step in gastric Helicobacter colonization is adhesion to the gastric mucosa. Bacterial 
outer membrane proteins (OMPs) are directly involved in the interaction of symbiotic bacteria 
with their host. H. heilmannii is equipped with a large set of OMPs which role in the adhesion 
process remains to be further elucidated. Interestingly, this bacterium lacks all H. pylori 
adhesins described so far, highlighting that other OMPs are involved in binding. In the second 
study of this thesis, we investigated the role of the H. heilmannii hof gene locus encoding the 
HofH/F/E/G/C/D OMPs in adhesion to the gastric mucosa. This locus is absent in H. pylori. 
Actually, the hof genes of H. pylori are scattered across its genome. Additionally, the role of 
the Hof OMPs in gastric  MUC13/Muc13 expression during H. heilmannii colonization was 
studied as well. We first defined the H. heilmannii hof gene expression patterns in response to 
different conditions reflecting the gastric environment. Based on these results and the 
genomic analysis of the H. heilmannii hof gene locus, HofE, HofF and HofG were selected 
for further study. H. heilmannii ΔhofE, ΔhofF and ΔhofG mutants were created and tested in 
vitro and in vivo for their adhesion characteristics and their capacity to induce gastric 
MUC13/Muc13 expression. In H. pylori research, only the HofF OMP has been shown to 
play a role in gastric colonization. Therefore, a H. pylori ΔhofF mutant was included for the 
purpose of comparison. H. heilmannii strains lacking HofE or HofF showed a clear decrease 
in binding to gastric mucins and epithelial cells as well as a lower gastric colonization level in 
the stomach of Balb/c mice at 4 and 9 weeks post-infection compared to the H. heilmannii 
wildtype strain. The previously shown role of H. pylori HofF in gastric colonisation was also 
confirmed. Interestingly, H. heilmannii ΔhofE and ΔhofF and H. pylori ΔhofF did not induce 
an increased expression of MUC13 in human gastric epithelial cells and of Muc13 in the 
stomach of mice. Finally, we demonstrated that IL-1β is induced in the stomach as a response 
to H. pylori and H. heilmannii colonization which on its turn is involved in the expression of 
MUC13/Muc13 in the gastric epithelium. These novel results in Helicobacter research in 
general identified H. heilmannii HofE and HofF as adhesins and suggest an important role of 
H. heilmannii HofE and HofF and H. pylori HofF in IL-1β-induced gastric MUC13/Muc13 
expression. 
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 Summary 
In conclusion, research included in this thesis demonstrated that both an acute and chronic H. 
heilmannii infection in mice induce changes in the distribution and expression of mucins in 
the stomach, in particular Muc6 and Muc13.  
Finally, we identified two novel H. heilmannii adhesins, HofE and HofF, which also seem to 
be involved in gastric MUC13 signalling. 
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Helicobacter pylori is de best bestudeerde Helicobacter soort bij de mens. Deze kiem wordt 
geassocieerd met gastritis, peptische ulcera en maagkanker. De mens kan evenwel ook besmet 
worden door zogenaamde gastrale niet-H. pylori Helicobacter species. Deze kiemsoorten zijn 
afkomstig van dieren, zoals varkens, honden en katten. H. heilmannii is een niet-H. pylori 
Helicobacter species dat de maag van honden en katten koloniseert. Bij de mens veroorzaakt 
deze kiem gastritis, peptische ulcera en lymfomen van het lymfoïd weefsel van de 
maagmucosa (MALT-lymfomen). Bovendien is het risico op het ontwikkelen van MALT-
lymfomen hoger bij een infectie met niet-H. pylori helicobacters dan bij een infectie met H. 
pylori. H. heilmannii werd gedetecteerd bij 8-19% van de mensen met maagklachten, 
veroorzaakt door niet-H. pylori Helicobacter species. Dit percentage is waarschijnlijk een 
onderschatting van de werkelijke prevalentie, aangezien het moeilijk is om een diagnose te 
stellen van een infectie met deze kiem. Het kan ook niet uitgesloten worden dat een H. 
heilmannii infectie soms zonder symptomen verloopt of enkel milde klachten veroorzaakt die 
niet grondig onderzocht worden.  
Het voorkomen van H. pylori infecties in de westerse samenleving is aan het afnemen, wat 
zou kunnen betekenen dat er meer ruimte gecreëerd wordt voor infecties met niet-H. pylori 
helicobacters. Mensen die in nauw contact leven met honden en katten hebben ook meer kans 
om besmet te geraken met H. heilmannii. 
 
Aanvankelijk was er zeer weinig informatie beschikbaar over de pathogenese van de 
maagpathologieën veroorzaakt door een infectie met H. heilmannii. Dit onderzoek wordt 
voornamelijk bemoeilijkt doordat het bijzonder moeilijk is om deze kiem te kweken in het 
laboratorium. De eerste succesvolle in vitro isolatie van H. heilmannii uit kattenmagen in 
2011, opende nieuwe deuren om de rol van dit agens in de humane maagpathologie te kunnen 
bestuderen. 
De maagmucosa wordt bedekt door een mucuslaag die voornamelijk bestaat uit sterk 
geglycosyleerde mucines en ervoor zorgt dat vastzittende partikels worden weggewassen. Dit 
is één van de eerste barrières die Helicobacter tegenkomt in de maag. Het maagepitheel onder 
de mucuslaag bestaat uit verschillende celtypes. Een infectie met H. pylori kan leiden tot 
veranderingen in het expressiepatroon en de distributie van maagmucines en tot aantasting 
van de maagmucosa door verlies van epitheliale cellen. Een verlies van pariëtaalcellen kan 
leiden tot mucosale metaplasie, wat gekenmerkt wordt door de aanwezigheid van mucines die 
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in een gezonde maagmucosa normaal niet voorkomen. H. heilmannii is, net zoals H. pylori, in 
staat zich vast te hechten aan humane maagmucines en maagepitheelcellen. Beide species 
bevinden zich voornamelijk dicht tegen het oppervlakte-epitheel, maar H. heilmannii kan ook 
teruggevonden worden in nauw contact met de zuur-secreterende pariëtaalcellen aanwezig in 
de maagklieren. 
Bij aanvang van deze thesis was er nog geen informatie beschikbaar over de dynamiek van 
mucines in de maag tijdens een infectie met H. heilmannii. Het was tevens ook niet gekend 
hoe deze bacterie bindt aan de maagmucosa, wat een essentiële stap is om de infectie te 
initiëren en in stand te houden. 
 
Tijdens een eerste studie werd het expressiepatroon en de distributie van mucines in de maag 
van muizen bestudeerd gedurende 1 jaar na een initiële H. heilmannii infectie. Tijdens deze 
dierproef evolueerde de maagpathologie van gastritis tot lesies die sterk lijken op MALT-
lymfomen. Merkers voor zuurproductie door pariëtaalcellen en mucosale metaplasie werden 
ook onderzocht. Een muis-geadapteerde H. pylori stam, die ook MALT-lymfomen kan 
induceren in de maag van muizen, werd mee ingesloten ter vergelijking. Na 9 weken infectie 
was de mRNA expressie van het Muc6 mucine duidelijk verhoogd, zowel in het antrum als in 
de fundus van de maag van de met H. heilmannii- en H. pylori-geïnfecteerde muizen. Vanaf 1 
dag na de initiële infectie was de mRNA expressie van Muc13 reeds verhoogd in de fundus 
van de maag van de met H. heilmannii- en H. pylori-geïnfecteerde muizen, wat een 
interessante en nieuwe bevinding is. Het expressieniveau van Muc13 in de maag bleef hoog 
gedurende de gehele infectieproef. In een gezonde maag komt Muc13 niet tot expressie en tot 
nu toe werd een verhoogde expressie van dit mucine enkel beschreven bij maagkanker. 
Daarnaast kon de verhoogde expressie van zowel Muc6 als Muc13 tijdens het acuut stadium 
van infectie, positief gecorreleerd worden met een toenemend aantal H. heilmannii bacteriën 
in de maag. Dit duidt erop dat deze mucines een rol spelen tijdens de eerste fase van 
kolonisatie van de maagmucosa door H. heilmannii. Bij de met H. pylori-geïnfecteerde 
muizen kon een toenemend aantal H. pylori bacteriën in de maag positief gecorreleerd worden 
met een verhoogde expressie van Muc13, maar niet met een verhoogde expressie van Muc6. 
Tijdens latere stadia van de infectie met H. heilmannii daalde de mRNA expressie van H+/K+ 
ATPase α/β en KCNQ1 (merkers voor zuurproductie), terwijl de expressie van Muc4, Tff2, 
Dmbt1 en PigR (merkers voor metaplasie van de mucuslaag) steeg vanaf 16 weken infectie. 
Dit suggereert de aanwezigheid van metaplasie (“spasmolytic polypeptide-expressing 
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metaplasia”) in de fundus van de maag van met H. heilmannii-geïnfecteerde muizen. Ook na 
histologische analyse kon metaplasie in de maagmucosa rondom de lesies gelijkend op 
MALT-lymfomen bevestigd worden. Dezelfde resultaten werden teruggevonden in de maag 
van de muizen geïnfecteerd met H. pylori. Als conclusie kunnen we stellen dat een H. 
heilmannii infectie ernstige maagpathologieën veroorzaakt en veranderingen kan 
teweegbrengen in het expressiepatroon van maagmucines zoals Muc6 en Muc13. Infectie met 
H. heilmannii kan ook de homeostase in de maag verstoren door een verlies aan 
pariëtaalcellen te induceren, wat aanleiding kan geven tot de ontwikkeling van mucosale 
metaplasie. 
 
Adhesie aan de maagmucosa is een zeer belangrijke stap in het kolonisatieproces van gastrale 
helicobacters. Bacteriële buitenste membraanproteïnen zijn rechtstreeks betrokken bij de 
interactie van symbiotische kiemen met hun gastheer. H. heilmannii beschikt over een 
uitgebreide set van buitenste membraanproteïnen, maar de rol van deze eiwitten in het 
adhesieproces  was bij de aanvang van dit doctoraatsonderzoek niet gekend. Het is 
opmerkelijk dat alle buitenste membraanproteïnen die bij H. pylori functioneren als adhesines, 
afwezig zijn bij H. heilmannii. Dit impliceert dat er andere eiwitten betrokken zijn bij adhesie 
van H. heilmannii aan de maagmucosa. Daarom werd tijdens de tweede studie van deze 
thesis de rol van het hof locus van H. heilmannii, dat codeert voor de HofH/F/E/G/C/D 
buitenste membraanproteïnen, in de adhesie van dit agens aan de maagmucosa onderzocht. 
Dit hof locus is afwezig bij H. pylori. Bij dit species liggen de hof genen verspreid over het 
hele genoom. Daarnaast werd ook de rol van deze Hof eiwitten in de expressie van 
MUC13/Muc13 tijdens kolonisatie van de maagmucosa door H. heilmannii bestudeerd. 
Eerst werden de expressiepatronen van de hof genen van H. heilmannii bestudeerd als respons 
op verschillende gesimuleerde maagcondities. Daarnaast werd er ook een genoomanalyse 
uitgevoerd van het H. heilmannii hof locus. Op basis van de bekomen resultaten werden 
HofE, HofF en HofG geselecteerd voor verdere analyse. Er werden ΔhofE, ΔhofF en ΔhofG 
mutanten van H. heilmannii gecreëerd en zowel hun bindingseigenschappen als hun 
mogelijkheid om MUC13/Muc13 expressie te induceren in het maagepitheel, werden in vitro 
en in vivo getest. Voor H. pylori werd er reeds aangetoond dat enkel het HofF eiwit een rol 
speelt bij de kolonisatie van de maag. In ons onderzoek werd er daarom ook een ΔhofF 
mutant van H. pylori ingesloten om vergelijking tussen beide bacteriën toe te laten. In 
vergelijking met de wild-typestam van H. heilmannii, vertoonden de H. heilmannii mutanten 
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zonder HofE of HofF een duidelijk lagere bindingscapaciteit aan maagmucines en 
epitheelcellen. Beide mutanten hadden ook een lagere kolonisatiecapaciteit in de maag van 
muizen op 4 en 9 weken na de initiële infectie.. De rol van het HofF eiwit in de kolonisatie 
van de maag door H. pylori werd bevestigd in deze studie. Opmerkelijk was dat H. heilmannii 
ΔhofE en ΔhofF en H. pylori ΔhofF geen verhoogde expressie induceerden van MUC13 in 
humane maagepitheelcellen of van Muc13 in de maag van geïnfecteerde muizen. Tenslotte 
werd er ook aangetoond dat kolonisatie van de maagmucosa door H. pylori en H. heilmannii 
leidt tot inductie van het cytokine IL-1β in de maag, dat op zijn beurt betrokken is bij de 
expressie van MUC13/Muc13 in het maagepitheel. 
Deze vernieuwende resultaten voor het Helicobacter onderzoek resulteerden in de 
identificatie van de H. heilmannii HofE en HofF eiwitten als adhesines en tonen een 
belangrijke rol aan voor H. heilmannii HofE en HofF en H. pylori HofF in de IL-1β-
geïnduceerde expressie van MUC13/Muc13 in het maagepitheel. 
 
Als conclusie kunnen we stellen dat dit doctoraatsonderzoek heeft aangetoond dat zowel een 
acute als een chronische H. heilmannii infectie in muizen veranderingen in de distributie en 
expressie van maagmucines induceert, met in het bijzonder een verhoogde expressie van 
Muc6 en Muc13. Er werd eveneens aangetoond dat deze mucines een rol spelen in de 
kolonisatie van de maag door H. heilmannii. 
Daarnaast werden twee adhesines geïdentificeerd bij H. heilmannii, namelijk HofE en HofF. 
Deze buitenste membraanproteïnen spelen ook een rol in de MUC13 signalisatie in de maag. 
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